Heel Pressure Ulcers: a study of wound healing by McGinnis, Elizabeth
  
 
Heel Pressure Ulcers: a study of wound healing 
 
 
 
 
Elizabeth McGinnis 
 
 
 
 
Submitted in accordance with the requirements for the degree of 
Doctor of Philosophy 
 
 
The University of Leeds 
School of Healthcare 
August 2011 
 
 
 
 
This copy has been supplied on the understanding that it is copyright material 
and that no quotation from the thesis may be published without proper 
acknowledgement. 
 
 
 
-ii - 
Intellectual Property and Publication Statements 
 
The candidate confirms that the work submitted is her own, except where work 
which has formed part of jointly-authored publications has been included. The 
contribution of the candidate and the other authors to this work has been 
explicitly indicated below. The candidate confirms that appropriate credit has 
been given within the thesis where reference has been made to the work of 
others. 
 
The systematic review was co-authored by Nikki Stubbs, Lead Nurse, Tissue 
Viability, Leeds Community Healthcare. My own contributions, fully and 
explicitly indicated in the thesis, have been the writing of the protocol, the 
development of the search strategy, the selection of studies from the list of titles 
and abstracts, the assessment of each study for inclusion according to the 
selection criteria, the production of the data extraction sheet, data extraction, 
identification of the included study, the analysis including the assessment of 
bias and the writing of the review and is the guarantor of the review. 
 
The co-authors contribution was to proof read and approve the protocol, 
collaborating on the development of the search strategy, the selection of 
studies from the list of titles and abstracts, the assessment of each study for 
inclusion according to the selection criteria, data extraction, contacting experts 
in the field and authors of retrieved studies for details of study data specific to 
heel pressure ulcers and missing data, identification of the included study, proof 
reading and approving the review.  
 
A senior podiatrist (Linda Gregory) and Cochrane Wounds Group staff also 
contributed to the development of the search strategy. The strategy was run by 
a member of the Cochrane Wounds Group. 
 
-iii - 
The protocol and review were reviewed by the Cochrane Wounds Group 
referees (David Brienza, Duncan Chambers, Mike Coulson, Madeleine 
Flanagan, Lisa Jones, Ruth Ropper, Janet Yarrow) and Editors, Julie Bruce, 
David Margolis, Joan Webster and Gill Worthy In addition Sally Bell-Syer and 
Ruth Foxlee of the Cochrane Wounds Group and Nicky Cullum, Department of 
Health Sciences, University of York helped in developing the protocol, search 
strategies and review. 
 
-iv - 
Acknowledgements 
This work has been supervised by: 
Prof E Andrea Nelson, Professor of Wound Healing, University of Leeds 
Prof Jane Nixon, Professor of Tissue Viability and Clinical Trials Research, 
Clinical Trials Research Unit, University of Leeds 
Dr Darren Greenwood, Senior Lecture in Biostatistics, Centre for Epidemiology 
and Biostatistics, University of Leeds 
 
Statistical advice was also provided by Dr Samuel Manda and Mrs Theresa 
Munyombwe, Centre for Epidemiology and Biostatistics, University of Leeds.  
 
This research was funded initially by Leeds Teaching Hospitals NHS Trust 
Charitable Trustees Fellowship award and subsequently by a Smith & Nephew 
Foundation/ Multiple Sclerosis Society Studentship 
 
The following person assisted with data collection during the second year:  
Sally Blundell, Research Nurse, Leeds Teaching Hospitals NHS Trust 
 
I wish to acknowledge Professor Nicky Cullum, Department of Health Sciences, 
University of York for her support with the intial preparation of ideas for this 
project. 
 
Thank you also to the patients and staff of Leeds Teaching Hospitals Trust and 
my family without whose support and co-operation this thesis would not have 
been possible.  
 
-v - 
Permissions 
Permission to use images of body positions (figure 1.1) low air loss mattress 
(figure 3.2b), air fluidised bead bed (figure 3.2c) and the mechanism of an 
alternating mattress (figure 3.3) have been granted from Huntleigh Healthcare. 
 
Images (Figures 1.3-1.7) are reproduced with permission from Primal Pictures 
Limited. 
www.primalpictures.com  
All intellectual property rights and copyright remain are maintained by Primal 
Pictures Limited 
 
Permission to copy Figure 1.2 is granted under the terms of the GNU Free 
Documentation Licence, version 1.2 
 
Permission to use images of the, PRAFO boot and Repose heel trough (figure 
3.4), has been granted from their manufacturers. 
 
Permission to use illustration of the foam mattress support surface (figure 3.2a), 
has been granted from Sleep matters.co.uk  
 http://www.sleep-matters.co.uk/Memory-Foam-Mattress/Breasley-Viscofoam-
250-mattress.html a4cessed 26.7.11 
 
 
 
 
 
 
 
 
 
 
 
-vi - 
 
 
-vii - 
Abstract 
 
 
Background 
Heels are a common location for pressure ulcers (PUs); they may be 
physiologically different to other PU sites and their healing is poorly understood.  
Aim   
To summarise the effects of support surfaces and identify prognostic factors in 
healing heel PUs. 
Objectives 
1. Review the effects of support surfaces for heel PU healing 
2. Identify factors which independently impact on heel PU healing 
3. Describe the characteristics of patients, current management practices 
and progress of heel PUs 
 
Methods  
Systematic review of the evidence of effectiveness for pressure relieving 
devices in the treatment of heel PUs. 
Prospective cohort study of patients with heel PUs ≥ Grade 2 in an acute 
hospital and followed for 18 months or up till healed.  
Results  
Systematic review identified 467 potentially relevant articles, retrieved 70 for 
screening and included 1in a narrative synthesis. No recommendations for 
practice could be made.  
Cohort study recruited 140 people with 183 heel ulcers. 77 (42%) ulcers healed, 
88 (48%) did not heal due to death, 5 (3%) were on limbs subsequently 
amputated, 11 (6%) were unhealed at 18 months, 2 (1%) were lost to follow-up. 
Cox proportional hazards models identified 12 significant (p≤0.2) variables 
affecting time to healing in the univariate analysis. Eight entered the 
multivariate model: 2 reached significance (p≤0.1): severe (cf superficial) ulcers 
and the presence of (cf the absence) peripheral vascular disease (PVD) 
reduced the chance of healing. 
-viii - 
Ulcer area did not change in a uniform manner. Treatments e.g. support 
surfaces and dressings were inconsistently used. Many patients experienced 
non-pressure ulcer related infections during the study. 
Conclusion 
It is not known if support surfaces aid heel PU healing.  The severity of the PU 
and the presence of PVD are independent prognostic factors for healing. 
Further work is needed to explore prognostic factors which change over time.  
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Pathology The study of the nature of diseases and especially of the structural 
and functional deviations from the normal that constitute or characterise a 
particular disease 
Pressure Pressure is the force per unit area applied in a direction 
perpendicular to the surface of an object.  
Prevalence This is the proportion of persons with a particular disease within a 
given population at a given time. 
Prognostic factor Demographic, disease-specific, or co-morbid characteristics 
associated strongly enough with a condition's outcomes to predict accurately 
the eventual development of those outcomes  
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Prospective study Study design where one or more groups (cohorts) of 
individuals who have not yet had the outcome event in question are monitored 
for the number of such events which occur over time.  
Retrospective study Study design in which cases where individuals who had 
an outcome event in question are collected and analyzed after the outcomes 
have occurred 
Risk factor A risk factor is a variable associated with an increased risk of 
developing a condition or disease in the first place  
Shear A strain, or change of shape, of an elastic body, consisting of an 
extension in one direction, an equal compression in a perpendicular direction, 
with an unchanged magnitude in the third direction. 
Stepwise regression Variables are entered into the equation based on their 
measured relationship to the dependent variable. Methods include forward 
entry, backward removal, and a combination of forward and backward called 
stepwise 
Abbreviations 
AP Alternating pressure 
support  
NCTV Nurse consultant – tissue 
viability  
CI Confidence interval NPUAP National pressure ulcer advisory 
panel 
CCT Controlled clinical trial PU Pressure ulcer 
CLP Constant low pressure 
support 
PVD Peripheral vascular disease 
DFU Diabetic foot ulcer SD Standard deviation 
EPUAP European pressure ulcer 
advisory panel 
SE Standard error 
LU Leg ulcer TVN Tissue viability nurse 
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Dissemination and publications 
The following conference presentations have been given: 
 
3
rd
 Congress of the World Union of Wound Healing Societies. (2008) Toronto, 
Canada 
Poster presentation: Is the current pathophysiology evidence relevant to heel 
pressure ulcers?  
This paper reviewed the evidence base for the effects of pressure on skin and 
underlying tissues and described it’s relevance to the development of PUs on 
different body sites. Differences between data collected at heels and other sites 
were highlighted. 
 
12
th
 Annual European Pressure Ulcer Advisory Panel (2009) Amsterdam, 
Holland 
Oral presentation: Support surfaces for the healing of heel pressure ulcers: A 
Cochrane Systematic Review* 
This paper presented the results of the systematic review The Preferred 
Reporting Items for Systematic reviews and Meta-analysis (PRISMA) statement 
was used to present the findings of the study.  
 
13
th
 Annual European Pressure Ulcer Advisory Panel (2010) Birmingham, 
England** 
Oral presentation: A review of heel ulcers by comparing the anatomy of the heel 
to other body sites with photographic evidence of heel ulcers to illustrate the 
progress of wound healing 
This paper presented a review of authoritative sources on anatomy and 
physiology of the skin and soft tissue which had identified differences between 
the heels and other pressure ulcer sites. The process of wound healing was 
discussed in context of the anatomy and physiology of the heel. This was 
illustrated with photographic evidence. 
 
Post-graduate research student conference, University of Leeds and accepted 
for oral presentation at the 14
th
 Annual European Pressure Ulcer Advisory 
Panel meeting (2011) Oporto, Portugal: 
This paper will present the findings of the prognostic factor analysis.  
 
The Cochrane Systematic Review has been approved for inclusion in the next 
submission to the Cochrane Library (issue 9, 2011, publication date 7
th
 
September 2011) 
 
*This paper was also presented at the Post-graduate research student 
conference, University of Leeds (2010) 
**This paper was also presented at the 2011 Annual Conference of the Tissue 
Viability Society. Kettering, England 
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Chapter 1 Background 
 
1.1 Introduction 
This chapter describes what pressure ulcers are, why they are important and 
the size of the problem. It then explains how they develop and finally puts 
forward the argument that pressure ulcers on the heels are different from other 
body sites. Many of the papers referenced here are several decades old, these 
are seminal papers. Searches for more recent work have revealed no repeats 
of the experiments or further studies that explore their findings with other 
methods of investigation. 
 
The following chapter describes how pressure ulcers develop and heal and 
explores risk factors for development and potential prognostic factors for 
healing. 
 
1.2 What are pressure ulcers? 
Pressure ulcers have been the topic of at least two international organisations, 
the American National Pressure Ulcer Advisory Panel (NPUAP) and the 
European Pressure Ulcer Advisory Panel (EPUAP). These organisations 
recently collaborated and have agreed a common definition for pressure ulcers:  
 
‘A pressure ulcer is a localised injury to the skin and/or underlying tissue usually over a 
bony prominence, as a result of pressure, or pressure in combination with shear. A 
number of contributing or confounding factors are also associated with pressure ulcers; 
the significance of these factors is yet to be elucidated’ (EPUAP, 2009).  
 
Pressure ulcers usually occur over bony prominences such as the heel and 
sacrum (Dealey, 1991b) where there is little soft tissue, in particular 
subcutaneous fat, to provide padding. They can range in severity from intact 
skin with persistent redness to deep cavities extending down to the bone (see 
section 2.4 for more details). The diagrams in figure 1.1 identify with red dots 
the most common sites on the body where pressure ulcers occur based on the 
persons position. 
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Figure 1.1 Body sites for pressure ulcers, adapted from Huntleigh   
Advanced Clinical Education presentation (2010) 
 
1.2.1 What are heel pressure ulcers? 
The heel is understood to be the back of the foot. The term usually refers to the 
lower, posterior aspect of the foot and extends around the plantar surface. It 
covers the apex of the calcaneum bone. Heel pressure ulcers are injuries 
caused by pressure and usually occur when a person is in the supine or semi-
recumbent position as illustrated in figure 1.1.  
 
1.3 Why are pressure ulcers important? 
Pressure ulcers have a serious impact for the patient on their morbidity and 
quality of life. A systematic review by Gorecki et al (2009) identified the impact 
of pressure ulcers and pressure ulcer interventions on the health related quality 
of life (HRQOL) of adult patients. This review was produced by an international 
panel of experts; it was the first to use robust methods to synthesis the 
research on pressure ulcer related quality of life. The search strategy was not 
specifically stated but was assumed to be very broad, as the large number of 
studies initially identified. The systematic review identifies studies including 
acute, community and long term care populations. However no details are given 
in the review for where on the body the pressure ulcers were or the patients 
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underlying medical conditions. The systematic review identifies a number of 
themes and interventions which cause a substantial burden to patients but does 
not attempt to quantify them.  
 
A study included in the Gorecki et al (2009) review, by Franks et al (2002) sets 
out to quantify the effects in a community population. This appeared to be a 
well executed study that identifies random samples of patients from District 
Nursing caseloads both with (cases) and without pressure ulceration (controls). 
The presence of pressure ulcers was confirmed by clinical examination. 
Patients were then assessed using the SF36 and the modified Barthel Scale. 
Although the study identified that patients with pressure ulcers had a 
significantly poorer physical and social function with a decrease in their mobility 
and ability to self care, than the control group, the overall findings show few 
demonstrable differences. A possible explanation for this could be the validity 
(sensitivity and specificity) of the assessment scales used with this population. 
It is also difficult to infer any causal relationship between the pressure ulcers 
and the decreased mobility as this type of study does not capture the pre-ulcer 
mobility. It is known that poor mobility is a risk factor for pressure ulcer 
development and hence it is expected that people with pressure ulcers have 
lower mobility than those without. 
 
There is much debate amongst experts about whether pressure ulcers are a 
preventable complication (Fox, 2002). A survey of experts in the USA 
demonstrated divergent opinion on this issue (Brandeis, Berlowitz and Katz, 
2001); personal experience of debates on this issue suggest that in an ideal 
world with optimal equipment and care then most pressure ulcers could be 
prevented. However in reality this is not achievable, therefore some pressure 
ulcers are inevitable. More recently in the UK the Department of Health has 
produced definitions of ‘avoidable’ and ‘unavoidable’ pressure ulcers based on 
a position paper by the Wound Ostomy and Continence Nurses Association in 
America (Patient-Safety-First, 2010). This suggests that if all the preventative 
measures that should have been done were not, then the pressure ulcer is 
avoidable. Likewise if the patients’ condition was evaluated, care planned and 
-4 - 
implemented, with monitoring and evaluation, and revised plans if necessary, 
then the pressure ulcer is unavoidable. 
 
Pressure ulcers are used as an indicator of quality of care, particularly in the 
care home setting both in the UK and the USA and as such are subject to 
litigation. Brandeis et al (2001) suggested that the spectrum of opinion over the 
appropriateness of pressure ulcers being a marker of quality supports the 
notion that pressure ulcer development is a complex process affected by a host 
of modifiable extrinsic factors, which makes prediction of risk an unreliable 
process.    
 
The impact for the health care provider is also significant as there is an 
increased use of resources. In the UK one study carried out in 1993 the cost of 
preventing and treating pressure ulcers in a 600-bedded large general hospital 
was estimated at between £600 000 and £3 million per year (Department of 
Health, 1993). A more recent paper (Bennett, Dealey and Posnett, 2004) uses 
data from incidence and prevalence studies and trials to construct a model to 
estimate the cost of treating pressure ulcers. This is given as £1.4 - £2.1 billion 
annually (4% of total NHS expenditure). This paper has detailed explanations of 
the method used to derive costs. As all the data were taken from previous 
studies this presents several concerns over the reliability of costs which are 
partially acknowledged in the study:  
 There is no search strategy given for the identification of studies used to 
calculate healing times and complication rates. It is not known if these 
are a reliable representation of normal healing rates.  
 The data used have not fully taken into account the pressure ulcer 
healing rates i.e. while many ulcers heal within a few months, little is 
know about the duration and subsequent costs of those which take 
longer to heal Most studies of pressure ulcer healing use an endpoint of 
proportion of ulcers healed at a given point in time, there is no 
information on what happens to those which do not heal 
  The relationship between grades; studies by Allman and Fowler (1995) 
and Nixon et al. (2007) have demonstrated a six fold increase in risk of 
subsequent skin breakdown of Grade 1 pressure ulcers. 
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 The use of trials data from intervention studies, where healing occurs in 
a controlled environment, may not be representative of usual care where 
there is greater variability. 
 Despite agreed treatment regimes, the reality that compliance is difficult 
to achieve e.g. data collected during the PRESSURE trial (Nixon et al., 
2006) has indicated that not all pressure ulcers have dressings in place 
all the time. The implication of this would be reduced costs for dressings 
and nursing time, however the healing rates may be extended.  
 
The costs calculated in this study were mostly attributed to nursing time, and 
increased significantly with the severity of the ulcer and the presence of 
complications such as infection. The costs in the study were based on 
institutional care. There is no information on the proportion of patients with a 
pressure ulcer which develops in hospital, then return to their own home and 
continue to receive care. Costs for domiciliary nursing visits are more per 
intervention than institutional costs. No account was taken of costs to the 
patients e.g. laundering costs, bedding, etc. It is likely that this study has 
underestimated the real costs of pressure ulcers. 
 
1.4 The extent of the problem 
The number of people affected by pressure ulceration can be measured 
through incidence and prevalence studies. Prevalence rates measure the 
number of people affected at a certain time or period and are given as a 
percentage of the population studied or at risk. Incidence rates measure the 
number of people who develop a new pressure ulcer during a given period of 
time and are also presented as a percentage of the population studied or at 
risk. The incidence rate gives an estimate of the probability or risk of developing 
a pressure ulcer, whereas the prevalence rate is dependent on the duration of 
ulceration and the incidence rate (adapted from Lilienfeld and Stolley (1994)). 
There are many prevalence and incidence studies published that show large 
variation in the reported rates. Some explanations for these discrepancies have 
been suggested via a systematic review by Kaltenthaler et al (2001): 
 substitution of incidence for prevalence in analysis 
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 use of different classification (of the Grade or severity of the ulcer) 
systems  
 under-reporting of pressure ulcers on transfer from different care 
facilities 
 overestimation of prevalence data by not taking case-mix into account 
 use of pressure ulcers as a measurement of quality, causing under 
reporting 
 use of different study designs (prospective versus retrospective, 
observation versus chart reviews). 
 
The inclusion or not of Grade 1 ulcers (description in section 2.4) affects the 
rates. Grade 1 ulcers are often excluded as they are often difficult to detect and 
this may lead to unreliability of their measurement (Kaltenthaler et al., 2001).  
 
It is important to know when different practitioners use a tool to assess an ulcer, 
that they reach a similar conclusion. Testing inter-rater reliability will identify 
this. Nixon et al. (2005) assessed the reliability of skin classification (all grades) 
and the presence of a pressure ulcer (defined as Grade 2 or above) between 
expert nurses and also between expert nurses and qualified ward-based 
nurses. Some of the methodological problems associated with using 
photographs was reduced by using a process of paired assessments of the 
patient’s skin. They reported 100% agreement for the presence or absence of a 
pressure ulcer in paired assessments by experts, but noted some difficulties in 
the assessment of normal, blanching and non-blanching skin areas. 
Importantly, agreement between experts and qualified ward based nurses 
indicated clinically important differences in reporting the presence or absence 
of a pressure ulcer (ie Grade 2 and above) and high levels of under-reporting 
(39.7%) of Grade 1s by ward-based staff compared to experts.  
 
DeFloor et al (2006) studied intra and inter-rater reliability between nurses 
assessing photographs of skin lesions and pressure ulcers and found intra-rater 
agreement was low (kappa = 0.38). Vanderwee et al (2006) studied nurses and 
researchers assessing patients and found a high level of agreement using a 
transparent disc (91.7%) and ‘light finger pressure’ (92.1%) to detect non-
blanching erythema. Healey 1995, found that reliability was not good especially 
with the lower grades of ulcer (kappa = 0.29 for Torrance scale, kappa = 0.02 
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for Stirling 2 digit scale, kappa = 0.37 for Surrey. This was a small study with 
other limitations e.g. the use of photographs and the lack of training of 
observers,. Bates-Jenson et al. (1992) developed the Pressure Sore Status 
Tool, which was tested for validity and inter-rater reliability. Although this was 
claimed to be high initially only 2 specifically trained nurses were studied. In 
summary, if the tool used to assess the presence of a pressure ulcer or not and 
the grade of the ulcer is not reliable then the interpretation of the results from a 
prevalence or incidence study must be considered with caution.  
 
Studies cited in the Kaltenthaler review have a range of prevalence in UK 
healthcare settings from 4.4% (Hallett, 1996) by a postal survey in a community 
setting to 37% by patient examination in a palliative care setting (Hatcliffe and 
Dawe, 1996). Incidence rates cited range from 2.2% (Bridel, Banks and Milton, 
1996) in a year by medical record examination of a hospital population to 66% 
in 18 months by examination of elderly hip fracture patients (Versluysen, 1985).  
 
These findings confirm as expected that prevalence and incidence are higher 
when the populations studied are more at risk e.g. in settings where patients 
are higher acuity and immobile, and where direct observation is used rather 
than record reviews or self reports. Case mix is suggested by Kaltenthaler et al. 
(2001) as a factor contributing to the variation; a study by Bours (2003) 
proposed a model for case mix adjustment for prevalence studies, taking into 
account factors such as age, sex, nutrition, incontinence. If modelling was used 
to standardise data then useful comparative measures could be obtained. A 
significant cause of variation in the data is due to information being collected 
using secondary sources rather than by patient examination (Kaltenthaler et al., 
2001).  
 
If it is acknowledged that pressure ulcers are mostly a preventable complication 
with prevalence rates up to 18% in UK hospital populations (O'Dea, 1993) and 
costs estimated at up to £2.1 billion annually then it is useful to compare them 
alongside other hospital or health facility complications in terms of scale, 
importance and impact. These include drug errors, hospital acquired infections, 
deep vein thrombosis, pulmonary embolism, etc. If the case of hospital 
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acquired infection (HAI), which has been the subject of much media attention in 
recent years, is compared, prevalence rates for HAI are quoted in the second 
national prevalence survey as 9% (Emmerson et al 1996) with the preliminary 
results from the third national survey carried out in 2006 similar at 8.19% (HIS & 
ICNA, 2007) with an estimated cost of £1 billion per annum (The Patients 
Association, 2010). However this information is interpreted, there is a clear 
indication that pressure ulcers present a significant problem in most healthcare 
settings. 
 
1.4.1 The extent of the heel pressure ulcer problem 
Heel pressure ulcers are mentioned in incidence and prevalence surveys but 
precise numbers for given populations are not well recorded. Studies which 
have included separate data for heel pressure ulcer prevalence are given in 
table 1.1. The numbers given are ‘number of patients with at least one pressure 
ulcer’ of the ‘total population surveyed’. The discrepancies described by 
Kaltenthaler (2001) also apply to this data. 
 
Study Population Prevalence of 
all patients 
with PUs (%) 
Prevalence of 
heel PUs (% 
of all PUs) 
Pearson et al. 
(2000) 
Acute care hospital patients in 
Australia 
40/634 
(6%) 
38% 
Garber & 
Rintala (2003) 
Spinal cord injured US veterans 
living at home 
215/553 
(39%)* 
26%** 
Baumgarten et 
al (2003) 
Newly admitted long term care 
facility residents in US 
208/2015 
(10.3%) 
24.2%* 
Vanderwee 
(2007) 
Acute hospital patients in Italy, 
Belgium, Portugal, Sweden and UK 
1078/5947 
(18.1%) 
26% 
* Three year period prevalence  
** Pressure ulcers on feet: includes malleolli and other sites 
Table 1.1 Pressure ulcer prevalence surveys with proportion of  
pressure ulcers which are on the heel 
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Within the researcher’s organisation the numbers are known for recent years as 
a point prevalence survey is carried out annually. The total number of pressure 
ulcers is given for one day in the year. These are given in table 1.2. 
 
Year Total number of patients with 
PUs (% of all in-patients at the 
time of the survey) 
Total number of heel 
PUs (% of all PUs) 
2006 274 (9.9%) 60 (22%) 
2007 333 (12%) 85 (26%) 
2008 336 (11.9%) 74 (22%) 
2009 557 (12.9%) 107 (19%) 
2010 372 (13.5%) 83 (22%) 
 
Table 1.2 Prevalence of heel pressure ulcers in one acute NHS Trust 
 
One study in the US suggests that prevalence of heel pressure ulcers is 
increasing (Barczak et al., 1997). Two studies have been identified which 
specifically studied heel pressure ulcers. Monaghan et al. (2000) surveyed an 
acute hospital population in the UK and found a prevalence of heel pressure 
ulcers of 1.2% (28 of 2314 patients surveyed). This is low, however the 
population included paediatrics, maternity and a mental health hospital (these 
areas are usually excluded in acute hospital population based prevalence 
studies as the likelihood of pressure ulcers in these specialities is very low) and 
was based on staff report and record review. Campbell et al (2010) in a 
Canadian study of 150 elective orthopaedic and acute hip fracture surgical 
patients found and an incidence of heel pressure ulcers of 13.3%. 
 
1.5 Duration of pressure ulcers 
Information on healing times can be derived from trials of treatment 
interventions or epidemiological studies. There is a lack of precise information 
on time to healing, most studies (interventions or epidemiological) do not follow 
up to complete ulcer healing. There are several possible explanations for this: 
 these wounds can take months/ years or never heal 
 many patients die before their pressure ulcers heal 
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 trial follow-up is not long enough to capture healing of all ulcers 
 
Bennett et al (2004) used the results from 15 trials of pressure ulcer treatments 
to calculate expected healing rates for the different grades of ulcers. They 
suggest mean time to heal for Grade 1 ulcers as 4.06 weeks, Grade 2 ulcers as 
13.4 weeks, Grade 3 as 18.2 weeks and Grade 4 as 22.1 weeks. The studies 
cited vary in length from 4-52 weeks and none of the studies had 100% healing; 
no information is given regarding the study populations, the site of the ulcers 
e.g. sacrum or heel, or whether the remaining ulcers were unhealed or the 
patients died. It is unclear how the mean healing times were calculated; this 
information was not available in the original studies (and could not be 
calculated as healing times were not available for all the ulcers). These results 
may not be generalisable as clinical trials may not be pragmatic i.e. represent 
the ‘normal’ clinical situation: certain patients will be excluded (e.g. those with 
diabetes, those unable or unwilling to consent, patients who do not conform to 
treatment); patients are being monitored so are more likely to receive the 
planned treatment (dressings applied do not always conform to the care plan, 
dressings which ‘fall off’ are not always replaced immediately). The NICE 
guideline CG29 (RCN, 2005) summarises all intervention studies for pressure 
ulcer healing known at the time, none of which use time to healing as the 
primary endpoint.  
 
There are very few prospective cohort studies which look at healing of pressure 
ulcers. This issue is acknowledged by Brown (2003) as the missing component 
of pressure ulcer quality assurance data. A prospective study has been 
identified whose primary aim was to validate a Pressure Ulcer Scale for Healing 
(PUSH) (Thomas et al., 1997). The study population was 23 long term care 
home residents in the USA. Data were collected for 6 months and 21 (66%) of 
the ulcers healed in mean of 5.6 weeks to closure (SD +/- 4.08) with a range of 
2 - 18 weeks. 
 
Two studies have been identified which carried out a retrospective analysis of 
medical records: 
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 Garber and Rintala (2003) studied a cohort of inpatients at a Veterans 
Affairs Medical Centre but specifically looked at those on the Spinal Cord 
Registry. Outcomes were defined as the result of pressure ulcer 
treatment during that year. These were determined from the medical 
records from the time the ulcer first appeared in the first year of the study 
to either healing or the end of the study. Of the 102 patients studied 23 
healed, 54 did not heal, 11 were surgically repaired and 14 were 
unknown. Duration was reported to be between one week and the entire 
3 year duration of the study. 
 Brown (2000) investigated the healing rates of 10 stage 4 pressure ulcers 
of the pelvic area on patients in a Veteran Affairs transitional care unit. 
They found healing times of 90-150 days. This study focused on healing 
trajectories and the relationship between wound area and healing rates 
and only selected patients whose ulcers had completely healed. 
 
This suggests that data on healing times which only includes patients whose 
ulcers completely heal are likely to be an underestimate of the true average 
healing times. 
 
1.5.1 Duration of heel pressure ulcers 
A search for heel ulcer studies which state time to healing has revealed a single 
case study (Clarkson, 2003). This was a patient who had a necrotic heel 
pressure ulcer which, although the patient had an episode of infection, healed 
in six months.  
 
1.6 Anatomy and physiology 
An understanding of the structure and function of the tissues involved in 
pressure ulcer development will enhance an understanding of how they occur. 
 
1.6.1 The skin 
Structurally the skin consists of 2 layers: the epidermis and the dermis. 
Underneath the dermis is the subcutaneous layer, which in turn is attached to 
the underlying tissues and organs (depending on the body site).  
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Figure 1.2 Structure of the skin 
http://en.wikipedia.org/wiki/File:HumanSkinDiagram.jpg accessed 5.12.11 
 
Epidermis 
The epidermis is composed of 5 layers or strata, the outer layer being flat dead 
cells that are constantly shedding (stratum corneum). The next layer is the 
stratum lucidum, which is more apparent in thick hairless skin e.g. palms and 
soles. The next layer is the stratum granulosum, this is the layer where keratin 
is formed. This gives the skin its waterproof and bacterial resistant properties. 
Underneath this sits the stratum spinosum, which have layers of cells with 
prickly spines. The inner layer is the reproductive membrane (stratum 
germinativum) that generates the keratinocytes which then migrate through to 
the outer surface (Tortora and Grabowski, 1996). 
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Dermis 
The dermis is composed of connective tissue containing cells, ground 
substance and fibres. The few cells in the dermis include fibroblasts, 
macrophages, plasma cells, adipocytes and mast cells (Tortora and Grabowski, 
1996).  
 
Collagen and elastic fibres contribute to the skins protection against mechanical 
damage. Within the deeper layers of the dermis, the collagen fibres are 
wrapped around with elastic fibres so that following extension, the elastic fibres 
are able to contract to return the tissue to normal. Studies have shown that 
tissue subject to initial high pressures has a good recovery rate, but periods of 
high pressure lead to realignment of the collagen and elastic fibres into parallel 
bundles (Edsberg et al., 2001). However, as the tissue adapts to abnormal 
loading it is seen to have fewer but thicker collagen and elastic fibres (Edsberg 
et al., 2000). 
 
The varying thickness of the reticular region of the dermis accounts for the 
differences in the thickness of the skin. The reticular region is attached to the 
underlying tissue e.g. bone or muscle by the subcutaneous layer or hypodermis 
(Tortora and Grabowski, 1996).  
 
1.6.2 Fascia 
Two types of fascia are found: superficial and deep.  
The superficial fascia lies immediately under the skin and contains varying 
degrees of areolar or fatty tissue depending on the site and the individual; it 
also connects the skin with the deep fascia (Tortora and Grabowski, 1996). 
Descriptions of the superficial fascia are sparse within general anatomy text 
books although some detail is provided in studies where the author’s interests 
are in correction of deformities i.e. plastic surgeons. A study by Abu-Hijleh et al 
(2006) describes the superficial fascia containing the fatty tissue or panniculus 
adiposus. The nerves, blood vessels and lymphatics pass through this to the 
skin. In certain areas of the body it contains muscles e.g. facial and subareolar 
muscle of the nipple. It is also traversed by strong connective tissue bands 
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which bind the skin to the underlying aponeurosis of the scalp, palm and sole of 
the feet. Although this study confirmed the presence and thickness of a 
membranous fascia in areas of the body studied e.g. thigh, abdominal wall, leg, 
dorsum of foot and arm, these areas are not sites for pressure ulcer 
development.  
 
The deep fascia covers or encloses either muscle layers or bone depending on 
the location. The strength of the fascia adds to the protection from damage of 
the underlying tissue. The deep fascia consists of predominantly collagen fibres 
to provide strength (Tortora and Grabowski, 1996).  
 
1.6.3 Subcutaneous tissue 
This is contained in the superficial fascia. It is made up of areolar connective 
and adipose tissue as well as some sensory nerve endings called lamellated or 
Pacinian corpuscles that are sensitive to pressure. In adults, adipose tissue 
contains relatively few blood vessels; its main function is insulation, energy 
reserve and protection. The depth and type of the subcutaneous tissue 
depends on body location, gender and body type. Soft adipose tissue forms an 
almost continuous layer under the skin. These fat cells are enmeshed in a 
loose fibrous tissue network with large amounts of tissue fluid and a rich 
network of blood vessels and lymphatics. The tissue can be distorted easily and 
slowly regains its shape through the pressure of the tissue fluid. Elastic adipose 
tissue however, is fibrous and firm and able to withstand sudden impacts or 
prolonged pressure. It is found in areas such as the heels, fingertips, and 
ischial tuberosities (Tortora and Grabowski, 1996). 
 
1.6.4 Blood supply 
The blood supply to the skin varies according to the region of the body and the 
age of the individual. The richness of the blood supply is usually attributed to its 
thermoregulatory function rather than the nutritional demands of the organ. 
Ryan, however points out that the blood supply also contributes to the swelling 
pressures of the ground substance, which promotes resilience, and turgor of 
the skin (Ryan, 1969). The arteries and veins are found in the subcutaneous 
layer and these produce capillary loops, which extend into the dermis.  
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1.6.5 Muscle 
Of the common sites for pressure ulcer development, muscle is only found 
overlying the ischial tuberosities (Linder-Ganz et al., 2008). Much work has 
been carried out studying the effects of pressure on muscle tissue both in 
animals and humans. It is important to note that these studies can only be 
generalised to pressure ulcers on this body site. See tables1.4-1.6 for a 
summary of studies. 
 
1.6.6 Bone 
The shape of the underlying bone predisposes certain weight bearing body 
sites to increased pressure. Most of these sites have several things in common: 
they are protruding parts of the body through which the weight of the body is 
transferred to the support surface (depending on the position and posture of the 
body), there is a generally a lack of soft tissue (e.g. muscle, adipose) between 
the bone and the skin, and the contour of the underlying bony structure has a 
small, curved surface area.  
 
The most common body sites are presented here: 
Sacrum (bottom of the spine) 
The sacrum consists of a bony plate at the base of the spine with almost no 
muscle cover. The crista mediana (medial sacral crest) is a spur or prominence 
on the sacrum where the pressure ulcer usually starts. This section has a small 
surface area, and hence pressure may be high when moderate external forces 
are applied (see glossary for definition of pressure). It is the point at which the 
greatest force intensity is applied when a body is supported on an inclined 
surface (semi-recumbent position in bed or chair) (Bader, Barnhill and Ryan, 
1986). 
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Figure 1.3 Bones of the sacrum illustrating the medial sacral crest 
www.primalpictures.com accessed 5.12.11 
 
Ischial tuberosities (buttocks) 
Ischial tuberosities are the names given to two small bony triangular eminences 
at the lower edge of the pelvis, they are points of the skeleton at which the body 
weight is supported when seated. These points provide the attachment for 
several muscles including the Levator ani, the pelvic fascia and the 
sacrospinous ligament, which support the structures inside the pelvis. They are 
partially protected externally by the gluteus maximus muscle layers. 
Figure 1.4 The hip bone illustrating the ischial tuberosity  
www.primalpictures.com accessed 5.12.11 
 
 
Greater trochanter (hip) 
The greater trochanter is the bony prominence at the proximal end of the femur. 
It provides attachment for the muscles of the buttocks (gluteal muscles) and 
those of the thigh (vasti muscles) but is not itself protected by muscle (Tortora 
and Grabowski, 1996). 
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Figure 1.5 The greater trochanter  
www.primalpictures.com accessed 5.12.11 
 
Lateral malleolus (outer ankle) 
The lateral malleolus or ankle is a bony prominence at the lower end of the 
fibula. It provides attachment for talofibular and calcaneofibular ligaments, but 
is not covered by muscles (Tortora and Grabowski, 1996). 
 
Figure 1.6 The lateral malleolus and associated bones and ligaments 
www.primalpictures.com accessed 5.12.11 
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Calcaneum (heel) 
The calcaneum is the bone of the heel. It has a tuberosity at its most prominent 
point where the plantar aponeurosis (thick fascia, along the sole of the foot) and 
the tendo calcaneous (Achilles tendon) are attached; this also has no muscle 
overlying (Tortora and Grabowski, 1996).  
 
Figure 1.7 The calcaneum bone and the ligaments of the foot  
www.primalpictures.com accessed 5.12.11 
 
All these bony sites described act as anchor points for muscles via the tendons 
and aponeuroses. These are inelastic fibres that are composed of albuminoid 
collagen, which are sparingly supplied with blood vessels (Tortora and 
Grabowski, 1996). 
 
1.6.7 Bursa 
A bursa is small pad situated over a bony prominence. Bursae are sacs filled 
with synovial fluid and help with cushioning between bones, muscles, tendons. 
Of the pressure ulcer sites they are found on the ischial tuberosities, trochanter 
head and calcaneum (Tortora and Grabowski, 1996). 
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1.6.8 The anatomy and physiology of the heel 
The above section has identified that variations exist with different body sites. 
Table 1.3 highlights some of the specific anatomic differences noted between 
the heel and other body sites. 
 
Tissue type Feet/ Heels Other sites Comment 
Epidermis Thicker stratum 
lucidum (1.4mm) 
Average thickness of 
stratum lucidum is 
0.1mm 
Appears thicker but 
looks transparent 
over heel 
Dermis 
Reticular 
region 
 
 
 
 
Sebaceous 
glands 
 
Eccrine sweat 
glands 
 
Hair follicles 
Reticular region 3 
mm or more thick 
 
 
 
 
 
Absent 
 
 
Abundant 
 
 
Absent 
Varying thickness 
across body but 
much less than 
plantar surface of feet 
 
 
 
Present 
 
 
Reduced or absent 
 
 
Present, but depends 
on site 
High number of 
collagen and elastic 
fibres in heel 
reticular region allow 
extensibility and 
elasticity 
 
No natural lubrication 
to keep skin supple 
 
Sweat assists with 
temperature 
regulation 
Subcutaneous 
tissue 
 
 
Elastic adipose 
tissue found under 
heels: fibrous and 
firm, able to 
withstand sudden 
impact or prolonged 
pressure 
 
Abundance of 
Pacinian corpuscles 
to identify pressure 
Soft adipose tissue is 
enmeshed in loose 
fibrous tissue, can be 
distorted easily and 
slowly regains shape 
 
 
 
Sparse Pacinian 
corpuscles in most 
areas 
Elastic adipose 
tissue also found 
under ischeal 
tuberosities 
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Blood supply Rich blood supply Varied depending on 
body site 
Contributes to the 
swelling pressures of 
the ground 
substance which 
promotes resilience 
and turgor of skin 
Nerve supply Rich nerve supply Varied depending on 
body site 
 
Muscle No muscle over 
calcaneum 
Muscle partially 
covers ischeal 
tuberosities when 
seated 
Trochanter, sacrum 
and malleolli also 
have no muscle 
cover 
Tendons and 
aponeuroses 
Attached and partly 
covering the 
calcaneum 
Also have some 
tendons and 
aponeuroses 
Inelastic fibres 
composed of 
collagen, sparingly 
supplied with blood 
vessels 
Superficial 
fascia 
Dense over the heel 
and contains loculi of 
fat in the fascial 
pockets (makes skin 
firm and resilient) 
Contains varying 
degrees of areolar 
tissue 
 
 
Connects the skin 
with the deep fascia 
(the deep fascia 
generally encloses 
the muscles) 
Deep fascia Thickened over heel Usually encloses 
muscles 
Thickened fascia 
offers extra 
protection from 
pressure and shear 
(adapted from Tortora and Grabowski (1996) 
 
Table 1.3 Summary of differences between the anatomy and  
physiology of heel and other body sites 
 
1.7 Aetiology: How do they develop? 
Injuries due to pressure can affect any tissues of the body. However damage to 
soft tissue occurs more easily than to bone due to the relative resistance of the 
structures. Damage to internal organs due to external forces is also less likely 
as they are mostly protected by bony structures or muscle. The use of the term 
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‘pressure ulcer’ is usually restricted to injuries of the skin and subcutaneous 
tissue. 
 
The external forces that are applied to the body which cause pressure 
ulceration are defined as pressure, shear and friction. In terms of the effects on 
the structure and function of soft tissues these will be considered separately 
although in a clinical situation shearing and friction cannot cause damage 
without pressure. 
 
The incidence and prevalence of pressure ulcers have changed very little in 
recent years despite considerable advances in devices designed to offload the 
pressure. Some experts would justify this with the lack of knowledge of the 
aetiology of their development. A review of the evidence identifies many gaps in 
our understanding of the pathophysiology. 
 
1.7.1 Pressure 
Direct or localised pressure, occurring at the interface between the body and a 
support surface e.g. a bed or chair, due to the weight of the body and gravity 
will compress any skin and soft tissue found between the bone (hard resistant 
surface) and the external surface.  
 
The effect of pressure on tissues has been studied extensively but not 
systematically. Tables 1.4 – 1.6 summarise some examples of some of the 
seminal studies, which are cited as evidence of our understanding of the effects 
of pressure. 
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Study Type of cell/ tissue Outcome measure Method of testing Findings 
Compressive deformation and 
damage of muscle cell 
subpopulations in a model 
system (Bouten et al., 2001) 
Seeded mouse 
skeletal myoblasts 
cells grown in an 
agarose construct to 
grow myoblasts with 
multinucleated 
myotubes 
Deformation index - Visual 
assessment and 
measurement of 
deformation using 
confocal microscopy 
Cell damage assessed 
from evidence of 
membrane disruption or 
nuclear pyknosis or 
fragmentation calculated 
as % of damaged cells 
per total number of cells 
Myoblasts and myotubes showed 
significant difference in 
deformation at 20% strain but less 
difference at 40% strain 
Cell damage was significantly 
higher in strained constructs than 
controls 
The etiology of pressure 
ulcers: skin deep or muscle 
bound? (Bouten et al., 2003) 
Seeded skeletal 
muscle cells 
Evidence of nuclear or 
membrane damage 
Bespoke loading 
apparatus 
Cell damage increases with the 
magnitude and duration of 
pressure 
An in vitro model system to 
study the damaging effects of 
prolonged mechanical loading 
of the epidermis (Bronneberg 
et al., 2006) 
Engineered human 
epidermis equivalent 
 
Histological examination, 
viability of cells 
(mitochondrial function) 
and the release of a pro-
inflammatory mediator 
Bespoke loading 
apparatus 
2 hour loading increased 
inflammatory markers but no 
visible damage. 20 hours loading 
gave visible tissue damage and 
reduced cell viability 
Table 1.4 In vitro studies of the effects of pressure 
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Study Type of cell or 
tissue 
Subject 
description 
Outcome measure Method of testing Findings 
Etiology and pathology 
of ischemic ulcers 
(Kosiak, 1959) 
Soft tissue 
over the 
femoral 
trochanter or 
ischial 
tuberosity 
Healthy 
dogs 
Blood tests  
(haemoglobin, 
heamatocrit, 
sedimentation rate, 
serum proteins) 
Air driven piston 
monitored with 
pressure adjustment 
mechanism 
Time plotted against pressure produced 
a parabolic curve correlation showing 
an inverse relationship 
No correlation with nutritional status 
was found 
Microscopic examination suggests 
changes due to pressure occur in 
tissues at all depths to bone 
Etiologic factors in 
pressure sores: an 
experimental model 
(Daniel, Priest and 
Wheatley, 1981) 
Soft tissue 
over the 
femoral 
trochanter 
(skin, adipose, 
fascia lata, 
muscle) 
Healthy pigs Photo and visual 
assessment of 
incisional cross 
section of tissue. 
Visual histological 
analysis. 7 days post 
injury 
Electromechanical 
pressure applicator 
on an immobile 
animal 
Muscle damage: high pressure short 
duration or low pressure long duration 
(no damage visible externally) 
Muscle and deep dermis damage: high 
pressure long duration or low pressure 
prolonged duration (no damage visible 
externally) 
Muscle and skin damage: long duration 
(visible skin lesion) 
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Etiologic factors in 
pressure sores: an 
experimental model 
(Daniel, Priest and 
Wheatley, 1981) 
Soft tissue 
over the 
femoral 
trochanter 
(skin, adipose, 
fascia lata, 
muscle) 
Paraplegic 
pigs 
Not stated Not stated ‘significant diminution of the pressure-
duration threshold’ 
Ischemia-reperfusion 
injury in chronic pressure 
ulcer formation: a skin 
model in the rat  (Peirce, 
Skalak and Rodeheaver, 
2000) 
Skin on the 
back 
Healthy rats Skin blood flow, % 
necrosis, trans-
cutaneous oxygen 
tension, leucocyte 
extravasation 
Implanted steel sheet 
under the skin, 
pressure applied via 
a magnet 
Laser Doppler flow 
meter, digital 
photographic 
analysis, Dual 
Channel Monitor, full 
thickness skin 
biopsies 
Results suggest that extent of tissue 
damage was attributable to total 
number of ischaemia/ reperfusion 
cycles, duration of ischaemia, and the 
cycle frequency, not all results 
supported this but the authors explained 
it through the testing procedure. (blood 
flow was measured over the whole of 
the wound surface - reading of 0 when 
necrosed, TcPO2 was taken part way 
along the surface) 
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Pressure sores - the 
problem (Brand, 2006) 
Foot pad Healthy rats Histological 
examination upon 
autopsy 
‘Walking simulator’ 
applying repeated 
pressures of 
1.5kg/cm
2 
Greater no. of repetitions led to greater 
temp. differential and longer to return to 
normal 
Stress (repeated daily applications of 
pressure) led to increase oedema, 
inflammation, cell separation in 
epidermis and then subcutis necrosis 
and adjacent hypertrophy 
Less ‘stress’ (lower pressures applied 
daily for 6 weeks with weekend breaks) 
led to hypertrophy with minimal 
inflammation and necrosis 
A new MR-compatible 
loading devise to study 
in vivo muscle damage 
development in rats due 
to compressive loading 
(Stekelenburg et al., 
2006) 
Tibialis anterior 
region 
Healthy rats Visual and MRI 
identified histological 
changes in muscle 
tissue during and after 
load application 
MR compatible 
loading devise 
Segmental necrosis was identified, loss 
of cross-striation 
Abnormal MR signal intensity 
associated with damaged muscle. 
 
Table 1.5 In vivo animal studies of the effects of pressure 
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Study Type of cell or 
tissue 
Subject 
description 
Outcome measure Method of 
testing 
Findings 
Micro-injection studies of 
capillary blood pressure in 
human skin (Landis, 1930) 
Capillaries in the 
skin of nail bed 
Healthy humans Closing pressures  Capillary closing pressure of 
32mmHg 
Experiences at Rancho los 
Amegos hospital with 
devices and techniques to 
prevent pressure sores 
(Reswick and Rogers, 
1976) 
Soft tissue over 
bony prominences 
(predominantly 
ischial tuberosities) 
Spinally injured 
patients 
Interface pressure 
measurements 
Supported by 
(subjective) clinical 
opinion and 
observations of 
potential and actual 
skin breakdown 
Clinical 
measuring 
system (sensor 
element with 
sphygmo-
manometer) 
A ‘guideline’ pressure time 
curve with acceptable 
maximum pressures over bony 
prominences 
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The recovery characteristics 
of soft tissues following 
repeated loading (Bader, 
1990) 
Soft tissue over 
sacrum or ischial 
tuberosities 
Healthy and 
debilitated 
humans 
Surface oxygen and 
carbon dioxide levels 
a)indentor applied 
to skin of sacrum 
b) dynamic 
sequential 
pressure relieving 
cushion 
pO2 at sacrum drops with 
pressure but recovery 
increases over time with 
healthy individuals. 
Recovering with relief of 
pressure but continues to drop 
with debilitated individuals. 
pO2 of healthy seated 
individual recovering to normal 
after 25 mins. of sequential 
pressure 
pO2 of debilitated individuals 
show varying responses 
Sweat analysis following 
pressure ischaemia in a 
group of debilitated subjects 
(Polliack, Taylor and Bader, 
1997) 
Skin over the 
sacrum 
Patients with 
severe and 
multiple 
physical 
disabilities 
Sweat metabolite 
concentrations 
Sweat pads 
applied to the 
patients sacrum 
Median lactate and urea 
concentrations were 16 and 
40% higher respectively. 
Wide variations in all 
metabolite concentrations 
were noted. 
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Blood perfusion hyperaemia 
in response to graded 
loading of human heels 
assessed by laser-Doppler 
imaging (Mayrovitz, 
Macdonald and Smith, 
1999) 
Heels Healthy 
volunteers with 
no arterial 
disease or 
diabetes 
Hyperaemic responses 
and tissue recovery 
times 
Laser Doppler 
imaging following 
fixed load 
pressure 
All heel loads and durations 
resulted in hyperaemic 
responses, largest response 
with loads between 60-120 
mmHg. Recovery times 
increased with load duration 
and magnitude 
The effects of pressure 
loading on the blood flow 
rate in human skin (Daly et 
al., 2006) 
Medial surface of 
the forearm 
7 Healthy young 
subjects 
Skin blood flow rates 
(derived form the Xe 
isotope clearance) 
Pressure loading 
devise and 
gamma isotope 
counter 
Flow rates dropped drastically 
between 0 and 15 mmHg then 
dropped again after 30mmHg 
Strains and stresses in sub-
dermal tissues of the 
buttocks are greater in 
paraplegics than in healthy 
people during sitting 
(Linder-Ganz et al., 2008) 
Gluteus muscle and 
fat tissue under the 
Ischial tuberosities 
6 healthy and 6 
paraplegic 
volunteers 
Compression, tension 
and shear strains were 
measured 
MRI imaging All parameters were 
significantly higher in the 
paraplegic individuals than the 
healthy ones 
 
Table 1.6 In vivo human studies of the effects of pressure
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Tissue deformation has been studied at different levels: 
 Cellular: different cell types can be cultured e.g. skin, muscle and subject 
to pressure e.g. (Bouten et al., 2003) 
 Functional cellular units: these can also be grown in a laboratory e.g. 
blood vessels, intracellular matrix e.g. (Bronneberg et al., 2006)  
 Composition of tissues: although each cell is subject to pressure, in the 
body there is likely to be interaction between tissue types, the effects of 
deformation will depend on the proportion and shape of the tissues over 
the bone. Deformation can be seen through Magnetic Resonance 
Imaging (MRI) and computerised modelling of tissues e.g. (Stekelenburg 
et al., 2006; Gefen, 2007)  
 
When animals are used to simulate pressure damage in humans they can be 
categorised into loose skin and fixed skin. Animals such as dogs, rabbits and 
mice have loose skin where as pigs have a fixed skin which is more like human 
skin. The density of hair growth through the skin is also different for loose 
skinned animals. Their skin is predominantly made up of hair follicles. The 
density of hair follicles in pigs is similar to humans. The clinical relevance of the 
study will be affected by the type of animal; the particular body site (whether 
skin or muscle is included); a healthy or debilitated individual; or a laboratory 
reconstruction of a body site is studied. Some examples of animal studies are 
summarised in Table 1.5. 
 
To study the effects on in vivo human tissue would require histological 
examination; it is unethical to biopsy an area of damaged tissue and create a 
wound where a pressure ulcer is likely to occur. One study of cadavers has 
been identified, the aim of this study however was to identify osteoporosis in 
the underlying bone (Turk, Tsokos and Delling, 2003). A study by Smalls et al. 
(2006) looked at differences in skin thickness and its biomechanical properties 
(elasticity, deformation, laxity, energy absorption) in 30 women volunteers on 3 
body sites (shoulders, calves and thighs). Significant differences were found 
between body sites for most properties tested. Although this study used a small 
number of mainly young healthy women the variations shown leads one to 
question the generalisability of results obtained from studies of a tissue on a 
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particular body site or individual to other pressure areas or individuals in 
different health states. Some examples of human studies are summarised in 
Table 1.6 
 
Additional comments on the studies cited in tables 1.4-1.6 are given here: 
In Bouten’s study (2001), deformation measured was only 2 dimensional, it 
probably needed to be a 3 dimensional reconstruction to look at whole cell 
shape. Predictions of cell deformation are based on the assumption that the 
cell behaves like an incompressible solid but this proved not to be the case at 
higher strain levels. The authors postulated reasons for differences in response 
to high stresses of the two cell types e.g. different diameters, reorganisation of 
nuclei, lack of mechanical homogeneity of the cell membrane. Cell damage was 
recorded as membrane disruption or nucleus damage but did not distinguish 
between the two in the results. Cell strength is also thought to be based on the 
integrity of the cytoskeleton.  
 
In Bader’s study (1990) it was noted that sacral pressure testing was carried out 
on 14 individuals and ischial seating test on 28 individuals. Results quoted are 
for only 6 patients. 
 
Tissue perfusion involves providing adequate nutrition and respiration at the 
cellular level. Pressure is thought to cause both collapse of the larger vessels 
and micro-vascular trauma which results in either haemorrhage or multiple 
micro-thrombi (Lowthian, 2005). The occlusion results in anoxia and cell death. 
 
Sustained pressure on tissues is thought to result in a gradual sideways flow of 
the interstitial fluid and ground substance. This will reduce the interstitial 
pressures; this in turn will lead to a rupture of cells and capillaries (Witkowski 
and Parish, 1982). 
 
The lack of venous and lymphatic drainage has been demonstrated by Miller 
and Seale (1981). The effect of this is assumed to be toxicity due to the build 
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up of metabolic wastes but no studies have documented this. 
 
Reperfusion injury as a possible effect of pressure on tissues in the skin has 
been suggested based on the evidence in cardiovascular ischemic assault. The 
injury when the pressure is removed is thought to be mediated by oxygen free 
radicals, which exacerbate the tissue damage (Bouten et al., 2003). 
 
Despite the limitations of the in vitro/in vivo animal and human studies, they 
have led to theories of the mechanisms of pressure and its effects on tissues. 
Pressure is thought to affect the tissues in several different ways: 
 Tissue deformation 
 Lack of blood supply (ischaemia) 
 Impaired interstitial flow 
 Lack of venous and lymphatic drainage 
 Possible reperfusion injury 
 
Pressure causes deformation of the tissues, the intensity and duration of the 
pressure has been found to be inversely proportional to tissue breakdown i.e. 
high intensity or prolonged duration increase the risk of tissue breakdown 
(Reswick and Rogers, 1976). The precise magnitudes have not been defined 
as these vary between individuals.  
 
1.7.1.6 Individual patient characteristics 
It is acknowledged in some papers that the precise level at which damage 
occurs is not generalisable due to variation between patients (Bouten et al., 
2003; Bridel, 1993a). 
 
Examples of factors which are reported, but not actually measured, in the 
studies to alter tissue’s ability to resist damage include: atrophy of soft tissue 
coverage associated with paraplegia; destruction of deep muscle and 
subcutaneous tissue with scar replacement following repeated pressure loads; 
extension of tissue necrosis due to secondary infection (mentioned in Daniel 
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1981 but not referenced); oedema due to increased interstitial fluid resulting in 
increases distance from capillary to cell (rate of diffusion of oxygen and 
nutrients) (mentioned in Kosiak’s (1959) theoretical paper); anaemia affecting 
the supply of oxygen which will be diminished with poor haemoglobin, also 
ischemia (Kosiak 1959) ; temperature and nutritional status (mentioned in 
Bouten (2003) but not referenced). Some of these are deductions from the 
anatomy and physiology; others are studied as risk factors and will be 
discussed in a later section. 
 
In summary it appears from the research findings available that: 
 there is no specific pressure at which tissue damage is certain to occur 
(Bridel, 1993a) 
 extent of damage is increased with intensity and duration (Reswick and 
Rogers, 1976)  
 repeated pressure can result in less damage if below a certain threshold 
(Bader, 1990) 
 repeated pressure above a certain threshold will lead to more damage 
than a single period of sustained pressure (Bader, 1990) 
 damage from repeated pressure may be due to inflammatory processes 
during reperfusion (Brand, 2006) 
 damage to the tissues is from cell compression and rupture; vascular 
and lymphatic damage (Bader, Barnhill and Ryan, 1986) 
 pressure affects skin and muscle tissue differently: different pressures 
are tolerated and damage occurs to the exoskeleton of muscle where 
the hemidesmosomes and tonofilaments between cells are affected 
(Stekelenburg et al., 2006) 
 the variables that affect this pressure include:  
o type of cells and tissues affected (Edsberg et al., 2000) 
o the area over which the pressure is applied (Husain, 1953) 
o the individuals posture (Linder-Ganz et al., 2008; Gefen, 2007) 
o underlying pathological processes which affect the tissues (Bridel, 
1993a) 
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1.7.2 Shear 
As pressure is defined as a force perpendicular to the skin surface, shear is the 
force parallel to the skin surface (Oomens, Loerakker and Bader, 2010). The 
clinical application of shearing occurs when soft tissue slides over bone. This is 
seen when a person is in a semi-recumbent position. The force of gravity tends 
to cause the person to slide down in the bed or chair. This force is opposed by 
the pressure and friction at the points of contact with the support surface 
resulting in the soft tissue resisting gravity and leading to shearing. 
 
There have been several studies on the effects of shear. The same issues arise 
regarding the generalisability of their findings; the authors of in vitro studies 
would argue that these methods are necessary in order to examine the effects 
of shear in isolation from pressure because this cannot be performed in vivo. 
Most studies identified relating to shear within tissues used sheer caused 
during deformation from applied perpendicular pressure rather than sheer in 
isolation from pressure. Other studies identified are summarised in the table 
1.7. 
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Study In vitro/ 
in vivo 
Type of 
cell or 
tissue 
Type of 
participant 
Outcome 
measure 
Method of testing Findings 
Effects of externally applied skin 
surface forces on tissue vasculature 
(Bader, Barnhill and Ryan, 1986) 
Probably 
in vivo 
 Healthy 
humans 
Collapse of 
superficial micro-
vasculature 
Skin stretching 
device on forearm 
Tissue vasculature 
assessed by vital 
capillary microscopy 
Occlusion of vessels 
occurred at a mean 
force of 1.33 N/mm 
and 10% strain 
Upon release of shear 
normal blood flow was 
restored even after 6 
mins. strain 
Stretch-mediated release of 
angiotensin II induces myocyte 
apoptosis etc (Leri et al., 1998) 
In vitro Rat 
myocytes 
from heart 
muscle 
 Apoptosis as seen 
under confocal 
microscopy 
Cell cultures 
adhered to a rubber 
substrate then 
stretched with 
equibiaxial stretch 
apparatus 
Apoptosis occurred 4 -
12 hours after 
stretching, no effects 
seen at 10, 30 mins. 
or 2 hours. 
A proposed pathway 
for the role of 
angiotensin II in cell 
death 
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Influences of external forces (pressure 
and shear) on superficial layers and 
subcutis of porcine skin and effects of 
dressing material: are dressing 
materials beneficial for reducing 
pressure and shear forces in tissues 
(Ohura, Takahashi and Ohura, 2008) 
In vitro Porcine 
skin 
 Maximum shear 
force when 
different dressings 
were compared to 
control skin 
1 Kilogram weight 
pulled across 
surface, measured 
with a strain gauge 
sensor under skin 
Shear force in 
subcutaneous tissue 
less than in superficial 
layer 
Dressings reduced the 
shear forces 
 
Table 1.7 Table of studies of shear forces 
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It is noted that the study by Bader & Barnhill & Ryan (1986) only looked at 
strain without pressure and only measured effects on blood vessels, no other 
cells were studied. 
 
The initial effect of shearing is the rupture of the vascular and lymphatic vessels 
in the skin and subcutaneous tissue. In the subcutaneous tissue the vessels 
are mostly parallel to the skin, however in the planes of the deep fascia and 
intramuscular septa they follow ligaments and nerves (Tortora and Grabowski, 
1996). This makes them vulnerable to distortion. Although the vessels in the 
dermis are more tortuous and less vulnerable in themselves, if deep vessels 
are damaged they will inevitably affect those in the dermis due to the lack of 
blood supply. 
 
1.7.3 Friction 
Friction forces occur when two surfaces rub together, this happens clinically for 
example when a person is slid up the bed during repositioning. The contact 
between the skin and the support surface can cause trauma to the epidermis 
and eventually the dermis. A study by Dinsdale (1974) demonstrated in pigs 
that a reduced pressure threshold is required for pressure ulcers to develop in 
the presence of friction. No human studies have been identified. The effects of 
friction are magnified by moisture (clinically this is due to incontinence or 
perspiration); this was demonstrated by Flam (1990) who found that moisture 
increased the abrasion of the skin when subject to friction. 
 
It is suggested by Allman (1989) that friction and shear are most important in 
the development of superficial skin breakdown, whereas the effects of pressure 
and shearing begin in deeper tissues and spread up to the surface. He also 
suggests that friction and moisture produce their most harmful effects in the 
presence of excessive pressure. 
 
1.7.4 The relationship between aetiology and severity of the pressure 
ulcer 
For a detailed discussion of severity and grading see section 2.4. The 
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relationship between the nature of the damage and the severity of the ulcer has 
yet to be fully explored. From the studies identified, the damage to muscle 
tissue has been subject to the most scrutiny; however the pathophysiology of 
Grade 1 ulcers is probably still the most controversial. Histological changes 
were noted by Witkowski and Parish in 1982 when they compared biopsies of 
normal skin and non- blanching erythema. A study by Nixon et al. (2005) 
identified high blood flow of differing intensities between blanching and non-
blanching erythema of the skin over sacrum and buttock regions following the 
removal of pressure. Studies of friction are pertinent to Grade 2 ulcers as these 
include blisters and superficial skin breakdown. Shearing forces will affect the 
skin and deep tissue although Bader and Barnhill’s (1986) study of healthy 
humans suggest no sustained damage to skin. 
 
1.7.5 Disease processes that specifically affect the heel 
It has already been suggested in section 1.7.1.6 that systemic disease and 
homeostatic variations can affect tissue tolerance to pressure. There are 
particular clinical situations that affect the lower extremities more than other 
sites where pressure ulcers occur, which are likely to lead to change in duration 
of pressure or tissue tolerance.  
1.7.5.1 Circulatory – Peripheral arterial disease 
The circulation to the lower limbs can become compromised due to arterial 
diseases such as atherosclerosis. Although associated with increasing age 
poor circulation is seen in younger people particularly in association with factors 
such as smoking, diabetes and hypertension (Vogt, Wolfson and Kuller, 1992). 
The internal capillary pressures reduce and if subjected to external pressure 
are not able to respond appropriately to prevent occlusion. This was reported in 
the seminal work by Kannel and Shurtleff (1973). 
1.7.5.2 Neurological  
Neuropathy (reduced or altered sensation) has been identified as a risk factor 
for ulceration in the feet of people with diabetes (McNeely et al., 1995). 
Neuropathy is also known to be associated with other diseases such as stroke, 
pernicious anaemia, spina bifida and multiple sclerosis although its precise 
prevalence is unknown (Neale et al., 1981). Although no published papers have 
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been identified so far, data collected during a study of pain in leg ulcers (Briggs, 
2003) has shown that many older people have some degree of neuropathy of 
the lower limbs. The presence of neuropathy may result in a person being 
unaware of pressure and, therefore, not responding to it (Raney, 1989). 
1.7.5.3 Structural 
Structural changes are seen in conditions such as Charcot foot in diabetic 
patients. The foot is often a site for trauma and fractures in all patients leading 
to changes in shape and potential pressure points. Gefen(2010) demonstrated 
through mathematical modelling that atypical anatomy such as a heavier foot 
with a sharp posterior calcaneum results in higher internal pressures on the 
tissues. 
1.7.5.4 Oedema  
Oedema is the presence of excess extra-cellular fluid which causes localised 
swelling. It is associated with peripheral vascular disease, especially venous 
incompetence (Cho and Atwood, 2002), the effects of gravity on a dependent 
limb and other physiological changes (Ciocon, Fernandez and Ciocon, 1993). 
The presence of oedema compromises tissue perfusion and removal of waste 
products (Ryan, 1969). Also, the weight of the extra fluid in the feet is likely to 
result in normal resting pressures being exceeded; which may have an impact 
on tissue tolerance of pressure (Gefen, 2010). 
1.7.5.5 Diabetes 
Although all the above clinical situations may apply in patients with diabetes, 
the additional feature of micro-vascular dysfunction is thought to be an 
important factor that affects the risk of ulceration to the foot. The processes 
involved are summarised and the evidence critiqued in a review by Chao and 
Cheing (2009). This review suggests hyperglycaemia is the central causative 
factor as it results in impaired vascular permeability, vascular tone and the 
auto-regulation of blood flow. Chronic hyperglycaemia results in structural and 
functional changes in nerve microvasculature with diabetic peripheral 
neuropathy and impaired inflammatory response. 
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1.8 Summary  
Pressure ulcers are a major health problem causing distress to patients and 
costs to the health care provider. They occur predominantly on load bearing 
body sites where there is a bony prominence with the lower body and the heel 
being the most common sites. Information regarding how long they take to heal 
is sparse. This is most likely because of the long duration, high mortality rates 
in this affected population and studies of insufficient duration.  
 
A review of the anatomy and physiology of the potential body sites affected has 
shown the similarities e.g. underlying bony prominences with small surface 
areas and differences e.g. only the ischial tuberosities have noticeable muscle 
present.  However particular differences are noted for the tissue organisation at 
the heel.  
 
The exact pathophysiology of pressure ulcers is unknown, probably because of 
the difficulties in researching this topic area: in vitro studies at a cellular level 
cannot capture the complex interactions of tissues. Animal models do not have 
similar enough skin structure and healthy human subjects do not present with 
the altered tissue ability to resist damage that is found in the potential pressure 
ulcer population; caution needs to be taken in generalising findings from these 
studies.  
 
The differences between feet and other body sites in terms of anatomy, 
distribution and density of structures and blood supply, mechanical properties 
and potential for being affected by disease processes has been demonstrated. 
Pressure ulcers occur on the heel as it is a small surface area which can be 
subject to high pressures when the body is in a supine position or seated with 
the heels on a stool. Heel pressure ulcers are worthy of specific scrutiny in 
terms of prevention and healing. This will be presented in the next chapter. 
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Chapter 2 Pressure ulcer healing and prognostic factors 
 
2.1 Introduction 
In order to understand the healing process for heel ulcers and reveal what is 
already known about this topic some fundamental concepts need to be 
presented and the evidence to support them discussed. The order in which 
these are presented has been a difficult choice as there is no logical 
progression for understanding. Should the explanation of grading/ severity 
precede or follow the type of tissues found in the ulcer? The reader is advised 
to consider all sections of this chapter together to build a picture of heel 
pressure ulcer healing.  
 
This chapter firstly clarifies some definitions that are used in the wound healing 
literature. It then describes the traditional model of wound healing in section 
2.3. In section 2.4 it explains how pressure ulcers are classified in terms of their 
depth or severity. It explores what is specifically known about pressure ulcer 
healing in section 2.5. Section 2.6 relates the theory of healing to what is seen 
clinically as types of tissues in the pressure ulcers. There are many factors 
thought to influence pressure ulcer healing. These are discussed in section 2.7. 
 
2.2 Definitions: healing intention, acute and chronic wounds, 
partial and full thickness wounds 
Healing by primary (or first) intention was defined by Roper in 1987. It is said to 
occur when the edges of a clean wound are accurately held together, healing 
occurs with the minimum of scarring and deformity. Examples of wounds 
healing by primary intention are surgical incisions or clean traumatic wounds 
with minimal tissue loss. They are usually held together by sutures, staples, 
tape or glue.  
 
Healing by secondary intention (Roper, 1987) is said to occur when the edges 
of the wound are not held together, the gap is filled by granulation tissue before 
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epithelium can grow over the wound. These are usually wounds which have 
large amounts of tissue loss or high bacterial levels e.g. abscess, leg ulcers or 
pressure ulcers. 
 
Acute wounds are understood to be new wounds such as surgical incisions or 
traumatic injuries. They progress through stages of wound healing described in 
section 2.3.  
 
Chronic wounds have various definitions; most of them refer to the time taken 
for a wound to heal regardless of the cause e.g. any wound which has failed to 
heal within three months (Mustoe, 2005). Alternative definitions describe 
chronicity in terms of wound type e.g. leg ulcers, pressure ulcers and diabetic 
foot ulcers (Brem et al., 2003) as these wounds are associated with long 
healing even though they may heal in less than three months Difficulties arise 
when dealing with acute wounds e.g. surgical incisions or burn that take longer 
than 3 months to heal. 
 
The terms ‘partial thickness’ and ‘full thickness’ wounds are often used when 
the process of wound healing is being discussed. Their origin is probably from 
texts on burns wounds where the terms are most commonly used but an 
original definition has not been identified. Alterescu and Alterescu (1992) note 
that a ‘partial thickness’ wound is one which only penetrates the epidermis, but 
not the entire dermis, whereas a ‘full thickness’ wound penetrates the epidermis 
and the dermis. The clinical implications of this differentiation are that because 
the dermis does not regenerate, full thickness wounds will need to contract, 
granulate and epithelialise which will result in a scar whereas partial thickness 
wounds only need to epithelialise to regenerate normal epidermis and there is 
no resultant scarring. The relevance of this to pressure ulcers is discussed in 
section 2.6. 
 
2.3 Classic model of wound healing 
Wounds are usually described as a break in the integrity of the skin. To 
understand what will affect the healing of pressure ulcers, knowledge of the 
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wound healing process is required. The stages of wound healing are described 
in similar ways in many text books. However the duration and significance of 
each stage is rarely discussed for different wound types e.g. pressure ulcers, 
surgical wounds, leg ulcers, etc. The knowledge about wound healing in 
humans was noted to be incomplete in 1975 (Lindstedt and Sandblom, 1975). 
A review of the evidence since this time suggests that gaps still exist. Many 
similarities exist between connective tissue healing in animals and humans, but 
it is not possible to completely transfer the information from animal experiments 
to humans.  
 
The following summary is primarily adapted from a review paper by Broughton 
et al (2006), written by plastic surgeons. This is a well referenced and detailed 
account that includes details of chemical factors associated with impaired 
wound healing. Many of the studies cited in this review, or specifically 
referenced in this section, are based on the analysis of wound fluids taken 
during the various stages of wound healing and cultured in vitro. No studies 
have been identified which give precise details of the patient characteristics e.g. 
age, co-morbidities or the current wound management i.e. whether fluid was 
taken from under clot/ scab formation or occlusive wounds. Some animal 
studies e.g. mice are included, these have experimental incisional wounds. 
Very few studies are carried out on pressure ulcers in vivo. There are ethical 
concerns with this, e.g. taking biopsies from pressure ulcers may further 
compromise healing.  No papers have been found which specifically describe 
the healing process for pressure ulcers. Details of what is known about 
pressure ulcer healing are given in section 2.4. 
 
The wound healing process is usually described in 4 stages: 
 Haemostasis  
 Inflammation 
 Proliferation  
 Maturation 
 
These phases are distinct in terms of the cellular and chemical activity but can 
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occur simultaneously, notably in chronic wound healing (Harding, Morris and 
Patel, 2002). The following sections describe each stage in more detail. 
 
2.3.1 Haemostasis 
This is the initial local reaction to tissue damage. Where damage to blood 
vessels has occurred there is extravasation of blood constituents into the 
interstitial space. Haemostasis is achieved through the vasoconstriction of the 
damaged vessels. Clot formation occurs; this is made up of collagen, platelets, 
thrombin and fibronectin. These factors release cytokines and growth factors 
that initiate the inflammatory response. This is a biochemical cascade, initiated 
by the release of platelets that results in the release of fibrinogen, which is 
converted to fibrin. This process is thought to be complete in less than one hour 
(Broughton, Janis and Attinger, 2006). 
 
According to a review article by Singer and Clark (1999), in injuries where there 
is an absence of haemorrhage, platelets then are not essential to wound 
healing. No reference is provided for this statement.  
 
2.3.2 Inflammation 
During the clotting process, triggers are released, which activate other cascade 
processes. These result in a local vasodilatation, increased permeability of the 
blood vessels and attraction of neutrophils to the wound. The presence of 
kinins also enhances phagocytosis and stimulates the sensory nerve endings 
(Cooper et al., 1994). As the blood vessels dilate there is an increase in the 
interstitial fluid, this carries plasma proteins, antibodies, erythrocytes, 
leucocytes and platelets. Platelets are responsible for the release of many 
growth factors e.g. tissue growth factor beta (TGF-β) and platelet derived 
growth factor (PDGF). Growth factors are cytokines, which in wound healing 
stimulate angiogenesis, fibroblast formation and epithelial cell migration (Mast 
and Schultz, 1996). Following the initial surge of neutrophils to the wound, other 
white blood cells, namely monocytes and T-lymphocytes migrate into the 
wound. Their role is the removal of nonviable tissue and bacteria (autolytic 
debridement) through phagocytic digestion and proteolytic enzyme (protease) 
activity (Broughton, Janis and Attinger, 2006). Proteases can have broad or 
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specific targets e.g. metalloproteinases specifically digest collagen. 
Undamaged collagen (intact extra-cellular matrix) is protected from destruction 
by protease inhibitors (Yager and Nwomeh, 1999) and the release of 
prostaglandin, which maintains the inflammatory response. It is suggested that 
this phase usually lasts 4-6 days depending on the extent of the damage and 
size of the wound.  
 
The transition of the wound from inflammation to proliferation should occur as 
non-viable tissue is removed. Broughton et al (2006) stress the importance of 
the haemostatic and platelet derived factors in this transition. Reduced levels of 
these and other growth factors have been found in chronic wounds compared 
to acute wounds (Cooper et al., 1994; Higley et al., 1995). This has been 
suggested (Harding, Morris and Patel, 2002) as one of the reasons chronic 
wounds such as pressure ulcers are slow to heal. Other explanations for why 
some wounds are slow to heal include:  
 reduced levels of protease inhibitors (this has been found in chronic leg 
ulcers) (Bullen et al., 1995);  
 impaired response to grow; fibroblasts found in venous leg ulcers had an 
impaired response to growth hormones attributed to senescence (Agren 
et al., 1999). 
Senescent cells are fibroblasts that have a (wound) age related decrease in 
proliferation potential.  
 
2.3.3 Proliferation 
This phase has a minimal role in wounds closing by primary intention e.g. 
sutured surgical wounds, as there is minimal tissue loss. Wounds healing by 
secondary intention may have a prolonged proliferative phase where there is 
extensive tissue loss. Proliferation can be subdivided into granulation and re-
epithelialisation. It is suggested that this phase lasts from day 4 to day 14 
according to Broughton et al. (2006). 
Granulation 
The reconstruction of the subcutaneous tissue consists of the formation of 
collagen, myofibroblasts, regrowth of blood vessels and capillary loops in an 
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extra-cellular matrix (Harding, Morris and Patel, 2002). This process is also 
stimulated by growth factors. Collagen is produced in this phase in order to give 
strength to the wound (Pierce et al., 1991). The vascular regeneration is also 
prolific in order to maximize the supply of oxygen and nutrients. The 
myofibroblasts enable wound contraction. According to a study by Majno et al 
(1971) this is responsible for approximately 50% of wound closure. Although 
this was an in vivo study of wounds with extensive tissue loss on mice this 
figure is still quoted in many text books.   
Epithelialisation 
During this phase new epithelial cells are produced under the influence of other 
growth factor which are produced by the platelets and macrophages (Lawrence 
and Diegelmann, 1994). The cell proliferation takes place at the wound edges 
and hair follicles. The cells migrate laterally in a zipper like fashion, over the 
new granulation tissue till a continuous layer is formed. This was demonstrated 
by Clark et al. (1982) in guinea pigs.  A moist environment is thought to be 
required for optimum growth: this theory was originally demonstrated in an 
animal model by Winter (1962). In 1991 faster healing rates were demonstrated 
with moist wound healing in human partial thickness biopsy wounds although 
not in full thickness wounds (Nemeth et al., 1991). This study was criticised for 
the use of antiseptics under the occlusive dressings. In 2001 Agren et al. 
studied wounds on the lower legs of healthy volunteers, they found significantly 
better healing after 7 days of moist versus dry wound healing, but the difference 
was not significant after 14 days. Recently this notion of moist wound healing 
has been challenged in a study by Ubbink et al. (2008) who compared modern 
occlusive dressings with dry gauze and found no significant difference in 
healing rates in a variety of wounds (including dehisced surgical incisions, leg 
ulcer and pressure ulcers) on surgical patients. In wounds healing by primary 
intention, epithelialisation can occur within the first 48 hours (Broughton, Janis 
and Attinger, 2006). However in wounds healing by secondary intention, it may 
take days, weeks or months before there is a surface of viable granulation 
tissue for the epithelium to adhere. 
 
2.3.4 Maturation 
This phase occurs once the skin integrity has been re-established. During 
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maturation there is a reduction in vascularisation of the skin, realignment of the 
collagen and elastic fibres to increase the tensile strength of the wound. This 
phase can take 3 months to several years. The tensile strength immediately 
after wound closure is less than 50% of normal tissue. After 10-12 weeks a 
wound will regain 70-80% of its maximum strength (Kapan et al., 2003). 
However this evidence is from rat models. A newly healed pressure ulcer would 
be at high risk of breakdown if subject to further pressure.  
 
2.4 Pressure ulcer classification 
The detail of the healing process, which takes place in pressure ulceration, 
depends on the severity and the associated phases of wound healing (see 
sections 2.5 and 2.6). Terminology used to define the severity of the ulcer, i.e. 
grade, stage or category is often used interchangeably. Briggs (2006) suggests 
this may lead to confusion among clinicians when attempting to describe 
pressure ulcers. 
 
Many scales have slight variations in definitions, with most variance existing 
during the classification of the early stages of damage (Bethell, 2003). The 
relevance of this to pressure ulcer incidence and prevalence reporting has been 
discussed in section 1.4. 
 
The purpose of grading as part of the assessment process is: 
 To assess the extent of the damage 
 To inform the management plan 
 To monitor progress 
 Improve outcomes 
 Standardise record keeping 
 
Many classification scales exist e.g. (AHCPR, 1992; Reid and Morison, 1994; 
EPUAP, 1998; NPUAP, 2009). Some classify Grade I as non-blanchable 
erythema (red skin which does not turn white with light finger pressure), 
although some (NPUAP, 2009) recognise that this is not practical to detect in 
highly pigmented skin. Henderson et al. (1997) extends the definition of Grade 
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1 to include pressure related alterations in skin colour, temperature, texture and 
sensation compared to adjacent or opposite skin. Scales that include blanching 
erythema e.g. Torrance (Torrance, 1983) are controversial as this thought to be 
is a transient state, which is not pathological (Harker, 2000; Nixon, Cranny and 
Bond, 2007; Bell, 2011). Some variation in the classifications relate to the 
description of the wound bed e.g. slough or granulating tissue, the presence or 
absence of necrotic tissue (preventing the depth of the wound to be accurately 
assessed) and the condition of the surrounding tissue. There are now two 
internationally recognised grading scales: EPUAP(2009) in Europe and NPUAP 
(2009) in the US. Their classifications are equivalent. 
 
Disease assessment scales can be evaluated in a number of ways. These 
include assessment of validity (internal and external) and reliability (inter and 
intra-rater). Currently there is no objective test for diagnosing or measuring the 
severity of pressure ulceration, although some studies have attempted to 
develop the technology for clinical use one (Nixon et al., 1999; Baldwin, 
2001).This means that assessment of internal validity of a grading scale can 
not be formally tested. The reliability of an instrument will have implications for 
it’s validity; a scale which is not reliable cannot have validity (Polit and Beck, 
2004). Table 2.1 gives details of some of the more commonly used scales to 
highlight the differences between them. The term Grade is used (this includes 
grade or category) in this table and will be used throughout this thesis. 
 
The importance of these variations in the way each Grade is defined becomes 
relevant when comparing incidence and prevalence data and has been 
discussed in section 1.4. A systematic review of inter-rater reliability of pressure 
ulcer classification systems has been performed by Kottner et al. (2009). This 
was a well executed review; details are given of the search strategy, the quality 
assessment and the numbers of studies identified, reviewed and included. It 
records that only studies published in English or German were included. The 
heterogeneity of studies resulted in a narrative review. Comments related to: 
 the quality of studies (only 24 out of 339 potentially relevant studies met 
the inclusion criteria)  
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 the assessment methods (assessment of photographs rather than patients 
is thought not to be appropriate however the inter-rater reliability of both 
methods is both high and low in different studies) 
 the qualification and training of raters (most studies did not provide 
sufficient detail of this)  
 no study randomly identified raters (this suggests lack of generalisability of 
findings) 
 classification systems used and the inclusion or not of intact skin (high 
inter-rater reliability is given in studies where high proportion of 
assessments were intact skin) 
 testing in non-white skin was not mentioned.  
This review did not discuss the fact that many studies do not give details or 
perform separate analysis for different body sites. It is unknown whether a 
pressure ulcer on the heel compared with another part of the body would affect 
the reliability of the assessment. Finally, Kottner et al’s review was completed in 
2008, it does not include any studies of the new NPUAP/ EPUAP grading 
launched in 2009 
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Author Grade 1 Grade 2 Grade 3 Grade 4 Additional Grade Comment 
Torrance 
(1983) 
Blanching 
erythema 
Non-
blanching 
erythema 
Ulceration 
through dermis, 
distinct edges 
surrounded by 
erythema and 
induration  
Ulceration into 
subcutaneous fat. 
Small-vessel 
thrombosis and 
infection 
compound. 
Muscle is swollen 
and inflamed, 
lateral extension 
results in 
undermining  
Grade 5: 
Infective necrosis penetrates deep 
fascia, muscle destruction. Spreads 
along the fascial planes and bursae. 
Osteomyelitis can easily develop 
First Grade of 
damage is = 2 
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National 
Pressure 
Ulcer 
Advisory 
Panel 
(NPUAP) 
(1989) 
Non-
blanchable 
erythema of 
intact skin 
Partial-
thickness skin 
loss involving 
epidermis 
and/or dermis 
Full thickness 
skin loss 
involving 
damage or 
necrosis of 
subcutaneous 
tissue that may 
extend down to, 
but not through, 
underlying 
fascia 
Full thickness 
skin loss with 
extensive 
destruction, 
tissue necrosis or 
damage to 
muscle, bone or 
supporting 
structures. 
 Adopted by 
the Agency 
for Health 
Care policy 
and Research 
(AHCPR) for 
use in the 
USA 
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Reid and 
Morison 
(1994) 
2 digit 
Stirling 
scale 
 
1.1 non-
blanching 
erythema with 
localised heat 
1.2 Blue/ 
purple/ black 
discolouration 
2.1 Blister 
2.2 Abrasion 
2.3 Shallow 
ulcer without 
undermining 
2.4 Any of 
these with 
underlying 
blue/ purple/ 
black 
discolouration 
3.1 Crater 
without 
undermining 
3.2 Crater with 
undermining 
3.3 Sinus, the 
full extent is 
unknown 
3.4 Full 
thickness skin 
loss with 
necrotic tissue 
(true extent of 
damage 
unknown) 
4.1 Visible of 
bone, tendon or 
capsule 
4.2 Sinus 
assessed as 
extending to 
bone, tendon or 
capsule 
Grade 0: 
0.1Normal appearance, intact skin 
0.2Healed with scarring 
0.3Tissue damage but not assessed as 
a pressure sore 
A simplified 
version is 
known as the 
1 digit scale 
 
Only scale to 
document ‘no 
damage’  
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European 
Pressure 
Ulcer 
Advisory 
Panel 
(EPUAP) 
(1998) 
Non-
blanchable 
erythema of 
intact skin 
Partial-
thickness skin 
loss involving 
epidermis 
and/or dermis 
Full-thickness 
skin loss 
involving 
damage or 
necrosis of 
subcutaneous 
tissue that may 
extend down to, 
but not through, 
underlying 
fascia 
Full thickness 
skin loss with 
extensive 
destruction, 
tissue necrosis or 
damage to 
muscle, bone or 
supporting 
structures. 
 Used 
extensively in 
Europe 
including the 
UK 
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National 
Pressure 
Ulcer 
Advisory 
Panel 
(2009) 
Intact skin 
with non-
blanchable 
redness of a 
localised area 
usually over a 
bony 
prominence. 
Darkly 
pigmented 
skin may not 
have visible 
blanching: its 
colour may 
differ from the 
surrounding 
skin 
 
Partial 
thickness loss 
of dermis 
presenting as 
a shallow open 
ulcer with a 
red pink 
wound bed, 
without slough. 
Also may 
present as an 
intact or 
open/ruptured 
serum filled 
blister 
Full thickness 
tissue loss. 
Subcutaneous 
fat may be 
visible but bone, 
tendon or 
muscle is not 
exposed. 
Slough may be 
present but 
does not 
obscure the 
depth of tissue 
loss. May 
include 
undermining or 
tunnelling. 
Full thickness 
tissue loss with 
exposed bone, 
tendon or muscle. 
Often includes 
undermining or 
tunnelling. 
Unstagable: Full thickness tissue loss 
in which the base of the ulcer is 
covered by slough(yellow, tan, grey, 
green or brown) and/or eschar (tan, 
brown or black) in the wound bed 
Deep tissue injury: Purple or maroon 
localised area of discoloured intact skin 
or blood filled blister due to damage of 
underlying soft tissue from pressure 
and/or shear. The area may be 
preceded by tissue that is painful, firm, 
mushy, boggy, warmer or cooler as 
compared to adjacent tissue. Deep 
tissue injury may be difficult to detect in 
individuals with dark skin tones. 
Evolution may include a thin blister over 
a dark wound bed. The wound may 
further evolve and become covered by 
thin eschar. Evolution may be rapid 
exposing additional layers of tissue 
even with optimal treatment. 
Produced in 
collaboration 
with the 
EPUAP. The 
European 
version does 
not include 
the categories 
of Unstagable 
or Deep tissue 
injury 
Table 2.1 Examples of pressure ulcer grading scales 
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Recent developments both in the US and Europe have led to new standardised 
definitions of pressure ulcer severity (NPUAP, 2009; EPUAP, 2009). This was 
included in table 2.1, however more detail is given in table 2.2. Classification 
systems use the term ‘stage’ or ‘grade’, although the recommendations of the 
combined European and US advisory panels is to use the word ‘category’ as 
this does not imply a hierarchy. In the US there was a need to separate 
‘unstagable’ and ‘deep tissue injury’ as there are medico-legal aspects of 
attributing when or where the ulcer originated and reimbursement implications 
for these types of injuries. Although this was not fully supported in Europe, in 
practice in the UK many clinicians have found it beneficial to introduce these 
categories. 
 
PU Grades Definitions Further description 
Grade 1 Intact skin with non-blanchable 
redness of a localised area usually 
over a bony prominence. Darkly 
pigmented skin may not have visible 
blanching: its colour may differ from 
the surrounding skin 
The area may be painful, firmer, soft, 
warmer or cooler as compared to 
adjacent tissue. Grade 1 may be 
difficult to detect in individuals with 
dark skin tones. May indicate ‘at risk’ 
persons (a heralding sign of risk) 
Grade 2 Partial thickness loss of dermis 
presenting as a shallow open ulcer 
with a red pink wound bed, without 
slough. Also may present as an 
intact or open/ruptured serum filled 
blister 
Presents as a shiny or dry shallow 
ulcer without slough or bruising. 
Bruising indicates suspected deep 
tissue injury 
Grade 3 Full thickness tissue loss. 
Subcutaneous fat may be visible but 
bone, tendon or muscle is not 
exposed. Slough may be present but 
does not obscure the depth of tissue 
loss. May include undermining or 
tunnelling. 
The depth of a Grade 3 pressure ulcer 
varies by anatomical location. The 
bridge of the nose, ear, occiput and 
malleolus do not have subcutaneous 
tissue, Grade 3 ulcers can be shallow. 
In contrast areas of extreme adiposity 
can develop extremely deep Grade 3 
ulcers 
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Grade 4 Full thickness tissue loss with 
exposed bone, tendon or muscle. 
Often includes undermining or 
tunnelling. 
The depth of a Grade 4 ulcer varies by 
anatomical location. Grade 4 ulcers 
can extend in to muscle and/or 
supporting structures e.g. fascia, 
tendon or joint capsule making 
osteomyelitis possible. 
Unstagable 
(U) 
Full thickness tissue loss in which 
the base of the ulcer is covered by 
slough(yellow, tan, grey, green or 
brown) and/or eschar (tan, brown or 
black) in the wound bed 
Until enough slough and/or eschar are 
removed to expose the base of the 
wound, the true depth and therefore 
the Grade cannot be determined. 
Stable (dry, adherent, intact without 
erythema or fluctuance eschar on the 
heels serves as the ‘body’s natural 
(biological) cover’ and should not be 
removed 
Suspected 
deep tissue 
injury 
(sDTI) 
Purple or maroon localised area of 
discoloured intact skin or blood filled 
blister due to damage of underlying 
soft tissue from pressure and/or 
shear. The area may be preceded 
by tissue that is painful, firm, mushy, 
boggy, warmer or cooler as 
compared to adjacent tissue. Deep 
tissue injury may be difficult to 
detect in individuals with dark skin 
tones. Evolution may include a thin 
blister over a dark wound bed. The 
wound may further evolve and 
become covered by thin eschar. 
Evolution may be rapid exposing 
additional layers of tissue even with 
optimal treatment. 
 
Adapted from (Black et al., 2010) 
Table 2.2 NPUAP/ EPUAP Pressure ulcer Grades based on the  
2009 reclassification 
 
The main difference in the new definitions is that any wound with slough 
present is now considered a Category 3 ulcer. The presence of slough is 
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discussed in more detail in section 2.5. By classifying sloughy wounds as 
category ‘3’ there is a working hypothesis that the wound has penetrated the full 
thickness of the dermis. The rationale is that epidermal or superficial dermal 
injuries do not produce enough inflammation to generate slough (Black et al., 
2010).  
 
The new category of suspected deep tissue injury seems to be controversial: a 
paper by Gefen (2009) discusses the evidence base for each element of the 
statement e.g. changes in skin colour, pressure and/or shear and tissue 
firmness. Most of the evidence is from animal models or muscle tissue under 
ischial tuberosities in seated patients. He argues, for example, that changes in 
colour due to deep damage in muscle tissue are unlikely to be detected on the 
skin. In the researcher’s clinical experience the presentation of maroon or 
purple discolouration or blood filled blisters on heels definitely exists. What is 
lacking is the physiological explanation and healing pathway for these. 
 
2.5 Healing of pressure ulcers 
Section 2.3 has already described a model of wound healing which is 
generalised for all wound types. It was noted however that most of the evidence 
for the particular processes and presence of growth factors and hormones, etc 
was based on samples from acute wounds. Some references were made to 
particular evidence for healing in chronic wounds. The following section 
attempts to consolidate what is known specifically about healing of each Grade 
of pressure ulcer. The Grades described are based on EPUAP (1998).  
 
2.5.1 Healing Grade 1 pressure ulcers 
These ulcers do not present with broken skin, while the exact nature of the 
damage has yet to be established, in particular no detail of whether blood 
vessel rupture and the need for haemostasis and the ensuing chemical 
cascades occurs in every Grade 1 ulcer.  It is assumed that the process of 
healing involves repair to the microcirculation and lymphatics and removal of 
toxins from the interstitial space. The progress of these ulcers is unclear, 
Halfens et al (2001) identified that following diagnosis of Grade 1 ulcers, re-
assessment 4 hours later found that half had resolved but 21% subsequently 
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reoccurred.  Furthermore 27.8% of patients in acute care settings, who had 
Grade 1 ulcers at the first and second (4 hours) assessment, went on to 
deteriorate to a higher Grade. The authors concluded that while Grade 1 ulcers 
are reversible, they provide a good indication of the patient being at risk as 
some patients went on to develop more severe ulcers. This study gives details 
of the body location of the pressure ulcer. It is noted that Grade 1 ulcers on the 
sacrum were less likely to change, however ulcers on the heel, particularly 
those in acute care were less stable and 17.6% went on to develop more 
severe ulcers. In a prospective inception cohort study by Allman et al. (1995), 
which aimed to identify risk factors for the incidence of Grade 2 and above 
pressure ulcers, they found that a non-blanching erythema (Grade 1 pressure 
ulcers) was an independent significant risk factor for development (Risk ratio = 
7.52 Confidence interval 1.0 – 59.12). This study only mentions pressure ulcers 
in the sacrococcygeal area; of the 19 patients who had a Grade 1 pressure 
ulcer, 11 (57.9%) developed into a Grade 2 or greater. Bridel (1993b) reported 
the findings of her pilot study of patients undergoing major surgery.  Thirty six 
patients had non-blanching erythema on either sacrum, buttocks or heels. Four 
out of the 36 patients remained either non-blanching or blanching up to day 
eight. These studies have demonstrated that the resolution or healing of Grade 
1 pressure ulcers does not always occur, controversy still exits over whether 
these should be classified as pressure ulcers or predictors of pressure damage 
(Helberg et al., 2006) 
 
2.5.2 Healing Grade 2 pressure ulcers 
Grade 2 ulcers require re-epithelialisation, if damage to the basal membrane 
(stratum germinativum) has not occurred, then re-epithelialisation will occur with 
restoration of full structure and function (Tortora and Grabowski, 1996). This is 
likely to be occurring with blisters and scuffing. Initially the reformed epidermis 
is only a few cells thick and appears translucent and light pink in colour. It takes 
several weeks for the layers to thicken and keratinize, allowing restoration of 
the previous integrity. In a study of intra-operative pressure ulcers (Nixon, 
2001), of the five Grade 2 pressure ulcers on various body sites, two resolved 
within 24 hours to blanching erythema, one resolved to Grade 1 and two 
remained as Grade 2, all of which were still present after eight days.  
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If the damage is the full thickness of the dermis then granulation tissue will be 
required to support the re-epithelialisation (see section 2.2.3). This could occur 
in an ulcer without resulting in a cavity, but evidence has not been found which 
would reassure the researcher that slough would never be present. Although 
Black et al. (2010) state that Grade 2 ulcers do not have sufficient inflammation 
to generate slough it is unclear whether they have considered full thickness skin 
loss as Grade 2 or Grade 3 pressure ulcers. 
 
2.5.3 Healing Grade 3 pressure ulcers 
Grade 3 pressure ulcers have tissue loss that involves dermis and 
subcutaneous tissue. These ulcers may contain devitalised tissue (see section 
2.3.2); a prolonged inflammatory phase during which autolysis of the devitalised 
tissue takes place and a prolonged proliferative phase to permit the 
replacement with new tissue has reasonable face validity however evidence to 
confirm this has not been found. Ryan et al. (1971) examined biopsy 
specimens from acute and chronic pressure ulcers, they found normal or 
increased fibrinolysis in acute ulcers and loss of fibrinolysis and heavy deposits 
of fibrin in chronic ulcers. Wound exudate in chronic ulcers has been found to 
be an excellent medium for fibroblast stimulation (Sporn, Roberts and 
Wakefield, 1986). It has also been suggested that wound fluid may sustain 
increased bacterial overgrowth, stimulating epidermal migration (Falanga, Zitelli 
and Eaglstein, 1988).  
 
2.5.4 Healing Grade 4 pressure ulcers 
Very little information is available about the healing of Grade 4 ulcers that 
involve underlying tissues such as muscle, tendon or bone. This may because 
they are relatively rare events. While the principles of healing of Grade 3 
lesions apply, some texts report the association with osteomyelitis (Seiler and 
Stahelin, 1986).  
 
Clinically, Grade 3 and 4 ulcers are likely to present initially with some non-
viable tissue such as slough or necrosis. The resolution of this is the autolytic 
debridement process of inflammation described in section 2.3.2. The new 
category of unstagable (see table 2.2) is used to describe the non-viable tissue 
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of undetermined depth, in the EPUAP (1998) definitions these were included in 
the Grade 4 ulcers. 
 
2.5.5 Healing of heel pressure ulcers 
In terms of heel ulcers no studies have been identified which specifically 
describe all of the healing process.  A study has been identified by Campbell et 
al (2010a) who looked at heel pressure ulcers in a population of patients 
following hip replacement. They found 12 pressure ulcers on admission to the 
rehabilitation unit (two Grade 1, five Grade 2, four suspected deep tissue injury 
and one unstagable (see table 2.2 for details of classification)). After one month 
both Grade 1 ulcers had resolved, two of the Grade 2 ulcers had not resolved 
and three of the sDTI and unstagable had not resolved. This was primarily an 
incidence study so no detail is given of treatments.  
 
2.5.6 Bacteria and pressure ulcer healing 
All wounds that do not heal by primary closure will be colonised with micro-
organisms. Wounds such as pressure ulcers and leg ulcers, which contain non-
viable tissue will have more micro-organisms (Smith et al., 2010). The role of 
these micro-organisms in wound healing has not been defined, some studies 
indicate a positive association between higher bacterial counts and delayed 
wound healing, others show no association (O'Meara et al., 2000).  
 
Patients with pressure ulcers may be treated to reduce or eliminate the micro-
organisms either by topical application directly to the wound or with systemic 
antibiotics.  
 
The evidence for the effectiveness of systemic and topical anti-microbial agents 
in pressure ulcer healing has been reviewed as part of the NICE guideline 
CG29 (RCN, 2005). This review found very few studies of reasonable quality, 
none of the studies evaluated systemic antibiotics. Of the five small trials which 
evaluated topical antimicrobial treatments, only one showed a significant 
difference in healing rates (Gerding and Browning, 1992) (the others may have 
been too small to show any significant effect). This study found that Grade 1 or 
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2 pressure ulcers treated with oxyquinoline ointment had better healing rates 
than those treated with standard emollient.  
 
A search for trials of topical anti-microbials carried out since the above review 
identified 3 further studies which included pressure ulcers (Meaume et al., 
2005; Beele et al., 2010; Sibbald, Coutts and Woo, 2011). All 3 studies found 
better healing rates or reduction of bacterial burden in wounds treated with 
topical anti-microbial dressings. Unfortunately all studies had very small 
numbers, short follow up periods and the data for pressure ulcers was not 
presented separately from the other wounds studied, such that any conclusions 
drawn from the findings need to be viewed with caution. 
 
2.6 Tissues described in pressure ulcer classification systems 
The anatomical tissues related to pressure ulcers have been described in 
section 1.6. Additional tissue types may be also be present in the wound bed 
depending on the time since the injury and the stage of the healing process. 
Individual pressure ulcers progress to their maximum severity before healing 
commences. Once healing commences, the severity classification is not 
applicable as the new tissue does not restore previous structure and function 
(National Pressure Ulcer Advisory Panel (NPUAP), 1995). Although a healing 
Grade 3 or 4 pressure ulcer will reduce in depth, the new granulation tissue 
does not have the same structure and function as the previous tissue e.g. 
muscle, adipose (see section 2.2).  It is important to identify the tissue type as 
these can be used to describe ulcer healing. These are described below. 
Individual studies use various classification systems or provide a description of 
the wound, in order to make comparisons and for ease of interpretation all 
references to grading have been converted to those given in the 
EPUAP/NPAUP (2009) scales. This also applies to the studies cited in section 
2.7 and throughout this thesis unless otherwise stated: 
 
2.6.1 Blister 
Although blisters are initially not open wounds, they are included here as they 
result from pressure damage to the skin. Blisters or sub-epidermal bullae are 
formed when the epidermis and dermis separate; they become filled with 
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serous fluid. Detached epidermis shows no visible damage at first, but 
becomes necrotic hours later (Seiler and Stahelin, 1986). Blisters caused by 
friction appear within the epidermis beneath the stratum granulosum and not in 
the sub-epidermal tissue (Sulzberger et al., 1966). 
 
If the loose epidermis of a blister becomes detached then the fragile dermis is 
exposed, which is then at risk of further damage from pressure, shear, friction 
and trans-dermal water loss. These are categorised as Grade 2 pressure ulcers 
(both when the blisters are covered or open). 
 
2.6.2 Granulation tissue 
Granulation tissue is new tissue produced during the proliferative phase 
(described in section 2.3.3). This tissue remains undifferentiated, soft and 
fragile. It can however, support the re-epithelialisation of the dermis as it 
migrates from the ulcer edges. Granulation tissue is seen in healing Grade 3 
and 4 pressure ulcers. 
 
2.6.3 Slough 
Slough is described by Black et al. (2010) p.37 as:  
‘a coagulum of serum and matrix proteins produced by inflamed wounds. Slough is 
usually described as a type of necrotic tissue. However, slough is a mixture of serum 
proteins (fibrin, albumin, immunoglobulin) and denatured matrix proteins (collagen). 
These extracellular fluids form during inflammation and leak into interstitial spaces due 
to capillary dilation.’ 
Slough occurs during the inflammatory phase of wound healing and will be 
naturally removed through autolysis or ‘passive debridement’. While it’s removal 
by debridement is recommended as this is thought to speed up the healing 
process (see section 2.3.2), there is no evidence that this has any beneficial 
effect on pressure ulcer healing. Slough can be seen in Grade 3 and 4 pressure 
ulcers. 
 
2.6.4 Necrosis 
Non-viable tissue is described as necrotic. This may be any anatomical tissue 
e.g. skin, muscle or granulation tissue or slough. It is recognized by its dark 
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colour and leathery appearance. This is due to desiccation and the presence of 
haemoglobin. In its desiccated state it is known as eschar (Black et al., 2010). 
In previous categories of severity, necrotic tissue was included as Grade 4, 
mainly because the depth of damaged tissue was unknown. This is now 
categorized separately as ‘Unstagable’(NPUAP, 2009). 
 
2.7 Factors which affect the healing of pressure ulcers 
Potential factors were identified from a review of the epidemiological data on 
wound healing and through extrapolation of the theory of wound healing.  
Epidemiological studies identified, which include an analysis of factors 
associated with healing, have been compiled into table 2.3 and table 2.4 gives 
details of other studies of prognostic factors for healing for other similar types of 
wounds such as diabetic foot ulcers. These studies are cited in the subsequent 
sections.  
 
Consideration was also given to factors that affect pressure ulcer development 
as these may also affect healing. It is thought that prevention of pressure ulcers 
is a good marker for healing (Margolis, Knauss and Bilker, 2002). A systematic 
review of the evidence for risk factors for pressure ulcer development has been 
conducted as part of a programme of research on pressure ulcers funded by 
the National Institute for Health Research (NIHR). Findings of this review have 
been personally communicated to the researcher and are soon to be published 
(Nixon et al., 2010) Table 2.5 gives details of epidemiological studies of 
pressure ulcer development that specifically include heel ulcers. 
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Study Types of study 
and setting 
Type of 
wound 
No of 
wounds/ 
patients 
Analysis type Significant 
Independent 
prognostic factors* 
Prognostic factors: 
significant in 
univariate but non 
sig. in multi-variate 
analysis 
Findings 
Van 
Rijswijk & 
Polansky 
(1994) 
Secondary 
analysis of 
prospective 
cohort study 
data 
Acute, 
extended care 
or rehabilitation 
facility 
Grade 3 and 4 
pressure 
ulcers (mean 
ulcer area 
used for 
multiple ulcers) 
body site not 
stated 
48 patients 
with 56 
wounds 
Cox proportional 
hazards (PH) at 
baseline then at 2 
weeks (time to 
healing) 
Nutrition at baseline 
Age, nutrition, % 
reduction in ulcer 
area after 2 weeks 
Coherent/ confused 
Immobility 
Age, gender 
Incontinence 
Diabetes 
General health 
Skin condition 
Number of ulcers 
Weight and body build 
Tissue type 
Surrounding skin 
Odour 
Exudate 
Pain 
21 (37.5%) 
ulcers healed. 
Mean time to 
healing 70.3 
days (SD=52.9) 
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Berlowitz 
et al. 
(1997) 
Retrospective 
cohort 
Long term care 
institution 
PU (largest 
ulcer, no 
details of body 
site) 
819 
patients 
Logistic 
regression 
(healed at 6/12) 
Age ≥75 years 
Rehabilitation 
services 
Immobility (-ve) 
Incontinence (-ve) 
Grade 2 (comp Grade 
4) 
Grade 3 (comp Grade 
4) 
Bedridden 
Unable to feed self 
MS 
Quadriplegia 
Oxygen therapy 
No rehab. services 
 
Grade 2=72% 
healed 
Grade 3=45% 
healed 
Grade 4=31% 
healed 
Bergstrom 
et al. 
(2008) 
Retrospective 
cohort 
Long term 
care institution 
PU - all Grade 
2 ulcers (excl. 
Grade 1,3,4) 
1241 PUs 
on 774 
people 
Cox PH with 
frailty model for 
clustering of 
patients Max 96 
days follow up 
Smaller ulcer size 
Agitation 
Eating problems 
Needing physical 
assistance (-ve) 
A&E attendance (-ve) 
Ulcer on extremity (-
ve) 
High blood nitrogen 
levels 
Low albumin 
High or low BMI 
High temperature 
Dehydration 
Incontinence 
Peripheral oedema 
Heart failure 
Death 
45% healed 
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Takahashi 
et al. 
(2009) 
Retrospective 
cohort 
Patient’s home 
consultations 
by the Mayo 
clinic wound 
specialist 
PU or other 
chronic – 
ischaemic, 
venous, 
neuropathic, 
mixed 
397 
patients 
Logistic 
regression 6/12 
follow up 
Multiple ulcers (-ve) 
High haemoglobin 
Ulcer area 
Age 
Gender 
Stroke 
PVD 
Diabetes 
Depression 
Dementia 
Arthritis 
Falls 
Neuropathy* 
34% healed in 
6/12 
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Bergstrom 
(2005) 
(Same 
data set 
as (2008) 
Retrospective 
cohort 
Long term care 
institutions 
PU Grade 2 
(partial 
thickness) or 
Grade 3 and 4 
together (full 
thickness) on 
coccyx, back, 
buttock, feet, 
trochanter or 
ischial 
tuberosities 
1589 ulcers 
on 882 
patients 
Bivariate analysis 
Grade 2 v Grade 
3and 4 
Multivariate 
ordinary least 
squares 
regression 
12/52 follow up 
Grade 2: 
Dementia with 
agitation 
Episode duration 
PU size 
Moist or dry dressing 
Incontinent of urine 
Soap/ saline cleanser 
Grade 3 or 4: 
Debridement 
Dementia and 
depression 
Sufficient enteral 
feeding 
PU size 
Moist (as opposed to 
dry) dressing 
Same as independent 
factors for both Grade 
2 and Grade 3 or 4 
 
Analysis was for 
change in ulcer 
area, no time to 
healing 
information 
given 
 
*All factors a positive influence on wound healing unless otherwise stated 
Table 2.3 Prognostic factor studies of pressure ulcer healing  
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Study Types of study and 
setting 
Type of wound No of 
wounds/ 
patients  
Analysis type Significant 
Independent 
prognostic 
factors 
Prognostic factors: 
significant in 
univariate but non 
sig. in multi-variate 
analysis 
Findings 
Winkley 
et al. 
(2007) 
Prospective cohort 
Community chiropody 
and hospital foot clinics 
First diabetic 
foot ulcer 
253 
patients 
Cox PH with 
robust standard 
errors Modelled 
for outcomes of 
mortality, 
amputation and 
recurrence 
18/12 follow up 
Mortality: Age, 
Better glycaemic 
control 
Moderate 
ischaemia 
Depression  
Amputation: 
Severity  
Recurrent 
ulceration: 
Microvascular 
complications  
Neuropathy 
Type of diabetes 
Diabetic treatment 
Smoker 
Alcohol 
 
84% survival 
rate 
15% 
amputation 
43% 
recurrence 
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Margolis 
et al. 
(2000) 
Retrospective cohort 
study 
Meta-analysis of 
control arm data from 
RCTs -Settings not 
stated 
Diabetic 
Neuropathic foot 
ulcer (reference 
ulcer) 
27 630 
patients 
Multivariable 
logistic 
regression 
(data set split 
into modelling 
and validation 
sets 70:30) 
Healed wound 
by 20/52 
Wound size, 
duration and Grade 
Age 
Gender 
Treatment centre 
47% healed, 
6% 
amputated, 
0.2% died in 
modelling set 
 
Nather 
et al. 
(2008) 
Prospective cohort 
study 
Patients treated by the 
multi- disciplinary foot 
team  
Diabetic foot 
problems 
202 
patients 
Stepwise 
logistic 
regression 
17/12 data 
collection 
PVD 
Infection 
 
Age 
Gender 
Race 
Smoking 
Alcohol 
Obesity  
Hyperlipidaemia 
Stroke 
Hypertension 
IHD 
Duration of diabetes 
Neuropathy 
Minor 
surgery on 
75% patients 
Major 
amputations 
in 27% 
Table 2.4 Prognostic factor studies of other similar chronic wound healing studies 
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Study Types of study and 
setting 
Type of 
wound 
No of 
wounds/ 
patients  
Analysis type Significant 
Independent 
prognostic 
factors 
Prognostic factors: 
significant in 
univariate but non 
sig. in multi-variate 
analysis 
Findings 
Tourtual 
(1997) 
Prospective cohort 
study 
Nursing units within 
acute hospitals 
Heel PUs 209 in first 
study 
291in 
second 
study 
Forward 
stepwise 
logistic 
regression 
Braden subscale 
of friction and 
shear and 
moisture 
Race 
Conscious level 
Pain 
Oedema 
Previous PU 
Topical treatment 
Support surface 
Compression devices 
Smoking 
Diseases: endocrine, 
metabolic, nutritional, 
immune, diabetes, 
circulatory, respiratory 
, renal 
26% 
developed 
heel ulcer in 
first study 
21.7% 
developed 
heel ulcer in 
second study 
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Okuwa et al. 
(2006) 
Prospective cohort 
study 
Long term care facility 
Lower 
extremity 
pressure 
ulcers (toe, 
heel, malleoli, 
tibia, fibula) 
259 
patients 
Backwards 
stepwise Cox 
regression 
model 
ABPI 
Length of bedfast 
period 
Male gender 
Contractures 
Haemoglobin 
Sodium levels 
Chlorine levels 
 
37 PU 
developed on 
33 patients 
 
Table 2.5 Risk factor studies of pressure ulcer incidence which specifically  
include heel ulcers 
-71 - 
2.7.1 Patient related factors 
Age 
Age is often associated with delayed healing (Jaul, 2010). Wywialowski (1999) 
attributes this to reduced body fat, collagen and elastin. Age was not 
associated with healing in the Bergstrom study (2005). In the Berlowitz et al. 
study (1997) older age was associated with better healing. Age has also found 
to be a risk factor for development of pressure ulcers in 12 out of 32 studies 
that included it as a variable in their model (Nixon et al., 2010). Whether age is 
a confounder due to the probability of other disease processes increasing with 
increase in age is unknown. 
Gender 
It is thought that wound healing can be delayed in women who are post 
menopause, due to lack oestrogen (Campbell et al., 2010b). In one study, 
being male was associated with better healing rates than female (van Rijswijk 
and Polansky, 1994). However in the study by Takahashi et al. (2009) better 
healing was achieved in the females, the authors attributed this to higher 
burden of co-morbidities in men.  In several studies gender was identified as a 
prognostic factor but did not emerge as independent from a multi-variate model. 
A case-cohort study (comparing information from a cohort of individuals with all 
patients with the disorder of interest in the population) by Margolis et al. (2002) 
identified an association between women over 65 years being treated with 
hormone replacement therapy (HRT) and a reduced risk of developing pressure 
ulcers. Nixon et al.(2010) found limited evidence that gender was associated 
with pressure ulcer development (4 out of 15 studies that included it as a 
variable in their model however the studies had serious limitations). 
Nutrition 
The argument that adequate nutrition is required for wound healing has good 
face validity; however evidence to support this is limited. Bergstrom et al. 
(2005) found that sufficient enteral feeding was positively associated with 
healing. Van Rijswijk and Polansky (1994) found longer healing times in 
patients who had satisfactory or poor (rather than good) nutritional status. A 
Cochrane systematic review of nutritional support for prevention and treatment 
of pressure ulcers (Langer et al., 2003) found insufficient evidence such that it 
is unclear whether nutritional support is beneficial for healing. In the Nixon et al. 
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(2010) review, although 34 studies included nutrition and in 13 of these it 
emerged as an important risk factor, the quality of the studies resulted in 
uncertainty. Consideration needs to be given to how this factor is measured (i.e. 
proxy markers such as food intake, ‘body mass index’, haemoglobin and 
albumin levels) and whether malnutrition increases the risks or whether more 
than adequate nutrition reduces the risks compared to adequate nutrition. 
Co-morbidities 
The effect of co-morbidities needs to be considered in terms of their influence 
on mobility or perfusion. Diabetes and cardiovascular disease were not 
associated with healing in the Bergstrom et al. (2005) study; functionally 
debilitating conditions such as multiple sclerosis and quadriplegia were 
independently associated with reduced healing in the Berlowitz et al. study 
(1997). Takahashi et al. (2009) found several co-morbid conditions emerging as 
significant in the univariate analysis but non remained significant after 
adjustment in the multi-variate model. In the Nixon et al. (2010) review, most 
co-morbidities were not considered as individual risk factor but they were 
included in the ‘general health status’ factors, diabetes however, did emerge as 
an independent predictor of pressure ulcer development in 5 out of 12 studies.  
Activity and mobility 
Immobility is considered to be one of the main contributing factors in pressure 
ulcer development (Bergstrom et al., 1987). It also emerged strongly in the 
Nixon et al. (2010) review. In the study by Berlowitz et al. (1997) immobility 
emerged as a significant independent predictor of non-healing. In the 
Bergstrom et al. (2008) study ‘needing assistance with activities of daily living’ 
was a factor entered in the model but was not significantly associated with 
improved healing. However in their explanation for the patients with dementia 
and agitation having improved healing they suggest the increased mobility of 
the agitation could increase tissue perfusion. They noted they had not included 
mobility or tissue perfusion in their study. 
Mental state 
Although dementia with agitation was associated with a greater reduction in 
ulcer area in the Bergstrom et al study (2005), the authors attributed this to 
increased mobility and perfusion. Patients in the van Rijswijk (1994) study, who 
were coherent had significantly better healing rates than those who were 
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confused, independent of other factors. Mental status was considered in the 
Nixon et al. (2010) review, very few studies included this and it did not emerge 
as a key risk factor for pressure ulcer development. Consideration of mental 
status in the literature mostly focuses on cognitive ability rather than mood; it is 
possible that low mood or depression will affect a patient’s motivation to move.  
Incontinence 
The study by Berlowitz et al. (1997) found patients with incontinence to be 
significantly less likely to heal (independent of other factors). They attributed 
this to the bacterial colonisation and infection inhibiting wound healing. 
Incontinence was included in the Bergstrom et al. (2008) study but did not 
emerge as significant. Nixon et al. (2010) considered skin moisture, which 
included incontinence, as a risk factor. This emerged as statistically significant 
in 14 out of 28 of the studies that included it in their model. 
Haemoglobin 
A higher haemoglobin was found to be significantly associated with better 
chronic ulcer healing in the study by Takahashi et al. (2009). Haemoglobin is 
sometimes considered as a marker for nutritional deficits. In the Nixon et al. 
(2010) review, haemoglobin emerged as a significant factor in 5 out of 11 
studies which included it, although the studies had major limitations. 
Smoking 
Smoking was identified in studies of diabetic foot ulcers (Margolis et al., 2000; 
Nather et al., 2008; Winkley et al., 2007) and in the incidence of heel pressure 
ulcers (Tourtual et al., 1997) as a prognostic factor but did not emerge as 
independent of other factors in any of these studies. It has not been identified 
as a potential factor affecting the healing of pressure ulcers, however it is not 
clear whether it was considered as a potential factor in some of the studies. 
The evidence of delayed wound healing and risk of complications such as 
infection is reported in surgical wounds (Salcido, 2007). Smoking is considered 
as an element of perfusion in Nixon et al.’s review (2010), although the studies 
identified had serious limitations smoking emerged as a significant risk factor in 
2 out of 4 studies, which included it in their model. 
Medications 
Medications have not been considered in the pressure ulcer healing literature; 
this is probably because they may not be independent prognostic factors. They 
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may however be considered markers for the diseases they are treating and 
their effects on perfusion or mobility. Particular medications such as steroids 
and antibiotics may have a direct effect in terms of suppressing inflammation 
and reducing the toxicity from bacteria respectively. However no robust 
evidence has been found to support or refute these notions. 
 
2.7.2 Wound related factors 
Ulcer size  
Most references to ulcer size are interpreted as the surface area of the wound. 
Graumlich et al. (2003) include ulcer depth as a variable, both small ulcer area 
and small ulcer depth were associated with better healing in the univariate 
analysis. Ulcer depth may be more relevant to ulcer Grade or severity 
(considered in the next paragraph), Berlowitz et al.(1997) refers to the variable 
of ulcer size but reports this as Stage 2, 3 or 4. Work by van Rijswijk and 
Polansky (1994) has demonstrated that changes in ulcer area can predict 
healing in full thickness pressure ulcers. They found that ulcers which did not 
achieve either 45% reduction in wound area after 2 weeks or 77% reduction in 
wound area after 4 weeks were significantly less likely to heal during the study 
(maximum 4 months). However ulcer area at baseline was not a predictor of 
healing. This may be because this was not an inception cohort (a study 
recruited patients with pressure ulcers, which were new events or had been 
present for varying lengths of time and would be at different stages in the 
healing process). Larger ulcer size was associated with delayed healing in the 
univariate analysis in the study by Graumlich et al. (2003). Data for the adjusted 
analysis is not given independently of the intervention. In the study by 
Takahashi et al. (2009) ulcer area was also significantly associated in univariate 
analysis, but did not emerge in the multivariate analysis. Ulcer size was found 
to be an independent predictor of healing in both the Grade 2 and the Grade 3 
or 4 ulcers in the Bergstrom et al. (2005) study. 
Ulcer Grade/ severity 
The record review by Berlowitz et al. (1997) found that pressure ulcer Grade 
was an important predictor of healing: Grade 2 ulcers were most likely to heal 
and Grade 4 ulcers were least likely. Bergstrom et al. (2005) analysed Grade 2 
and Grade 3/4 ulcers in separate models. Takahashi et al. (2009) did not 
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consider Grade, probably because they included several types of chronic 
wounds such as leg ulcers and foot ulcers. 
Location 
In the Bergstrom et al.(2008) analysis of time to healing of the Grade 2 ulcers, 
pressure ulcers on the extremities (head, arms, thighs, lower legs or heel) were 
significantly and independently less likely to heal than other body locations. 
None of the other studies identified consider location of as a predictor of 
healing. 
Tissue type 
Based on the knowledge of the wound healing process, the type of tissue in a 
wound will be related to the progress of healing i.e. necrotic tissue will be 
present following the initial damage, granulation tissue will be found later 
following the removal of non-viable tissue. Analysis of the data from the van 
Rijswijk (van Rijswijk, 1993) study found that the presence of necrotic tissue at 
baseline was significantly associated with reduced healing and granulation 
tissue was significantly associated with improvement in healing of Grade 3 and 
4 pressure ulcers, however these were not subject to multi-variate analysis. In 
their later study van Rijswijk and Polansky (1994) did not find tissue type a 
predictor of healing, however there were small numbers of ulcers in this study. 
Xakellis and Chrischilles (1992) did find that the presence of necrotic tissue in 
Grade 2 and 3 pressure ulcers was associated with slower healing in a 
univariate analysis (but not when adjusted for the presence of exudate). 
Bergstrom et al (2005) and Graumlich et al. (2003) did not record tissue type. 
Exudate 
Exudate (volume or consistency) is not recorded in many studies; this is 
probably because it is most likely to be a subjective assessment. Higher levels 
of exudate are associated with the inflammatory phase of healing especially 
when autolytic debridement is taking place (see section 2.3.2), it may also be 
associated with increased interstitial fluid e.g. in the presence of oedema. 
Xakellis and Chrischilles (1992) found that exudate present at baseline was an 
independent prognostic factor for reduced healing rates in Grade 2 and 3 
pressure ulcers. Only 3 out of these 39 ulcers were on the calcaneum, there 
was not mention of local oedema but the authors suggest that the high exudate 
may be associated with infection. 
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Wound pain 
Although wound pain is acknowledged as a common feature of wounds and is 
strongly associated with the presence of infection (Woo et al., 2008) it has only 
occasionally been considered as a prognostic factor for healing. Van Rijswijk 
and Polansky (1994) did include it in their baseline covariates but it was not 
found to influence healing time, although this was a small study. 
Surrounding skin  
The condition of the surrounding skin may be associated with adverse 
conditions in the wound e.g. erythema is associated with wound infection 
(Santy, 2008), maceration is associated with increased exudate, oedema is 
associated with increased interstitial fluid. All these factors may have an 
adverse effect on wound healing. Van Rijswijk and Polansky (1994) did not find 
the condition of the surrounding skin to be a predictor of wound healing. 
Surrounding skin condition was not considered in other studies. 
Duration prior to recruitment 
None of the studies cited in this section were inception cohorts. Van Rijswijk 
and Polansky (1994) noted and grouped the number of days prior to 
recruitment with 14% of pressure ulcers being present for > 9 months but did 
not report this as a potential predictor of healing; Bergstrom et al. (2005) 
recruited existing long term care facility residents who developed a pressure 
ulcer but also newly admitted residents with a pressure ulcer (previous duration 
of the ulcer was not recorded); Berlowitz et al. (1997) recruited patients who 
had pressure ulcers on a given date but there is no mention of ulcer duration 
prior to recruitment; ulcer duration was included in the Graumlich et al.(2003) 
study which found the better healing with shorter duration; in the Takahashi et 
al. study (2009) patients were recruited from their first contact with the wound 
clinic but prior duration is not mentioned. Wound duration has been identified 
as a predictor of healing in other wound healing studies (Margolis, Berlin and 
Strom, 1999; Margolis et al., 2003). 
 
2.7.3 Interventions 
Wound cleansing and dressings 
The controversy over the benefits of moist wound healing has been discussed 
in section 2.3.3.  In the study by Bergstrom et al (2005) Grade 2 pressure ulcer 
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healing was positively associated with moist wound dressing as was the use of 
antiseptic, antibiotic or commercial cleansers compared with soap and water. A 
Cochrane systematic review of evidence for cleansing of pressure ulcers found 
a statistically significant improvement in healing with an antiseptic cleanser 
when compared with sodium chloride 0.9% (Moore and Cowman, 2008).  
Relief of pressure 
A Cochrane systematic review (Moore and Cowman, 2009) of repositioning has 
identified that this intervention has not been studied for healing of pressure 
ulcers. Pressure relieving devices such as mattresses were considered in the 
review of evidence for the NICE guideline (RCN, 2005), although many studies 
were identified the quality of studies was such that no firm conclusions could be 
drawn. There was some evidence to suggest that air flotation support surfaces 
when compared to alternating pressure supports or standard care did improve 
healing. There was no evidence of differences in healing of pressure ulcers with 
the use of low air loss (when compared with foam mattresses), alternating 
pressure therapy (when compared with each other or static fluid overlays) or 
continuous low pressure therapy (when compared with foam replacements). 
 
2.7.4 Factors specific to healing heel pressure ulcers 
In order to identify appropriate prognostic factors to include in a study of 
pressure ulcer healing specific to heels, consideration was given to all the 
factors mentioned in sections 2.7.1-2.7.3. As the types of wounds included in 
these studies were not specifically heels, consideration was given to factors 
which may be more pertinent to the pathophysiology of heel pressure ulcers 
(see sections 1.6.8 and 1.7.5).  
 
Prognostic factor studies of diabetic foot ulcers (Margolis et al., 2000; Winkley 
et al., 2007; Nather et al., 2008) were reviewed and two studies of risk factors 
for incidence of heel or lower extremity pressure ulcers (Tourtual et al., 1997; 
Okuwa et al., 2006), these studies were summarised in tables 2.4 and 2.5 
respectively.  
Braden subscale of friction and shear 
This was identified in the Tourtual et al. (1997) study along with skin moisture 
as being independent risk factors for heel pressure ulcer development. 
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Ankle Brachial Pressure Index (ABPI) or peripheral arterial supply 
The study by Okuwa et al. (2006) found several factors that were positively 
associated with development of lower extremity pressure ulcers but only ABPI, 
male gender and prolonged bed rest were independent predictors. Peripheral 
arterial disease was identified in the Winkley et al. (2007) study along with 
being older, low haemoglobin and depression were associated with mortality for 
patients with diabetic foot ulcers. ABPI was identified in the Nather et al.(2008) 
study along with infection as a significant independent predictor of major 
amputation. 
Other factors 
Margolis et al. (2000) in their study of predictors of healing of neuropathic 
diabetic foot ulcers found that wound size, duration and Grade were 
independent predictors of healing. 
 
2.8 Summary 
This chapter sets out what is known about the wound healing process in acute 
wounds then considers what happens specifically in pressure ulcers and heel 
pressure ulcers. It has highlighted how incomplete our knowledge of wound 
healing is generally and emphasises a greater lack of knowledge of pressure 
ulcer healing.  
 
The specific areas where there are gaps in knowledge of pressure ulcer healing 
are: 
 whether the evidence from acute wound healing and animal models can 
be translated to pressure ulcer healing in humans 
 whether vascular rupture always occurs with injury  
 whether the presence of platelets are an essential part of any wound 
healing process 
 the duration (and range) of each phase of wound healing in chronic 
wounds i.e. inflammatory phase, proliferative phase 
 whether the transition from the inflammatory to the proliferative phase can 
take place with little or no haemorrhage (reduced platelet derived growth 
factors) 
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 what levels of protease inhibitors are present in pressure ulcers 
 the role of myofibroblasts and wound tensile strength of healed pressure 
ulcers 
 
Classification systems and descriptors for the severity of pressure ulcers, the 
different tissue types and what is known about their relationship have been 
presented. Additionally no studies of inter-rater reliability of wound classification 
have been found specifically for heel pressure ulcers.  
 
No tests have been identified with the purpose of diagnosing or measuring the 
severity of pressure ulcers therefore the internal validity of any classification 
scale can not as such be measured. The classification of sloughy wounds as 
Grade 3 as full dermal loss has not been tested.  
 
It may be that more work has been dedicated to factors which influence the 
development rather than healing of pressure ulcers, however these factors are 
accepted as potentially influencing healing and so have been considered here. 
In order to identify potential prognostic factors for healing heel pressure ulcers 
a review of the evidence for healing all pressure ulcers and incidence in related 
wounds has been performed. No specific prognostic factors for heel pressure 
ulcers have been identified.  As heel pressure ulcers have been noted to differ 
in terms of anatomy, mechanical properties and potential for disease from other 
body sites the need to identify specific prognostic factors is apparent.  
 
The gaps in knowledge for healing of heel pressure ulcers has led to the 
following research questions: 
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What are the prognostic factors for healing of heel pressure ulcers? 
What are the characteristics of patients who have heel pressure ulcers?  
What are the characteristics of current practice i.e. the dressings and topical 
treatments including debridement, support surfaces used, specialist advice? 
What is the progress of heel pressure ulcers through the stages of wound 
healing? 
What are the adverse sequelae of this patient population e.g. death, 
septicaemia, amputation, infection, length of stay, destination post discharge? 
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Chapter 3 Pressure relieving devices for treating heel pressure 
ulcers: a systematic review 
 
3.1 Introduction 
This chapter reports a systematic review of the evidence of effectiveness of 
support surfaces or other medical devices for reducing pressure as part of the 
treatment of heel pressure ulcers. It describes the rationale for carrying out a 
systematic review, the research design, the process for identifying, appraising 
the quality and the risk of bias in the studies identified. It then comments on the 
findings of the studies and the risk of bias within and across studies. It 
summarises the recommendations for clinical practice and future research 
based on the findings of the review. 
 
The Preferred Reporting Items for Systematic Reviews and Meta-analysis 
(PRISMA) www.prisma-statement.org standard is now offered as a quality 
standard for reporting systematic reviews, this chapter utilises the statement in 
the review of the evidence.  
 
3.2 Research question 
What are the relative effects of pressure-relieving interventions used to treat 
heel ulcers? 
 
3.3 Research design 
It has already been suggested in the previous chapter that there are three 
elements, which are thought to contribute to the healing of heel pressure ulcers, 
namely: 
 Local wound management e.g. dressings and other therapies 
 Management of the patients’ internal risk factors such as co-morbidities 
 Relieving the pressure on the wound  
 
It is acknowledged that a study of the healing of heel ulcers should consider all 
aspects of treatment including devices used to relieve the pressure on the 
wound. While it is beyond the scope of this thesis to carry out a primary 
investigation into the use or effectiveness of pressure relieving devices, it was 
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thought to be important to identify any evidence base for their use. The findings 
of this investigation may identify effective pressure relieving interventions which 
will be used to inform the analysis of the epidemiological study of prognostic 
factors for healing of heel pressure ulcers. 
 
The most comprehensive way to review the evidence is to carry out a 
systematic review to a recognised quality standard. A systematic review is a 
method of secondary research which has the potential to assimilate all the 
available evidence; critically evaluate the quality and risk of bias in the studies; 
where appropriate combine results to produce a precise estimate of overall 
treatment effect (meta-analysis); provide a narrative result of the findings; 
generate new research questions and possibly demonstrate particular areas 
where there is a lack of evidence (Egger, Smith and Altman, 2001).  
 
When carrying out a search for information it is important to have the assurance 
that all the available information is identified, the quality of the information is 
scrutinised and results assimilated appropriately.  
 
It has been demonstrated by Antman et al. (1992) that evidence derived from 
narrative reviews or single studies may reach certain conclusions about the 
relative effectiveness of an intervention which are not supported by a 
systematic review of the evidence. These may mislead the user whereas a 
systematic review process provides the reader with the assurance of the 
findings based on the explicit nature of the quality assessment process.  
 
The process used in this review follows the guidance from the Cochrane 
Collaboration (Higgins and Green, 2008). The reporting of findings is in 
accordance with the statement of Preferred Reporting Items for Systematic 
reviews and Meta-Analysis (PRISMA) (Liberati et al., 2009). PRISMA is a 27 
item checklist of items which are essential for transparent reporting a 
systematic review and a four phase flow diagram which identifies the number of 
identified records, excluded articles and included studies.  
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The purpose of the PRISMA statement (Moher et al., 2009) is to guide readers 
of systematic reviews as to the quality of a review, enabling them to assess the 
strengths and weaknesses. The PRISMA statement was developed by an 
international group of review authors, methodologists, clinicians, medical 
editors and a consumer. It followed the previously devised statement, checklist 
and flow diagram which gave a preferred method for presenting the report of a 
meta-analysis. The objective was to revise and expand this Quality of Reporting 
of Meta-analysis (QUOROM) checklist (Moher et al., 2009). It had been 
recognised that the development of the science of reviews had progressed in 
recent years. However there were a few particular concerns that needed to be 
addressed: 
 The requirement to have a protocol, which is registered, (also the scope 
to amend the protocol in light of the studies identified) 
 More attention needed to be given to the assessment and reporting of 
bias, both within the individual studies and across studies e.g. 
publication bias 
 The recognition that not every systematic review will identify studies 
where results can be assimilated statistically (meta-analysis) 
 Declaration of funding 
 
The PRISMA statement checklist can be found at www.prisma-statement.org. 
This chapter uses the PRISMA statement checklist from Items 3-26 to present 
the review and then provides a critique of the process.  
 
3.4 Introduction 
Heel pressure ulcers, their development and management in terms of risk 
factors and topical treatments have been described in detail in the previous 
chapters. Very little is known about the contribution of the reduction or relief of 
pressure to the wound healing process. The rationale for this review is based 
on the assumption that the reduction of external pressure on the pressure ulcer 
will have a positive effect on the wound healing process. 
 
3.4.1 Ways of reducing pressure 
Reduction of pressure can be achieved through various actions: 
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1. Pressure can be removed by repositioning the body such that it is 
supported by areas of healthy tissue e.g. if the pressure ulcer is on the 
sacrum, the patient is placed in a lateral position (see figure 3.1).  
 
 
 
Figure 3.1 Patient shown in right lateral position  
While relief of pressure on the ulcer may be beneficial in the short term, if 
pressure is sustained on healthy tissue this may result in further ulceration at a 
different body site. Normal practice would be regular repositioning that aims to 
prevent pressure being sustained for long enough to cause damage. This may 
include a period of time with pressure on the ulcer, when the patient has 
several ulcers or a certain position is essential e.g. sitting up for eating. The 
physiological dose of this therapy is often difficult to determine as patients tend 
to roll back into the supine position.  
 
A systematic review of the evidence for repositioning to treat pressure ulcers 
has been conducted in December 2008 by Moore and Cowman (2009). This 
aimed to identify and synthesise the findings from all randomised controlled 
trials concerned with different repositioning regimes with the primary outcome 
being a measure of healing of any pressure ulcer.  This review found no RCT or 
Controlled Clinical Trials (CCT) which met the inclusion criteria. The authors 
concluded that the practice of repositioning patients has good face validity. 
However there is no available RCT evidence to provide specific guidance with 
respect to how frequently the patient should be moved, or what positions to use 
and which, if any, particular patients would benefit.  
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A support surface can be used, which reduces the overall pressure on the 
ulcer. In the laws of physics it is known that the pressure on an object is equal 
to the force exerted by the object divided by the area over which the force is 
applied. Any devices that increases contact with the body area by conforming to 
the shape of the body generally or the heel specifically will reduce the 
magnitude of the applied pressure.  The devices which work in this way are 
known as constant low pressure devices (CLP). They vary in their construction, 
for example foam, gel, sheepskin, air filled or water filled devices (see figure 
3.2). They also vary in complexity and price from simple homogonous foam or 
gel product through air filled cells e.g. low air loss mattress to highly technical 
and expensive air fluidised bead beds. 
 
 
  
Figure 3.2 Examples of CLP support 
surfaces  
(from top  left clockwise) Foam 
mattress; low air-loss mattress 
replacement; air fluidized bead bed 
 
 
A support surface can be used which mechanically varies the pressure on the 
ulcer, usually by alternating between periods of none and high pressure. These 
are known as alternating pressure (AP) surfaces (see figure 3.3). They are 
mostly found as beds, mattresses or seating cushions and are constructed of a 
series of air filled sacs which inflate and deflate in sequence. 
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Figure 3.3 Diagram of mechanism of alternating pressure support surface 
 A device may be used which constantly offloads the pressure from an ulcer e.g. 
Repose™ heel protectors. This results in other areas of the body giving support. 
There is therefore a potential risk of damage to these other body tissues, these 
devices are generally limited to use for a short period of time or in mobile 
patients e.g. a device which offloads the pressure from a heel ulcer when 
walking (see figure 3.4). Such devices may be used in the short term during a 
surgical operation e.g. devices which relieve pressure from the face when 
patients are in the prone position. 
  
 
Figure 3.4 Examples of offloading devices: Repose™ heel  
boot (left); PRAFO™ boot (right) 
 
3.4.2 Types of support surfaces 
When investigating the effectiveness of a support surface, a decision about a 
suitable control intervention will need to be made. The usual practice for the 
care of a patient with a pressure ulcer is to provide additional pressure relief to 
the standard hospital mattress or chair. In most cases it is deemed unethical to 
not provide additional relief for the control group. The multitudes of devices on 
the market vary considerably in terms of cost e.g. foam mattresses range from 
approximately £80 - £500 each and AP mattress replacements range from 
£2000 - £6000, depending on mechanical robustness, ease of use and patient 
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comfort. The choice of control intervention should take into account both 
primary outcomes (the healing of the pressure ulcer) and also the secondary 
outcomes such as unit costs, overall costs (including power supplies, service 
maintenance and depreciation), nursing time and patient quality of life. When 
considering the quality of a study of support surfaces, consideration will need to 
be given to the appropriateness of the control and the secondary outcomes. 
Categorisation of support surfaces would be helpful to trialists and reviewers as 
this would promote the use of a clinically meaningful comparator. 
 
The previous section described broad categorisations of pressure reducing 
devices. Using the CLP and AP supports categories there has been further 
detailed categorisation of CLP devices provided by NICE in their guideline 
CG29 (RCN, 2005) which are based on those defined in a previous Cochrane 
systematic review by Cullum et al (2004): 
‘CLP support surfaces can be grouped according to their construction: 
• Standard foam 
The conformability and resilience of foam products may vary considerably between 
manufacturers. Foam may be shaped, convoluted (“egg crate foam”), of various 
densities or of a combination of densities. 
• Visco-elastic foam 
This is specialised foam, available in varying densities, that moulds to body shape in 
response to body temperature. 
• Air flotation 
This is an inflated mattress replacement/overlay that manually or automatically adjusts 
airflow allowing immersion and redistribution of pressure. It is adjustable to individual 
reposition to maintain immersion and redistribution of pressures. 
• Air fluidised 
A constant flow of air is passed into a deep tank containing minute silicone beads 
retained by a permeable membrane. The agitated beads take on the properties of a 
fluid. Lying on the surface allows significant immersion and therefore redistribution of 
pressure. 
• Low air loss 
A constant flow of air inflates a row of permeable fabric cells. Manual or automatic 
adjustment of airflow allows significant immersion and therefore redistribution of 
pressure. 
• Gel/fluid 
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Fluid surfaces – e.g. water-filled mattresses – which allow significant immersion and 
therefore redistribution of pressure. The density/viscosity of the gel/fluid will govern the 
degree of immersion and how stable the support surface is in terms of posture. 
• Combination products 
Many CLP surfaces, particularly cushions, use a variety of materials to provide 
optimum pressure relief and postural stability. 
N.B. The type and construction of cover material may have a significant impact 
on the conformability of the surface.’ 
  (RCN, 2005) p.79 
However, a recent Cochrane systematic review (McInnes et al., 2008) of 
support surfaces for prevention of pressure ulcers, suggests a division of the 
support surfaces into ‘high tech’ and ‘low tech’. 
 
High tech includes all AP devices, air fluidised bead beds and low air loss 
mattress CLP. All other CLP devices are considered ‘low tech’ and other 
support surfaces such as limb protectors are considered in a separate category. 
In reality the paucity of evidence for any type of support surface makes it 
difficult to guide clinical practice. Studies such as Price et al. (1999) have 
attempted to challenge the assumption that ‘high tech is better than low tech’.  
 
3.4.3 Pressure relieving devices for prevention or treatment 
A study of the papers investigating the clinical effectiveness of pressure 
relieving devices in pressure ulcer prevention and treatment in 2002/3 found 
more studies focused on prevention than treatment (Zanca et al., 2003). The 
pathophysiology of the effects of pressure on body tissues leading to ulceration 
led to the notion of relieving the pressure as the key preventative intervention. 
Similar assumptions are made when identifying the relief of pressure as the key 
intervention for treating pressure ulcers.  
 
It is tempting to assume that interventions which are effective in prevention 
would also be effective in the treatment of pressure ulcers. While this 
proposition has face validity, there is insufficient evidence to suggest that the 
presence and magnitude of effectiveness would be the same.  
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McInnes at al. (2008) performed a systematic review of support surfaces for 
prevention concluding that foam mattress replacements were more effective 
than standard hospital mattresses at preventing pressure ulcers in patients at 
high risk. They were unable to draw any firm conclusions about the relative 
effectiveness of AP or CLP support surfaces but suggest that AP mattress 
replacements may be more cost effective than AP overlays. They did find that 
medical grade sheepskin overlays are more effective at reducing the incidence 
of pressure ulcers than standard care alone. However no details are given for 
the site of the pressure ulcer. The review did include some studies of heel 
pressure relieving devices, but no significant differences were found between 
the intervention and control groups. The McInnes review was conducted in 
2008, this reviewer is aware of one recently published RCT of a heel pressure 
relieving device (Donnelly et al., 2011), which was not included. Further studies 
may have been undertaken since this time. 
 
The RCN (2005) reviewed support surfaces for treatment and concluded that: 
‘There is some evidence to show that air flotation supports reduce the size of 
more established pressure ulcers compared to a modified alternating pressure 
support, or standard care (standard bed with CLP supports, medical grade 
sheepskin, gel pads, air-filled supports, water-filled mattresses and high-density 
foam pads).There is no conclusive evidence to support the superiority of either 
alternating pressure support surfaces or continuous low pressure supports in 
the treatment of existing pressure ulcers’. There is no detail given in the review 
to identify sites of the pressure ulcers on the body.  
 
A search of the Cochrane Central Register of Controlled Trials for any trials of 
support surfaces for treatment has not revealed any new studies although other 
studies may have been carried out.  
 
3.4.4 Heel pressure ulcers 
The previous chapter has already described the difference in the anatomy of 
the heel and the pathophysiology of pressure ulcer development relative to 
other body sites at risk of pressure ulcer development. It has also discussed 
what is known about the healing process and suggested potential physiological 
-90 - 
differences found in the feet, which may specifically influence the healing 
process in the heel. 
 
The systematic reviews discussed in section 3.4.3 were carried out over a year 
ago and do not give any details of healing heel ulcers. It is for these reasons 
that this systematic review has focused specifically on the healing of heel 
pressure ulcers.  
 
3.4.5 Objectives 
To examine whether any pressure relieving devices improve the healing of heel 
pressure ulcers this study reviews all randomised controlled trials (RCTs) that 
assess efficacy of devices for treating heel pressure ulcers compared to other 
devices or standard care in participants of any age in any care  
 
While several related reviews use the term ‘support surface’ to describe the 
intervention of interest, it was felt that this term was too limiting as it suggests a 
bed, mattress or cushion. It was felt that the term ‘pressure relieving device’ is a 
broader, more inclusive term which would be more appropriate for heel ulcers. 
It was expected that this would identify studies of specific devices for off loading 
the pressure from the heel as well as support surfaces.  
 
3.5 Methods 
3.5.1 Protocol and registration 
The protocol is published on the Cochrane data base, address: 
http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005485/frame.h
tml  
It is registered as - McGinnis E, Stubbs N. Pressure relieving devices for 
treating heel pressure ulcers (Protocol). Cochrane Database of Systematic 
Reviews 2005, Issue 4. Art. No.: CD005485. DOI: 
10.1002/14651858.CD005485.  
The full review will be published on 7
th
 September 2011 (Issue 9). 
 
This protocol was written by the researcher and approved by the co-author. 
According to Liberati et al. (2009), having a review protocol which is available 
for scrutiny reduces risk of bias occurring when carrying out the review. 
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Predetermined outcomes, methods of data extraction and analysis will reduce 
the likelihood of post hoc decisions such as selective outcomes reporting which 
may lead to bias.  
 
A study by Silagy et al. (2002) examined 47 Cochrane systematic reviews and 
found that 43 had a major change such as the addition or deletion of an 
outcome measure, between the protocol and full publication. While some of 
these changes may be due to the exclusion of outcomes which were not 
reported in any of the studies, it is well known that bias from selective outcome 
reporting in RCTs exists (Chan et al., 2004) and therefore the potential for this 
to be extrapolated to a review is high. This may lead to over estimates of the 
benefits of the intervention.  
 
3.5.2 Eligibility criteria  
3.5.2.1 Types of participants   
All patients with existing heel pressure ulcers in any care setting were eligible. 
For the purposes of this study, a heel pressure ulcer was defined as localized 
damage to the skin and underlying tissue (EPUAP, 1998) Grades 1-4, believed 
to be caused by pressure, shear or friction, found on all or part of the external 
aspect of the calcaneum (the bone at the back of the foot) extending from the 
plantar surface to below the Achilles tendon.  
 
Consideration has been given to the inclusion of patients with diabetic foot 
ulcers (DFUs) on the heel.  DFUs are wounds in people with diabetes, which 
occur anywhere on the foot, including the heel and can be pressure related. 
There are two Cochrane systematic reviews on preventing and treating DFUs, 
but these do not define foot ulcer so may include heel pressure ulcers 
(Spencer, 2000; Valk Gerlof, Kriegsman Didi and Assendelft Willem, 2001) 
Neither of these reviews looked at heel ulcers as a subgroup. Patients with 
DFUs of the heel will therefore be included. 
 
3.5.2.2 Types of interventions   
Pressure relieving or reducing aids are usually used in combination with wound 
care to improve healing of a pressure ulcer. Pressure-relieving aids include the 
following devices listed below. 
-92 - 
Mattresses: 
foam overlays 
foam mattress replacements 
alternating air-filled overlays 
alternating air-filled mattress replacements 
air overlays 
air-fluidised bead beds 
Heel-specific aids: 
air-filled booties 
foam foot protectors 
gel foot protectors 
pillows and other aids positioned under the legs to relieve pressure 
splints or other medical devices 
sheepskin 
 
It was intended that eligible studies would be those that compared any of the 
interventions listed above either with each other, no intervention or standard 
care as defined by the trial. Where records were identified, which did not 
specify on which body sites the pressure ulcers were, it was intended to retrieve 
full articles and, if appropriate, write to authors to establish whether heel ulcers 
were included and if data was available to carry out separate analysis. 
 
3.5.2.3 Types of outcome measures   
Primary outcomes   
1. Proportion of heel ulcers healed within a defined time period 
2. Time to complete healing of heel ulcer 
Secondary outcomes   
1. Costs of pressure relieving devices 
2. Total costs of interventions (including servicing and maintenance) where 
given 
3. Any measure of patient comfort 
4. Any measure of ease of use 
5. Any measure of health-related quality of life 
6. Adverse events associated with the intervention. 
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While the main outcome of interest is related to the healing of the ulcers, 
evidence from other studies (RCN, 2005) suggest that it is unlikely that a large 
body of evidence in this field will be found. In order to provide guidance for 
clinical staff where there is little evidence of effectiveness for interventions it is 
important to consider all the related outcomes which will be of relevance to both 
clinical staff and patients as these may inform decisions. 
 
3.5.2.4 Types of studies   
All randomised controlled trials (RCTs) which compared the effectiveness of 
pressure-relieving devices on heel pressure ulcer healing were included. RCTs 
which compared effects of pressure relieving devices for diabetic foot ulcers 
specifically were to be included if heel ulcers were separately identified. 
Controlled clinical trials (CCTs) were to be included only in the absence of 
RCTs. There was no restriction on publication status, year or language of 
publication. This is discussed in further detail in section 3.6.6. 
 
3.5.3 Information sources 
Trials to be considered for this review were sought from the Cochrane Wounds 
Group Specialised Register and the Cochrane Central Register of Controlled 
Trials (CENTRAL) which considers years from 1966 to present (searched 
25.3.11). Searches were also performed on Ovid MEDLINE – (1948 to 
November Week 3 2011), Ovid MEDLINE - In-Process & Other Non-indexed 
Citations (Searched 29.3.11) Ovid EMBASE - (1980 to 2009 Week 12), EBSCO 
CINAHL – (1982 to 25.3.11). 
 
The Cochrane Wounds Group Specialised Register has been compiled through 
searching the major databases including MEDLINE, CINAHL and EMBASE and 
is regularly updated through searching the Cochrane Central Register of 
Controlled Trials, hand searching of wound care journals and relevant 
conference proceedings.  
 
The search strategy was developed from strategies used in similar reviews of 
pressure relieving devices. It included additional terms used by current 
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manufacturers to describe their products, also terms used by podiatrists to 
describe heel specific devices. Terms used to identify RCTs and CCTs were 
those used by the Cochrane Wounds Group. The strategy was developed by 
the lead reviewer in collaboration with the co-reviewer, a senior podiatrist and 
the Cochrane Wounds Group. It was run by a member of the Cochrane 
Wounds Group. The strategy was approved as part of the protocol by the 
reviewers.  
 
3.5.4 Search 
The following search strategy was used: 
#1. BEDS single term (MeSH) 
#2. (bed or beds or bedding) 
#3. mattress* 
#4. (cushion* and (foot or feet)) 
#5. (foam or foams or cutfoam) 
#6. overlay* 
#7. (pad or pads or padding) 
#8. (gel near pressure) 
#9. (gels near pressure) 
#10. (pressure near relie*) 
#11. (pressure near device*) 
#12. (pressure near reduction) 
#13. (pressure near reducing) 
#14. (pressure near redistribution*) 
#15. silicore 
#16. ((low next pressure) and support*) 
#17. ((low next pressure) and device*) 
#18. (constant near pressure) 
#19. (alternat* near pressure) 
#20. (air near suspension*) 
#21. (water near suspension*) 
#22. (heel near protector*) 
#23. sheepskin* 
#24. (foot next waffle) 
#25. (air next bag*) 
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#26. (elevation near device*) 
#27. (static next air) 
#28. shoe* 
#29. footwear* 
#30. (callus near remov*) 
#31. hosiery 
#32. orthoses 
#33. orthosis 
#34. (orthotic near device*) 
#35. (orthotic near therap*) 
#36. (foot near pressure) 
#37. (foot near protect*) 
#38. (feet near pressure) 
#39. (feet near protect*) 
#40. (heel near pressure) 
#41. (heel near protect*) 
#42. (contact and cast*) 
#43. (walking near cast*) 
#44. (boot near pressure) 
#45. (boots near pressure) 
#46. (booties near pressure) 
#47. (glove* near water) 
#48. (heel near lift) 
#49. (heel near float*) 
#50. (heel near suspension*) 
#51. (heel near elevat*) 
#52. (splint* near heel) 
#53. (trough near leg*) 
#54. (trough near foot) 
#55. (trough near feet) 
#56. (trough near heel) 
#57. (glove* and heel) 
#58. (foot near device*) 
#59. (feet near device*) 
#60. (heel near device*) 
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#61. pillow* 
#62. (#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or 
#13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or 
#24 or #25 or #26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or 
#35 or #36 or #37 or #38 or #39 or #40 or #41 or #42 or #43 or #44 or #45 or 
#46 or #47 or #48 or #49 or #50 or #51 or #52 or #53 or #54 or #55 or #56 or 
#57 or #58 or #59 or #60 or #61) 
#63. DECUBITUS ULCER explode all trees (MeSH) 
#64. (decubitus near ulcer*) 
#65. (bed near ulcer*) 
#66. (pressure near ulcer*) 
#67. (pressure near sore*) 
#68. (bed near sore*) 
#69. (#63 or #64 or #65 or #66 or #67 or #68) 
#70. (#62 and #69) 
#71. (heel or foot or feet) 
#72. (#70 and #71) 
The search strategy was last run on 30
th
 March 2011. 
 
There was no restriction on date of publication, language of publication, or 
publication status (published or unpublished work). Studies and articles cited in 
articles identified were checked for eligibility. 
 
3.5.4.1 Searching other resources   
Experts in the field were contacted and asked if they had been involved in any 
further studies or were aware of recent or ongoing studies on the treatment of 
heel pressure ulcers. Manufacturers of pressure-relieving equipment were 
contacted for studies which included heel pressure ulcers. In the original 
published protocol (McGinnis and Stubbs, 2005) it was planned to hand search 
two journals: Phlebology and Diabetic Foot for the ten most recent years. At the 
time these journals were not indexed in any electronic data base and the 
reviewer thought that they may be a potential source of publication of relevant 
studies. These two journals are now indexed in Medline and the most recent 
year hand searched at the Cochrane Wounds Group editorial base. 
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3.5.5 Study selection 
Two reviewers separately examined the titles and abstracts of trials generated 
by the search to identify those with potential relevance. Disagreements were 
resolved by consensus. Full texts of potentially relevant articles were retrieved. 
With the full text of these articles, the two reviewers independently assessed 
each study for inclusion according to the selection criteria. 
 
3.5.6 Data collection process 
Details of eligible trials were extracted and summarised using a data extraction 
sheet. The data extraction sheet was devised by the lead reviewer, who 
identified the key information required from the study and had examined similar 
sheets used by other reviewers, it was piloted by each reviewer using it to data 
extract from the same publication and comparing the extractions 
 
Attempts were made to obtain any missing data by contacting the study 
authors. Data from studies that had been published more than once were 
included only once. However, where trials were published more than once, the 
data extraction process utilised all available sources to facilitate the retrieval of 
the maximum amount of trial data possible. Data extraction was undertaken by 
the two reviewers independently. Disagreements were resolved by consensus. 
 
3.5.7 Data items 
The following data was extracted: 
 author, title, date of study and publication 
 source of reference 
 sample size 
 patient inclusion and exclusion criteria; 
 country and study setting; 
 baseline variables, for example age, sex, diagnosis, co-morbidity, 
baseline risk, details of existing ulcers; 
 description of interventions; 
 numbers of patients - both randomised and analysed; 
 description of any co-interventions; 
 follow-up period; 
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 results; 
 outcome measures; 
 adverse events; 
 use of intention-to-treat analysis; 
 trialists' conclusions. 
 
3.5.8 Risk of bias in individual studies
 
 
The validity of the studies was assessed to detect potential sources of bias 
from the study design. Assessment included: 
 use of clear inclusion and exclusion criteria; 
 extent of allocation concealment at the point of randomisation; 
 method of generation of the randomisation sequence; 
 baseline comparability of treatment groups for important variables; 
 use of intention-to-treat analysis - whether participants were analysed in 
the groups to which they were originally randomised; 
 length of follow up and extent of loss to follow up; 
 evidence of blinded outcome assessment. 
 
The information was recorded on the data extraction sheet. Data was extracted 
by each reviewer separately for each trial, which definitely met the inclusion 
criteria. Those where there was uncertainty (usually due to lack of information), 
clarification was sought from the trial authors.  
 
Following attempts to contact authors the two reviewers then considered the 
included studies together with all additional information provided. This enabled 
agreement to be reached on what should be used in the data synthesis. 
 
3.5.9 Summary measures
 
 
Summary measures were not pre-specified.  The primary outcome measures 
were the number of ulcers healed in a given time or time to complete healing. 
The results of ulcers healed or not healed (dichotomous variable) were 
presented as Relative Risk (RR) with confidence intervals (CI). Relative risk is 
the pressure ulcer healing rate in the intervention group divided by the healing 
rate in the control group and indicates the likelihood of pressure ulcer healing 
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on an intervention device compared with a comparison device. RR will be used 
rather than odd ratio as event rates are high and odds ratio is likely to give an 
exaggerated impression of the size of the effect (Deeks, 1998). If studies had 
been identified with primary outcomes as time to complete healing (a 
continuous measure using the same scale) then results would have been 
presented as Mean Difference, This would be a calculation of the difference in 
means using the number of participants, the mean response and its standard 
deviation to weight each study. 
 
3.5.10 Planned method of analysis
  
A narrative summary and if appropriate, a meta-analysis, of results was 
planned. The method of synthesising the studies depends upon the quality, 
design and heterogeneity of studies identified. If the clinical characteristics, 
methodology, outcome measures or statistical tests are too variable it would be 
inappropriate to perform a meta-analysis. It was planned to estimate the extent 
of heterogeneity between study results using the I
2 
statistic (Higgins et al., 
2003). This examines the percentage of total variation across studies due to 
heterogeneity rather than to chance. Values of I
2
 over 75% indicate a high level 
of heterogeneity. In the presence of statistical heterogeneity we planned to use 
a random-effects model for pooling. If there was no statistical heterogeneity or 
where I
2
 is less than 75%, we planned to apply a fixed-effect model. Results 
would be presented with 95% confidence intervals. Estimates for dichotomous 
outcomes would be reported as relative risks and mean difference for 
continuous outcomes. 
 
3.5.11 Risk of bias across studies  
This inclusion of this item is a relatively new consideration for systematic 
reviews and it was not anticipated at the protocol stage of this review. It is 
however discussed in more detail in the results section.  
 
3.5.12 Additional analysis 
 
It was planned to carry out two subgroup analyses, to identify whether the 
summary effects would vary in relation to specific characteristics of study 
participants: 
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 Specific conditions e.g. diabetes or peripheral vascular disease are 
known to affect healing rates (Fahey et al., 1990) 
 Grade of ulcer. It is known that the reliability of pressure ulcer diagnosis 
and classification is particularly poor with Grade 1 pressure ulcers (Nixon 
et al., 2005). A comparative analysis of outcomes for groups which 
include or exclude Grade 1 ulcers was planned.  
 
3.6 Results 
3.6.1 Study selection
 
 
A flow diagram is given for the study selection process in figure 3.5 using the 
PRISMA template. 
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PRISMA 2009 Flow Diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 3.5 PRISMA flow diagram (adapted from Moher et al. (2009)) 
 
The initial search identified 472 records of studies. Letters or emails were sent 
to ten wound care experts, three replies were received. Fifteen letters were sent 
to manufacturers of pressure redistributing devices, two responses were 
received. No further trials were identified. 
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Records after duplicates removed 
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Full-text articles assessed for 
eligibility (n = 70) 
Full-text articles excluded, with 
reasons (n =  69) 
Studies included in  qualitative 
synthesis (n = 1) 
Studies included in quantitative 
synthesis (meta-analysis)(n = 0) 
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Following independent review of the abstracts by the two reviewers, 70 were 
thought to potentially meet the inclusion criteria or contain useful references 
and were retrieved. The two reviewers independently assessed the studies for 
inclusion according to the selection criteria. Several studies were thought to be 
potentially eligible if the original data was available and heel outcomes could be 
analysed separately. 20 authors were written to or contacted, three responses 
were received: one stating no heels were included, one stating no separate 
data was available and one providing the original thesis with full method and 
results. 
 
Fifteen studies were conference presentations. Searches for further 
publications by each of the listed authors were made but only two full 
publications with useful data were obtained. 
 
Sixty nine studies were excluded: ten were reviews, 18 studies were not RCTs, 
18 studies were concerned with prevention (rather than treatment of the ulcer), 
nine considered treatment of pressure ulcers on body sites other than the 
heels, 12 considered treatment of ulcers on various body sites including heels 
but data could not be analysed separately and two were reviews in another 
language. 
 
3.6.2 Study characteristics
: Russell (2000) Published and unpublished 
data 
One study met the inclusion criteria: 
Russell L, Reynolds TM. Randomised controlled trial of two pressure-relieving 
systems. Journal of Wound Care 2000;9,2:p52-55. 
 
Characteristic Description 
Sample size 141 patients (113 patients with heel ulcers) 
Inclusion and 
exclusion criteria 
Inclusion criteria - patients with a pressure sore Grade 2 
(Torrance, 1983) i.e. non blanching erythema with and without 
epidermal loss, and above; able to give informed consent. 
Exclusion criteria - patients who were unwilling to participate; 
randomised equipment was not available; patient who had 
previously been in the study; patients who weighed > 25 stones. 
Care setting Healthcare of the elderly unit in the UK 
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Baseline variables The following baseline variables were given and appeared to the 
reviewers to be similar - age, Waterlow score (risk of developing 
pressure ulcers (Waterlow, 1998), Burton score (nutrition 
indicator (Russell et al., 1998)), average Grade of sore, worst 
Grade of sore. Gender and duration or size of pressure ulcer 
was not recorded 
Study group A 70 patients (55 with heel ulcers): average severity of pressure 
ulcers (Torrance (1983)) = 2.46 
Study group B 71 patients (58 with heel ulcers): average severity of pressure 
ulcers (Torrance (1983))= 2.57 
Description of 
interventions 
Both groups had two interventions: AP mattresses and cushion 
systems 
Group A: Nimbus 3 mattress and Aura seat cushion 
Group B: Cairwave mattress and Proactive seat cushion 
Number of patients 
(randomised and 
analysed) 
In total this study recruited 186 patients, 141 were analysed. 
This included both heel and sacral pressure ulcers. As a result of 
further communication with the author, heel data were provided 
and could therefore be analysed separately. See figure 3.6 
below. 
Description of co-
interventions 
Pressure ulcers were treated according to the Trust Wound Care 
Formulary, the Tissue Viability (TV) nurse’s recommendations 
and the TV link nurses protocol. Patients were turned according 
to manufacturer’s recommendations: four hourly for those 
assigned to the Nimbus system and eight hourly for those 
assigned to the Cairwave system, or more often if requested by 
the patient or considered necessary by the nursing team. 
Follow up period Patients were followed up till they healed, were discharged or 
died. Data was collected weekly. No time to healing was given. 
Allocation method Randomisation was by computerised random number generation 
and treatment allocation was by consecutively numbered sealed 
opaque envelopes. Personnel and patients were not blinded to 
treatment. 
Results - both 
group 
113 patients with heel ulcers were randomised to either Nimbus 
+ Aura or Cairwave + Proactive. See figure 3.6 for details. 
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Outcome measures Completed study (healed, discharged or died), also patient 
comfort. Patient comfort was measured using a visual analogue 
scale taken from Gray and Campbell (1994) An economic 
evaluation was planned but no details are given in the available 
documents. Data collectors for healing outcomes were not 
blinded to the intervention but those who collected patient 
comfort data were. 
Adverse events No adverse patient events were reported. Two Nimbus 
mattresses, 10 Aura seat cushions, 7 Cairwave therapy systems 
and 6 Proactive cushions required repair. 
Use of intention to 
treat analysis 
Although the author says an intention to treat protocol was used. 
The analysis is given for those who ‘completed study’ and those 
who ‘completed study’ and died. Those who were discharged 
were assumed not to have healed. There is no analysis which 
takes full account of all those lost to follow up 
Trialists 
conclusions 
Nimbus mattress + Aura cushion is more effective for treating 
heel ulcers than the Cairwave mattress + Proactive cushion. 
Table 3.1 Russell (2000b) Study characteristics 
 
The data in Russell’s publication and personal communication included sacral 
pressure ulcers. This heel ulcer information has now been extracted and has 
been compiled into a flow diagram shown in figure 3.6. 
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Patients with heel pressure 
ulcers n=113
Nimbus/Aura
n=55
Carewave/Proactive
n=58
Alive
n=41
Died
n=14
Alive
n=44
Died
n=14
Healed
n=24
Healed
n=17
Discharged 
or did not 
heal n=17
Discharged 
or did not 
heal n=27
 
 
Figure 3.6 Flow chart of data heel ulcer data, extracted from  
publication and personal communication 
 
3.6.3 Risk of bias within the study 
When carrying out a review of research studies it is important to consider bias 
at both the study level and the review level. Bias at review level is considered in 
section 3.6.6. 
 
A bias in a research trial is ‘a systematic error or a deviation from the truth in 
results or inferences’ (Higgins and Green, 2008). Biases can occur when either 
the design, conduct, analysis or reporting of a trial have insufficient rigour. The 
effect of a bias may lead to an over or under-estimation of treatment effect 
depending on the type of bias. It is important to consider bias in each reviewed 
study as the process of meta-analysis carries a risk of overestimating effect 
size if the pooling of results are taken from poor studies, whose results are in 
favour of the intervention. It is important to recognise that the results of a study 
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may not be biased even though it may not have been carried out in a rigorous 
manner or it may have been inadequately reported (due to word limits in 
publications). In order not to assume ‘error’ the term ‘risk of bias’ is preferred by 
reviewers. The main types of bias can be classified as follows: 
 Sequence generation - was the sequence for allocation of the 
intervention adequately generated (truly random)?  
 Allocation concealment - was the treatment allocation adequately hidden 
from those who were recruiting subjects and the participants 
themselves? 
 Blinding of participants, personnel and outcomes assessors - was 
knowledge of the allocated intervention adequately prevented in the 
study such that any results could not be affected by individuals 
preconceived ideas or expectations? 
 Incomplete outcome data - where all outcome data was not available, 
has the analysis taken this into account and considered how this 
affected the results? 
 Selective outcome reporting - do reports of the study include all planned 
outcomes, omissions may suggest only favourable outcomes reported or 
not address important qualitative outcomes? 
 Other sources of bias - any other important concerns about the quality or 
validity of the study such as inclusion bias (selection of subjects from an 
unrepresentative group), performance bias (systematic differences in the 
care given apart from the intervention of interest), attrition bias (loss of 
participants to follow up, particularly when unequal across groups)? 
(Higgins and Green, 2008) 
 
3.6.3.1 Risk of bias in Russell (2000) 
In the Russell study, adequate sequence generation to allocate the intervention 
was achieved by using a series of computer generated random numbers to 
allocate intervention, which were placed in sealed opaque consecutively 
numbered envelopes to achieve allocation concealment.  
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The risks of biases present include: 
 Performance bias 
o blinding of participants and care providers did not take place. In a 
trial of a medical device it is usually impossible to blind the patient 
to the treatment. While both groups had a specific intervention, 
patients previous experience of particular equipment may 
influence their comfort reporting. It is not possible to blind the staff 
caring for the participants.  
o detection bias It is very difficult to blind the data collectors. An 
option would be to take photographs of the wounds and have 
them analysed by someone blinded to the intervention.  In this 
study the data collection was carried out by one of 3 designated 
nurses. There was no stated test of inter-rater reliability. However, 
the nurses ‘regularly work together’, suggesting some degree of 
agreement. A study by Nixon et al. (2006) included an 
assessment of inter-relater reliability for the grading of pressure 
ulcers. This study found good levels of agreement between 
research nurses although where agreement did not occur this was 
for intact skin, blanching and non-blanching erythema. The 
Russell study only recruited those with Grade 2 and above using 
the Torrance scale (1983). However, Grade 2 on this scale 
includes non-blanching erythema with and without epidermal loss. 
It is probable that their assessment of this Grade of pressure ulcer 
would not have good agreement. Reliability of the skin 
assessment cannot be assured. Data collection for the patient’s 
comfort rating was carried out by an auditor, who was unfamiliar 
with the treatments. The data collection tool was based on a non- 
validated scale used by Gray and Campbell(1994). 
 Attrition bias 
o Protocol deviations occurred with two patients being unable to 
sleep on the mattresses (no detail of which allocated treatment 
group these were). Loss to follow up has resulted in a high risk of 
bias. One aim of the study was to compare the efficacy of the two 
mattresses and cushion systems in the treatment of pressure 
ulcers. The results are given for numbers of patients who 
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completed the study (healed, discharged or died).  Intention to 
treat (ITT) analysis is reported to have been carried out, however 
the author only includes those who had died not those who were 
discharged from hospital. The loss to follow up was up to 56% in 
one group and 71% in the other. Even if a full ITT analysis had 
been carried out these significant losses can bias the study 
(Bowers, House and Owens, 2005). Details of loss to follow up 
are given and are summarised in figure 3.6 of this review.  
 
The length of follow up is not given; data were collected at weekly intervals 
many patients were discharged after only the baseline data collection. The 
average length of stay (21.5 days for both groups) gives an indication of follow 
up time although there is no suggestion of a relationship between hospital stay 
and healing. 
 
Both treatment groups were comparable at baseline for most of the relevant 
variables however the gender mix is not given or the size and duration of the 
ulcer prior to recruitment. It is known that healing in post menopausal women is 
longer than in men due to the influence of hormones (Gilliver and Ashcroft, 
2007), (Gniadecki et al., 1996) and studies of leg ulceration and diabetic foot 
ulceration have suggested that the size and duration of a wound is likely to 
influence its likelihood of healing (Margolis, Berlin and Strom, 2000; Margolis et 
al., 2000). If a treatment group had more older women or pressure ulcers of 
greater size and duration it is likely that the results would favour the other 
group.  
 
Although this was a well designed and executed study, the non-reporting of 
baseline comparability for gender and duration and size of ulcers and the 
significant loss to follow up through patients either dying or being discharged 
has a major impact on the confidence which can be placed on the findings of 
the study.  
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3.6.4 Individual results of the Russell (2000) study 
The primary outcomes of interest to this review were proportion of heel ulcers 
healed within a defined time period or time to complete healing of heel pressure 
ulcers. Russell (2000) used the outcome of ‘completed study’. Results are 
reported for the number of heel ulcer patients who completed the study and an 
ITT for those who completed and died. (Two patients healed in the Cairwave 
group and 6 patients in the Nimbus group).The following figures (figure 3.7 and 
3.8) show the risk ratios and forest plots for both these sets of data.  
 
Study or Subgroup
Russell 2000
Total (95% CI)
Total events
Heterogeneity: Not applicable
Test for overall effect: Z = 1.80 (P = 0.07)
Events
24
24
Total
41
41
Events
17
17
Total
44
44
Weight
100.0%
100.0%
M-H, Fixed, 95% CI
1.52 [0.96, 2.38]
1.52 [0.96, 2.38]
Nimbus Cairwave Risk Ratio Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours Cairwave Favours Nimbus
 
Figure 3.7 Data from Russell study including Forest Plot where  
event is healed and denominator is ‘completed study alive’ 
 
This gives a risk ratio of 1.52 with a confidence interval of 0.96 - 2.38. Although 
this shows a trend towards the effectiveness of the Nimbus and Aura system, 
the confidence interval crosses the line of no effect so the difference in effect is 
not statistically significant (p = 0.07) 
Figure 3.8 Data from Russell study including Forest Plot where event 
healed and denominator is ‘completed study alive + died’ 
 
Figure 3.8 represents an analysis carried out by Russell et al (2000) which 
includes the patients who died. It gives a risk ratio of 1.67 with a confidence 
interval of 1.07 - 2.59). As this does not now cross the line it is statistically 
significant (p = 0.02) in favour of the Nimbus and Aura mattress system. 
 
Study or Subgroup
Russell 2000
Total (95% CI)
Total events
Heterogeneity: Not applicable
Test for overall effect: Z = 2.27 (P = 0.02)
Events
30
30
Total
55
55
Events
19
19
Total
58
58
Weight
100.0%
100.0%
M-H, Fixed, 95% CI
1.67 [1.07, 2.59]
1.67 [1.07, 2.59]
Nimbus Cairwave Risk Ratio Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours Cairwave Favours Nimbus
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Further sensitivity analyses are performed taking into consideration patients 
who were either discharged prior to healing or did not heal is given in section 
3.6.7.  
Secondary outcomes: 
 Cost of pressure relieving device - costs of the mattresses and 
cushions are not given 
 Total cost of interventions - total costs of interventions are not given 
(an economic analysis was planned but not reported in the 
documents available) 
 Patient comfort - Patient comfort was measured using a non-
validated visual analogue scale taken from Gray and Campbell 
(1994). Data were collected by members of the audit department. It 
contained questions which assessed mattress comfort, sleep and 
cushion comfort. The information available is not presented 
separately for sacral and heel pressure ulcers. Statistical 
comparisons were only carried out on data from patients who 
completed the trial. Mean comfort scores were calculated for each 
question and did not show any statistical significant difference 
between the 2 groups. Full details are given in table 3 of the 
publication (Russell et al., 2000) 
 Ease of use - Ease of use was not specifically considered although 
reference is made to training on both mattress systems and a 'run in' 
period to ensure staff were familiar with both systems. No specific 
differences were reported. 
 Health related quality of life - this is not reported. 
 Adverse events - No patient adverse events were reported. 2 Nimbus 
mattresses, 10 Aura seat cushions, 7 Cairwave mattresses and 6 
Proactive cushions required repair 
 Subgroup analysis - not enough detail is available to perform 
subgroup analysis for either co-morbidity or Grade of ulcer. 
3.6.5 Synthesis of results 
As only one study was included, no synthesis could be undertaken. 
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3.6.6 Risk of bias across studies 
When carrying out a systematic review it is important to consider both the risk 
of bias within each study and the risk of bias across all the identified studies. It 
is well known that studies which show a statistically significant treatment effect 
are more likely to be published, more likely to be published in English, more 
likely to be cited by other authors and more likely to produce multiple 
publications and therefore more likely to be identified for systematic reviews 
(Sterne et al Chapter 11 p 189 in (Egger, Smith and Altman, 2001). It is with 
this in mind that the rigorousness of the method for finding studies is vital. A 
systematic review may show evidence of treatment effect from a number of 
studies when the reality is either no evidence of effect or a result which favours 
the control when unpublished studies are included. Even when searches for 
studies have been rigorous it is advisable to check for publication and other 
biases across the retrieved studies. It is also apparent that trial quality 
influences the size of estimated treatment effects and smaller trials are more 
likely to be of poorer quality (Egger, Smith and Altman, 2001)This information 
can be used to produce a funnel plot (a scatter diagram of treatment effect 
against study size) which will show asymmetry when either publication bias or 
exaggerated treatment effects are present in small studies of poor quality. 
 
While the main concern regarding bias across studies relates to whether 
studies are published or not, there are other potential sources of bias e.g.: 
 Duplicate publications (where the reviewers are unable to identify 
multiple publications of the same study). In 1989 Gotzsche 
demonstrated through a review of trials of non-steroidal anti-
inflammatory drugs for the treatment of osteoarthritis, the difficulties in 
identifying multiple publications and the discrepancies such as 
differences in outcomes reported and treatment effects, between 
different publications of the same study (Gotzsche, 1989). He 
recommended the adherence to editors’ guidelines to reduce these 
occurrences. While it could be argued that this problem is likely to have 
reduced in recent times a more recent review by Tramer et al. (1997) of 
trials of an anti-emetic to reduce post operative vomiting, also 
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demonstrated that the results of nine trials had been published 25 times, 
similar difficulties were found in identifying duplicates and the effect of a 
meta- analysis of all the studies led to a 23% over estimate of the drugs 
efficacy.  
 Time lag bias (where trialists have delayed submitting studies for 
publication with a view that non significant findings will not be of interest) 
A review by Hopewell et al. (2007) identified two studies which looked at 
time to publication. Trials were classified by whether they showed a 
positive effect or a non-significant or null. It was found that those which 
showed a positive effect were published several years sooner than those 
with a null effect.  
 Location bias (where studies have been published in non indexed 
journals and are difficult to identify or the study has been carried out in a 
third world country). A review by Pittler et al. (2000) demonstrated that 
trials of complementary therapies with a positive result were more likely 
to be published in low impact journals and were more likely to be of 
poorer quality whereas trials published in high impact journals showed 
equal positive and null or negative results. 
 Language bias (non significant findings are more likely to be published in 
a local rather than international journal). Egger et al. (1997) compared 
publications of studies in German and English and found that more 
studies with positive results were published in English. Although this 
study was carried out some time ago and it is thought that more studies 
are published in English now, it remains important for a review to 
consider all languages to reduce the possibility of bias in the results. 
 
In order to minimise any publication bias manufacturers of pressure relieving 
devices were contacted for unpublished data and leading experts at research 
centres were contacted for any unpublished studies. Attempts were made to 
reduce duplicate publication bias by checking trialists’ names and similarities in 
study settings, populations or interventions. As there was only one study 
identified, duplicate publication was not an issue. Language bias was hoped to 
be reduced by considering studies in any language however, although no 
original studies were identified in non English language, 2 reviews were 
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identified which were not translated. The search strategy identified several 
other treatment studies which included heel ulcers but attempts to contact the 
authors for separate heel data proved fruitless.  
 
3.6.7 Additional analysis 
It had been planned to look at subgroups such as those with diabetes, and 
those with Grade 1 (EPUAP) - non blanching erythema. In the Russell et al. 
(2000) study no detail was given for Grades of ulcer or co-morbidities to enable 
subgroup analysis.  
 
The issue of missing data in the Russell et al. (2000) is worthy of further 
investigation. Sensitivity analysis have been performed below, firstly looking at 
heel ulcers which healed in each group (figure 3.9) 
Figure 3.9 Data for Russell study showing risk ratio and forest plot for 
heel ulcers healed 
 
However, given that there were greater numbers of patients lost to follow up in 
the Cairwave group two alternatives were also considered: if all the patients lost 
to follow up in the Cairwave group had healed (figure 3.10) and if all the 
patients lost to follow up in the Nimbus group had healed (figure 3.11). 
 
 
 
 
 
 
Study or Subgroup
Russell 2000
Total (95% CI)
Total events
Heterogeneity: Not applicable
Test for overall effect: Z = 4.27 (P < 0.0001)
Events
41
41
Total
55
55
Events
17
17
Total
58
58
Weight
100.0%
100.0%
M-H, Fixed, 95% CI
2.54 [1.66, 3.90]
2.54 [1.66, 3.90]
Nimbus Cairwave Risk Ratio Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours Cairwave Favours Nimbus
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Figure 3.10 Data from Russell study showing risk ratio and forest plot: all 
patients lost to follow up in Cairwave group assumed to have healed and 
those in the Nimbus group assumed to have not healed 
 
Study or Subgroup
Russell 2000
Total (95% CI)
Total events
Heterogeneity: Not applicable
Test for overall effect: Z = 3.25 (P = 0.001)
Events
24
24
Total
55
55
Events
44
44
Total
58
58
Weight
100.0%
100.0%
M-H, Fixed, 95% CI
0.58 [0.41, 0.80]
0.58 [0.41, 0.80]
Nimbus Cairwave Risk Ratio Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours Cairwave Favours Nimbus
 
Figure 3.11 Data from Russell study showing risk ratio and forest plot: all 
patients lost to follow up in Nimbus group assumed to have healed and 
those in the Cairwave group assumed to have not healed 
 
Figures 3.10 and 3.11 represent best case scenarios for each intervention. It is 
clear that the study findings are dependent on what happened to the patients 
‘lost to follow up’. The study is therefore subject to attrition bias. 
 
3.7 Discussion 
3.7.1 Summary of evidence 
Overall, the evidence is not sufficiently robust to determine the relative 
effectiveness of pressure relieving devices for healing heel pressure ulcers. 
Only one randomised controlled trials was found, while having a robust design, 
randomisation and baseline comparability had so many lost to follow up that 
findings need to be viewed with extreme caution. The use of the outcome 
‘completed study’ made interpretation of data difficult. According to the trialists 
Study or Subgroup
Russell 2000
Total (95% CI)
Total events
Heterogeneity: Not applicable
Test for overall effect: Z = 1.56 (P = 0.12)
Events
24
24
Total
55
55
Events
17
17
Total
58
58
Weight
100.0%
100.0%
M-H, Fixed, 95% CI
1.49 [0.90, 2.45]
1.49 [0.90, 2.45]
Nimbus Cairwave Risk Ratio Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours Cairwave Favours Nimbus
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there was no reported difference in outcome of comfort between the two 
groups.  
 
The biases within the study would prevent it from being used as evidence to 
inform policy makers and care service providers. However it is recognised that 
using pressure relieving devices is standard practice for patients with heel 
pressure ulcers. This review does not recommend discontinuation of this 
practice.  
 
3.7.2 Limitations 
3.7.2.1 Identified studies 
The main limitation of this review is the lack of available studies which met the 
inclusion criteria.  
 
Although large numbers of papers were retrieved the lack of detail to enable 
subgroup analysis of heel patients or the lack of progress from conference 
presentation to full publication limited the findings. Earnest attempts were made 
to find full studies from authors, citations, internet searches, experts and 
manufacturers.  
 
One review was identified which was written in Chinese but no translator was 
found to assist with interpretation of this information, one review was identified 
which was written in Danish and published in the journal ‘Vard I Norden’, 
attempts to obtain this paper were unsuccessful. As reviews are not primary 
studies and were only being retrieved to explore citations these studies were 
excluded. One further title ‘Clinical trial of the Freedom Bed’ which, although 
written in English, was published in the journal ‘Prairie Rose’ but again the 
journal was not available, however advice from the Cochrane Wounds Group 
suggested that this journal would be unlikely to have trials published in it and 
was therefore excluded.  
 
The included study was carried out in a ‘Care of the Elderly’ setting. While 
many people who have heel pressure ulcers are elderly and are in care of the 
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elderly settings, there are also patients with heel ulcers in other settings such 
as orthopaedic wards, vascular wards and the community. While it is possible 
that any findings could be transferable, not enough is known about the wound 
healing process in different patient populations to be confident about the 
generalisability. 
 
3.7.2.2 Data collection form 
The data collection form, whilst capturing all the data required, from a practical 
perspective did not seem to be totally user friendly. In hindsight the reordering 
of the information and changing the size of some of the cells on the table would 
make data extraction and the visibility and explicitness of the information easier. 
When additional information was sought from original authors, the data 
extraction sheet was not comprehensive enough to capture this appropriately 
e.g. with the Russell paper it was not always clear which facts related to the 
whole study population (patients with sacral and heel ulcers) or which was heel 
specific. Also when a study was published more than once, the form should 
have the ability to record information from all publications. 
 
3.7.2.3 Search strategy 
The search strategy was developed to include studies of patients with diabetic 
foot ulcers. There was a possibility that such studies may have included heel 
pressure ulcers. The list of titles generated did not include any diabetic foot 
ulcer papers. On reflection this may have been related to the fact that the 
strategy did not include the free text term ‘(heel or foot or feet) near ulcer’, If 
this had been included as #69 in the search strategy before the heel pressure 
ulcer descriptors were merged it would have identified more studies.  
Discussion took place with a member of the Cochrane Wounds Group and 
citations of treatment studies for diabetic foot ulcers which were identified in 
other systematic reviews were informally examined. Most of these were found 
to include only ulcers on the plantar surface of the foot or forefoot and some 
specifically excluded ulcers on the heels.  The potential benefit of re-writing and 
running the strategy for all the years, in all the databases at this moment was 
not thought to justify the work entailed. This would however be a consideration 
for the future.  
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3.7.2.4 Study selection process 
The large number of records identified through the original database search 
was intentional; there was awareness of lack of potential studies which 
specifically looked at healing of heel ulcers. It was felt that it was more likely 
that heel data could be extracted from other studies which included all pressure 
ulcers sites or studies which looked at prevention and treatment. As the 
separate data was not identified in the full publications, many authors were 
written to. Unfortunately the response rate was disappointing: either people had 
moved on or just did not respond. Where records retrieved were conference 
presentations (15 records), Medline searches were also carried out for authors 
names in the hope that full publication had later taken place. This did not reveal 
any further studies.  
 
A paper by Dumville et al. (2008) looked at the publication rates of abstracts 
from wound care conferences (European Wound Management Association 
Conferences in 2001 and 2002). Of the abstracts identified (467) only 29 (6%) 
presented results of RCTs and only 57 (12%) of all abstracts were found to 
have an associated publication.  Dumville et al (2008) compared publication 
rates with previous studies and found that between 32-53% abstracts were 
subsequently published in full. These previous studies related to medical rather 
than nursing conferences and did not specify whether they included all types of 
studies. However Timmer et al.(2002) reviewed only publications of RCTs from 
gastroenterological conference abstracts and found a 51% publication rate.  
Dumville et al (2008) discuss the possible reasons for low publication rates and 
suggest that weaker study design, lack of ‘positive’ results (results significantly 
in favour of intervention) and motivation for conference presentation 
(conference attendance rather than increasing the knowledge in wound care) 
are contributing factors. While these suggestions are valid it is important to bear 
in mind the relative development of nursing as an academic profession ( a 
study by Hale and Hill (2006) also found lack of clinical research in the field of 
rheumatology nursing), how amenable nursing care is to RCTs (Lindsay, 2004) 
and necessity for expensive RCTs given that medical devices such as support 
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surfaces and wound dressings can be marketed without robust evidence from a 
clinical trial.  
 
Seven other reviews were included in the retrieval of papers as it was thought 
they may identify further studies not retrieved through the original search 
strategy. This was not the case however and probably resulted in unnecessary 
work. Other ways could be considered in the future for increasing the likelihood 
of finding studies e.g. searches of doctoral theses. 
 
3.7.2.5 Risk of bias in included studies 
With trials of medical devices such as mattresses it is virtually impossible to, 
‘blind’ the staff or patients to treatment allocation. It is important, therefore to 
discuss and include information about staff or patient preferences prior to the 
study and which treatment, if any was familiar to the staff as this could be seen 
as leading to significant bias in the study. This issue was not dealt with in the 
study. The importance of minimising other biases such as allocation 
concealment, masked outcomes assessment and good study follow up and 
reporting has already been discussed.  
 
3.8 Summary and Conclusions 
3.8.1 Implications for practice 
The findings of this review do not lead to any recommended changes in 
practice. Current guidelines for practice (RCN, 2005) based on a review of 
support surfaces for all pressure ulcers, recommend the use of pressure 
relieving devices for all patients with pressure ulcers.  Clinical staff, policy 
makers and users should be mindful that there is no evidence to support one 
support surface over another for heel pressure ulcers and consideration should 
be given to patients quality of life (pain, discomfort, activity and mobility, 
intrusiveness (noise, size of device)) as a priority as well as ease of use, 
reliability, direct and indirect costs (purchase price, lifespan, maintenance). 
 
3.8.2 Implications for research 
Clearly further well designed trials of support surfaces (and in particular devices 
specifically for heel pressure relief) for treating heel pressure ulcers are 
needed. These should include: 
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 Clear inclusion and exclusion criteria, ensuring sample is representative 
of an appropriate population 
 A sample size calculation to ensure the studies are adequately powered, 
taking into consideration the available evidence for death rates and other 
loss to follow up 
 Robust randomisation process and allocation concealment 
 Blinding of personnel and outcomes assessment as far as practically 
possible e.g. using photographs of the wounds which can be assessed 
by persons blind to the intervention 
 Appropriate outcome measures for healing such as time to complete 
healing  
 Clear secondary outcome measures using validated scales to capture 
patient related issues such as pain, discomfort, ease of mobilisation and 
cost effectiveness   
 Reporting baseline comparability to include important details such as 
ulcer size and duration 
 
Consideration needs to be given to populations to be studied, these need to 
include elderly, vascular, diabetic, orthopaedic patients in both hospital and 
community settings.  
 
Recruiting sufficient patients in pressure ulcer studies is often difficult as many 
patients appear incapacitous (lack capacity to consent). Recent changes due to 
the Mental Capacity Act (Great Britain, 2005) have led to better recruitment as 
the focus has been on an improved assessment of capacity specifically to 
research studies and for those who do not have capacity - identifying what 
would have been the patients intentions with regard to research studies rather 
than carers responding on behalf of the patients. 
 
The high death rate in the pressure ulcer population (Thomas et al., 1996a) is a 
major challenge when planning a trial. To ensure enough patients are followed 
up to healing will always be difficult. Possible alternative strategies could be 
considered e.g.: 
 identify risk factors for death and exclude these patients  
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 look at healing rates/ improvement in ulcers rather than a single end 
point of healing 
 more frequent data collection points to capture all changes in pressure 
ulcer status 
 look at alternative research methods other than RCTs (e.g. pre-post 
comparison, intervention-control comparison, adopters versus non-
adopters comparison (Kirkwood and Sterne, 2003)) 
 
In modern ‘in patient’ settings the movement of patients between wards and 
early discharge to alternative care risks compromising data collection. Robust 
patient follow up with the continuation of the trial intervention needs to take 
place.  
 
Given that many patients with pressure ulcers may have a very poor prognosis 
then healing may not be the most important outcome of interest. More 
consideration should be given to what are traditionally considered to be 
secondary outcomes such as patient quality of life (Gorecki et al., 2009) and 
cost effectiveness (RCN, 2005) of the interventions.  
 
The need to distinguish between the populations of patients with sacral, ischial 
and heel pressure ulcers remains: no studies were identified which looked 
specifically at pressure relieving devices for heel ulcers despite many different 
devices for heel pressure relief being on the market e.g. Repose heel boots, 
Heelift, Pressure Relief Ankle Foot Orthosis (PRAFO). The risk factors for 
healing are likely to be different (see previous chapter). The effects on the 
patients’ quality of life both of the ulcer and of the device used to treat it are 
also likely to be different from pressure ulcers on other body sites. 
 
3.8.3 Summary  
While this review is unlikely to lead to a significant change in clinical practice, it 
has clearly identified the lack of evidence base for pressure relieving devices 
for treating heel pressure ulcers. It will alert clinical staff and policy makers to 
the lack of robust evidence upon which to base decisions on the use of devices 
to support healing of ulcers on the heels. It may prompt one to being more 
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mindful of the effects of devices on patients’ quality of life and also to consider 
the cost effectiveness and utility of the devices available.  
 
It has also identified some key issues to inform future research design in this 
important field of pressure ulcer management. 
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Chapter 4 Methods 
 
4.1 Introduction 
The previous chapters of this thesis have identified the gaps in knowledge of 
pressure ulcer healing and in particular of heel pressure ulcers, and what 
influences the process. In order to increase the knowledge a cohort study was 
been identified that looked at the prognostic factors for healing. This chapter 
describes the rationale for this study method and the process of the study. This 
is summarised in the flow chart in figure 4.1.  
Patient on specific ward develops 
or is admitted with heel ulcer
Study discussed and Patient 
Information Sheet given*
Patient/relative does 
not give consent*
Patient/relative gives consent*
Normal care - record 
on screening log
Registration form completed
Baseline data collected and 
recorded. Clinical assessment 
recorded in CRF
Weekly follow up data collected
Trial completion:
Is wound healed?
Has 18 months elapsed?
Has study finished?
Study completion 
form. No further visits
Study Flow Chart
Patient discharged from hospital?
Complete discharge 
form
Monthly follow up data 
collected in 
community
Study completion 
form. No further visits
Trial completion:
Is wound healed?
Has 18 months elapsed?
Has study finished?
 
Figure 4.1 Study summary flow chart 
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4.2 Aims and Objectives 
The main aim of this study was to identify prognostic factors for healing of heel 
pressure ulcers. 
The secondary objectives are to: 
1. describe the characteristics of patients who have heel pressure ulcers  
2. describe the characteristics of current practice i.e. the dressings and 
topical treatments including debridement, support surfaces used, 
specialist advice 
3. describe the progress of heel pressure ulcers through the stages of 
wound healing 
4. determine the adverse sequelae of this patient population e.g. death, 
septicaemia, amputation, infection, length of stay, destination post 
discharge 
 
4.3 Research Design 
4.3.1 Choice of design 
This was a single centre prospective cohort study of the prognostic factors for 
wound healing in patients with pressure ulcers on their heels. Following 
informed consent, eligible patients with heel ulcers Grade 2 or greater of any 
duration had baseline assessments, then weekly follow-up during their stay in 
hospital and at monthly intervals following discharge for a period of 18 months 
or until healed.  
 
A cohort study design was chosen as it can identify exposures or 
characteristics of interest, which are thought to influence an outcome; in this 
case wound healing. It enables the exploration of possible causal relationships. 
A prospective cohort study is the preferred method for an observational study 
as the quality and nature of the data collected can be controlled (Altman, 1991).  
 
While a retrospective study may have been quicker and easier to perform, an 
informal review of clinical records of this population identified that there would 
not be the quality of information required due to missing data. Simon & Altman 
(1994) in their editorial on statistical issues caution against retrospective studies 
due to problems with missing data and the fact that data on potential prognostic 
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factors may not be available. Retrospective studies are subject to many biases 
including selection bias, detection bias, recall bias and inaccuracy of 
retrospective data (Altman, 1991).  
 
The main disadvantages of a cohort study are that if the outcome of interest is 
rare, then there is a need to recruit and follow up a lot of patients to provide 
enough data for analysis. The study can be expensive, especially if the time to 
the event of interest is long. There may also be difficulty maintaining contact 
with participants. 
 
4.3.2 Quality issues and potential for bias 
In experimental studies there are widely accepted standards for the design and 
conduct, analysis and reporting (Simon and Altman, 1994). A search for similar 
standards in observational studies has identified the STROBE statement 
(Vandenbroucke et al., 2007), which is intended to improve study reporting. 
Although no recommendation is made for the design of the study, this is implicit 
in how it is reported. The STROBE statement consists of a checklist of twenty 
two items of which eighteen are common to the cohort, case-control and cross 
sectional studies, and four are specific to each of the 3 study designs. The 
statement (the 18 generic items and the four specific cohort items) has been 
used in this chapter to guide the design and reporting of this study. 
 
4.3.2.1 Loss to follow-up 
Study participants can be lost to follow-up for several reasons. These include: 
 People who do not wish to continue with data collection for what ever 
reason and ask to be withdrawn from the study 
 People who leave the study site to an unknown location and contact is lost 
 People who move to a location outside the study site where follow-up 
cannot take place 
It is important to keep loss to follow-up to a minimum as it will reduce numbers 
for analysis and potentially introduce bias (if loss has occurred selectively). The 
potential for loss to follow-up was considered during the study design; in 
particular the burden of the study for the patients was kept to a minimum; 
patients were only recruited who lived in Leeds and approval was sought to 
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follow up patients within the Leeds community. The reasons for loss may be 
related to outcome and become a source of bias. To investigate this bias, those 
lost to follow-up were compared for baseline socio-demographic and clinical 
characteristics with those who continued in the study to identify any systematic 
differences.  
 
Loss to follow-up may not always lead to biased estimates. A study by Osler et 
al. (2008) which investigated bias due to loss to follow-up of a cohort of Danish 
men found the associations between the prognostic factor and outcome were 
nearly the same in the sample as in the full population. They drew this 
conclusion by calculating a relative odds ratio (OR) as the ratio of the OR of 
responders to the OR of the whole population, this being close to one. This 
methodology had been used in a previous study of low participation bias in 
cohort studies (Nohr et al., 2006) although both studies have concerns over the 
calculation and size of the confidence intervals and the generalisability of the 
findings.  
 
A review by Hudak et al (Hudak, Cole and Haines, 1996) set out criteria for 
clinical epidemiological validity assessment of prognosis, which assessed 
studies as providing strong evidence if follow-up was ≥ 80%. These criteria 
have been used by subsequent authors to gauge the strength of evidence of 
studies, it would seem reasonable to expect no more than 20% loss to follow-
up. 
 
4.3.2.2 Selection of participants 
The particular population from which the sample is selected may affect the 
probability of an outcome occurring. This may mean the findings of the study 
have limited external validity and are only relevant to this particular population. 
In this study the likelihood of healing may be affected by: 
 Being an inpatient with underlying medical problems of patients in a 
particular speciality 
 Being treated within a tertiary centre where patients may have more 
complex health needs 
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 Being cared for in a setting where there is a Tissue Viability (TV) Nurse 
Consultant  
 Being in a research study with regular contact with a Tissue Viability 
Specialist 
The characteristics of this study population will limit generalisability of the 
findings (Goldberg et al., 1985). This is considered further in the discussion in 
section 8.2.3.2. 
 
 
4.3.2.3 Changes over time 
Prior to the start of the study, consideration was given to the possibility that due 
to the study there would be an increased awareness of heel pressure ulcers in 
the staff looking after these patients and practices could change.  The literature 
review reassured the researcher that there was little evidence of effectiveness 
for any treatment interventions that were not already part of standard clinical 
practice in the participating research centre. If any new evidence had come to 
light during the study, then this would have been considered in the analysis. 
However, it was still possible that staff caring for the study patients would be 
more aware of their heel pressure ulcer due to the regular visits from the TV 
Nurse Consultant and practice would have developed above the normal 
standard. This is considered further in chapter 8. 
 
4.3.3 Point of recruitment 
This study is a prospective cohort study with patients having the exposure of 
interest i.e. a heel pressure ulcer. This type of cohort study is particularly useful 
as:  
 the researcher can determine the effects of changes in prognostic factors 
on outcomes 
 investigate several potential prognostic factors when the specific 
influencing factors are not known 
 maintain follow up 
adapted from Lilienfeld and Stolley (1994).  
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Ideally the duration of the ulcer should be calculated from the start date of the 
ulcer to healing. However some of the patients had a heel pressure ulcer that 
had been present for several months or years prior to recruitment. To have 
used the start date of the ulcer to calculate duration of healing would have 
presented several difficulties: 
 The time of onset was mostly established by patient report and as such 
may not have been accurate 
 The baseline characteristics were not known at the start of the ulcer 
 The presence or changes in potential prognostic factors is not known up to 
the point of recruitment 
 
To have only utilised data from new heel pressure ulcers i.e. the inception 
cohort, would have markedly reduced the number of patients recruited. As the 
potential heel ulcer population is already small the study has included patients 
with new and established pressure ulcer at recruitment. The concerns regarding 
the precision and lack of information will be addressed by sensitivity analysis. 
This is discussed in section 8.3.1. 
 
Figure 4.2 illustrates the different time points at which pressure ulcers occurred 
in relation to the recruitment and follow-up times in the study. The arrow heads 
may represent either the event (ulcer healing occurs) or censoring (patient lost 
to follow-up, death, amputation of affected limb, end of study or eighteen 
months of follow-up). The start of the arrow represents the point at which the 
pressure ulcer occurred, the ones which start to the left of the ‘start of study’ 
are known as left censored. For further details of endpoints and censoring see 
sections 4.12.2 and 4.12.3. 
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Start of Study End of Study
 
Figure 4.2 Diagrammatic representation of ulcer episodes in  
relation to patient recruitment over time 
 
While the majority of data are subject to right censoring, it can be seen that 
some patients are left censored. This was taken into account in the survival 
analysis when the model was fitted.  
 
4.4 Population and Sampling 
The patient population was defined as all those who were admitted to Leeds 
Teaching Hospitals NHS Trust with a heel pressure ulcer (≥ Grade 2) (EPUAP, 
2009) or developed one during their stay on one of the following wards: 
 Orthopaedics and Trauma 
 Vascular 
 Care of the Elderly 
 Neurosciences 
 Surgical 
 Diabetology 
 
These areas consistently demonstrate comparatively high prevalence of heel 
ulcers in the annual pressure ulcer prevalence audits in the Trust and will 
therefore be more likely to generate the most subjects for the study. It was 
impractical for the researcher to visit all wards within the Trust. The possibility 
of this affecting the external validity or generalisability of the findings is 
discussed in chapter 8. 
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4.4.1 Inclusion criteria 
 Patients who were aged 18 or over 
 Patients who were admitted with or developed a Grade 2 or greater heel 
pressure ulcer 
 Patients were on the wards of one of the above specialities  
 
If patients had or developed more than one heel ulcer they were still eligible. 
Patients able to consider the risks and benefits of being involved in the study 
were approached to ask for written informed consent. Where this could not be 
obtained from the patient their representative was approached to ask for 
‘relative assent’. 
 
The classification of severity of pressure ulcers has been discussed in Chapter 
2. As this study started prior to the new EPUAP(2009) pressure ulcer 
categories being introduced, the adaptation of the EPUAP (1998) classification 
has been used throughout, as described in Box 2.1. 
 
4.4.2 Exclusion criteria 
 Patients who were unable or unwilling to give informed consent or those 
who had no appropriate representative to approach for ‘relative assent’ 
 Patients who it was ethically inappropriate to approach e.g. those where 
death was imminent. Any patients meeting the criteria of the Liverpool 
Care Pathway (Marie Curie, 2010) for the dying were not approached.  
 
 
 
 
 
 
Box 4.1 Criteria for the Liverpool Care Pathway 
 
Liverpool Care Pathway eligibility criteria: 
The patient has a known irreversible life-threatening illness of any 
aetiology 
Reversible causes for the patient’s current deterioration have been 
considered and appropriately managed 
Intensive care and resuscitation have been discussed by the team 
and have been deemed to be inappropriate for the patient. 
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Patients were eligible regardless of whether or not they were under the care of 
a Tissue Viability Specialist/ Consultant (in the hospital or community) or a 
Medical Practitioner specifically advising on the wound management. This is 
because there is currently insufficient evidence to suggest that this affects 
healing rates.  
 
4.5 Recruitment and registration 
Patients were identified and recruited through two methods: 
 Clinical staff working in the study areas listed above, who were informed 
(verbally and in writing) of the study, were asked to refer any patients 
with a heel ulcer. 
 The researcher visited all relevant clinical areas weekly and identified 
any potentially eligible patients through questioning the nursing staff  
A full verbal explanation of the study and a Patient Information Leaflet were 
provided by the researcher for the patient to consider. This included detailed 
information about the rationale, design and personal implications of the study.  
Following information provision, patients had at least 24 hours to consider 
participation and were given the opportunity to discuss the study with their 
family and healthcare professionals before they were formally asked whether 
they were willing to take part. 
 
When consent had been obtained, the patient was registered and allocated a 
registration number. The patient was then only identified with this number.  
Details taken from the patients medical records and confirmed with the patients 
at registration were: 
Patient name 
Ward and hospital 
Address  
Telephone number 
GP name and address 
Date of birth 
Hospital number 
Name of Consultant  
Date of written informed consent/ assent 
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Ethnic origin 
The registration sheet was the only record of identifiable patient information; 
this was kept in a locked filing cabinet in a locked office at the hospital. 
 
4.6 Consent process 
4.6.1 Informed Consent 
Assenting patients were formally assessed for eligibility and invited to provide 
informed, written consent. Formal assessment of eligibility and informed 
consent were undertaken by the researcher or latterly by a research nurse. The 
right of the patient to refuse consent without giving reasons was respected. 
Furthermore, the patient remained free to withdraw from the study at any time 
without giving reasons and without prejudicing any further treatment. A copy of 
the consent was given to the patient, one filed in the hospital notes and the 
original retained by the researcher. 
 
4.6.2 Relative Assent 
Within the study population there is known to be a high proportion of elderly 
confused patients, who are unlikely to be able to give informed consent. This 
was demonstrated in a study by Mason et al. (2006) who found that 40% of 
people eligible to take part in their study were confused or lacked capacity to 
consent . To try and ensure that this group of patients were represented in the 
study, a process of relative assent was used. The current study based the 
Ethics Committee application on the Mason et al. (2006) study. Relative assent 
was requested from the patient’s named next of kin, defined as ‘those who 
were both a relative of the patient and the named next of kin (as recorded in the 
hospital or nursing notes). This included: spouse or common law partner, 
sibling, son or daughter, grandson or grand-daughter, daughter or son-in-law. 
Relatives were approached if they were visiting the patient but were not 
contacted by the researcher for the purposes of arranging to meet to discuss 
the study. Figure 4.3 represents the consent process used from August 2007 to 
August 2008. 
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The Mental Capacity Act (MCA)(DoH, 2008) changed the basis on which 
assent could be obtained and hence a substantial amendment to the protocol 
was needed in September 2008 to ensure compliance with the Act. This 
resulted in a change from the concept of relative assent to consultee 
agreement. The personal consultee is ‘someone who has a role in caring for 
the person who lacks capacity or is interested in that person’s welfare, but is 
not doing so for remuneration or acting in a professional capacity’(DoH, 2008). 
A nominated consultee is ‘someone who is appointed by the researcher to 
advise the researcher about the person who lacks capacity, wishes and feelings 
in relation to the project, and whether they should join the research’(DoH, 
2008). Figure 4.4 represents the consent process used from September 2008 
to August 2009. 
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All patients in specified clinical areas 
with a pressure ulcer
Are patients able and willing 
to discuss study
Yes No
Are they able but 
unwilling to discuss
Able but 
unwilling
Unable to 
discuss
Exclude and 
document 
reasons
Next of kin* contacted when 
visiting the patient - study and 
relative assent discussed
Relative willing to give 
assent
Yes NO
Exclude and 
document 
reason
Information 
sheet, assent 
form and 
letter given/
sent
Relative 
confirms 
assent
Yes No
Exclude and 
document 
reason
Consent/assent obtained. 
Patient assessment and data 
collection commences
Provide verbal and 
written information. 
Give at least 24 hrs to 
consider
Process for Consent/Assent
 
Figure 4.3 Assent/ consent process prior to substantial  
amendment in Aug 2008 
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Process for gaining consent
Patient identified in specific clinical area who 
meets the eligibility criteria
Does the patient have capacity to discuss and 
consent to the study?
Yes No
Yes
Yes
Yes
No
Yes
Is the patient 
willing to discuss 
the study?
Provide verbal and 
written information. 
Give at least 24hrs for 
patient to consider
Are they agreeable to 
participating in the 
study?
Consent/agreement 
obtained. Patient 
assessment and data 
collection commences
Exclude and 
document 
reasons
Is there an advanced statement in 
place identifying a named consultee?
Provide verbal and 
written information. 
Give at least 24hrs for  
consultee to consider
Does the consultee 
agree that the patient 
would have consented 
to the study?
No
Exclude and 
document 
reasons
No
Is there a 
personal 
consultee and 
are they 
agreeable to act 
for their relative?
Yes No
Provide verbal and 
written information. 
Give at least 24hrs 
for consultee to 
consider
Does the consultee 
agree that the patient 
would have consented 
to the study?
YesNo
Consent/agreement obtained. 
Patient assessment and data 
collection commences
Identify and 
agree a 
nominated 
consultee
 
Figure 4.4 Consent process used after Aug 2008 to comply with  
the Mental Capacity Act (2008) 
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4.6.3 Non-recruitment 
If there were systematic differences between those who took part in the study 
and those who did not, this would lead to bias and affect the external validity of 
the study. 
 
A log was completed for all patients screened for eligibility who were not 
enrolled. This stated their age, gender, ethnicity and the reason for non-
recruitment. This information was then compared with the baseline data for 
recruited patients. 
 
4.7 Measures 
The derivation of the variables is presented in the table 4.2. box 4.2 gives the 
mattress classification, box 4.3 gives the neuropathic assessment protocol, 
table 4.3 gives the classification of wound infection and box 4.4 gives the 
description of the Grades/ severity used in the study. 
 
In a study in which the researcher has no control over the exposure variables, 
any findings which suggest associations may be as a result of confounding 
effects of a variable e.g. age or interactions between two variables e.g. smoking 
and peripheral arterial disease. How these are dealt with in this study is 
explained in section 4.12.5.6. 
 
4.7.1 Patient related variables 
The variables collected are given in table 4.1, these included patients’ 
demographic details, potential prognostic factors and factors which would 
inform the secondary descriptive analysis: 
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Variable Demographic 
detail 
Potential 
prognostic 
factor 
Descriptive analysis/ 
wound healing process 
Age X X  
Gender X X  
Ethnicity X   
Speciality X X  
Co-morbidity  X  
Smoking  X  
Medication  X  
Pain*  X X 
Nutritional status  X X 
Braden* 
Nutrition 
Activity 
Mobility 
Moisture 
Friction/sheer 
Sensation 
 X  
Neuropathy*  X  
Arterial disease*  X  
Support surface*   X 
Severity of ulcer*  X  
Size of the ulcer 
(area)* 
 X X 
Ulcer duration prior 
to recruitment 
 X  
Tissue type*  X X 
Surrounding skin*  X X 
Dressings*   X 
Debridement*   X 
Bandages*   X 
Specialist 
involvement* 
  X 
Significant events*   X 
Photographs*   X 
 
*These elements were also collected on an ongoing basis.  
Table 4.1 Variables collected and how they were used 
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The choice of candidate variables for the prognostic factor analysis was derived 
from the review of other prognostic factor studies in section 2.7. Incontinence 
was included as the ‘moisture’ element of the Braden scale. Neuropathy was 
included in the current study, it is uncertain which of the studies cited included it 
as a candidate factor, however it was found to be a significant factor in the 
univariate analysis in the Winkley et al (2007) and Nather et al (2008) diabetic 
studies even though this did not emerge as independent in the multi-variate 
analysis. Pressure relief, wound exudate, wound cleansing and dressing type 
were all omitted as candidate factors, based on the researchers clinical 
experience, they were expected to vary so much during the study that a 
baseline exposure would not be representative. 
 
While it is recognised that several of the above factors may not be independent 
of each other e.g. speciality and co-morbidity, it was felt that the study being the 
first of it’s kind coupled with the lack of evidence particularly in this patient 
population and a concern for overlooking important factors led to the broader 
inclusion criteria.   
 
4.7.2 Patient logistics 
The following details were collected, which relate to the patient’s pathway 
through the study period: 
 Accommodation prior to admission and on discharge 
 Length of stay 
 Ward moves and readmissions 
 
4.8 Piloting 
When the data collection forms and data collection protocol had been devised 
these were piloted with the first three patients during August 2007. 
This internal pilot included a review of the following: 
 the data collection forms for ease of use and clarity of information 
recorded 
 the patient information leaflet and consent process (discussed with the 
patients) 
 the wound mapping 
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 the wound photograph procedure 
 the total burden of research for the patients 
 any impact of ward activity 
 
No problems were identified for the patients or ward staff, however the wound 
mapping and photographs presented practical problems for the researcher. As 
the ulcers were on the back of the foot they were difficult to access as patients 
were either sat in a chair or laid in bed and unable to lay prone. For details of 
how these variables were collected see table 4.2. 
 
Mapping the wounds was thought to be inaccurate due to the curved plane of 
the surface. Following discussion with the study supervisors it was agreed that 
precise wound area measurements were not required for the endpoints, but 
that trends in changes in size were useful. Mapping was therefore continued.  
 
The use of a colour target card with the photographs was initially proposed as it 
would give a centimetre scale, a colour reference, the date and the patient 
registration number for each photograph taken. This was discontinued after the 
pilot as there was no where to mount the target card.  
 
4.9 Data Monitoring and Validation 
Data collection during the first year (August 2007 – August 2008) was carried 
out by the researcher as chief investigator. Completeness of data for each 
patient was checked at each visit by examining the entry for the previous visit in 
the CRF. Where possible, missing data was sought and retrieved. During the 
subsequent data collection period (September 2008 – April 2010) the 
researcher was assisted by an experienced research nurse, whom she 
personally trained and supervised. Particular attention was paid to recording of 
skin/ulcer classification as previous research has demonstrated the need to 
address inter-rater reliability issues of classification scales (Nixon et al., 2005). 
At frequent intervals during the data collection period, ulcers assessed by the 
research nurse were also assessed and classified by the researcher (either by 
patient assessment or photographic review). 
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4.10 Data quality 
4.10.1 Missing data 
All data was entered into an Excel spreadsheet by the researcher. When 
routine data were absent in the research record, which had been taken from the 
medical records( e.g. Haemoglobin level and medication), these were retrieved 
and data entry completed. For non-routine data that was absent and could not 
be retrieved, this was recorded as ‘missing’ in the database.  
 
Reasons for missing data included:  
 the patient was too tired for data collection  
 they were due to attend X-ray or physiotherapy and data collection was cut 
short 
 conditional consent to the study which excluded taking part in the Doppler 
assessment 
 ABPI assessments placed more of a burden on the patient and were not 
appropriate to carry out 
 The patient’s cognitive ability prevented them giving appropriate 
responses to questions about pain or sensation.  
Hence complete data was not obtained for all patients prior to exiting the study.  
 
4.10.2 Range and consistency checks 
For all categorical variables, all observations were checked to ensure they 
belonged to one of the allowed categories. For continuous data, histograms 
were plotted to identify any ‘outliers’ and these were then checked with the 
original CRFs. All ulcer descriptors (severity, tissue type, surrounding skin 
condition) were validated with the photographic records, where these existed. 
As the Excel spreadsheet was continually revisited when variables were 
recoded for further analysis, completeness and accuracy of data was checked 
at each revisit. Data lock occurred on the 31st December 2010. 
 
4.11 Statistical considerations 
A sample size of approximately 200 patients was planned. This was based on: 
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 Lack of definitive evidence regarding event rate to aid calculation of 
sample size (Berlowitz et al., 1997) reported a healing rate of 50% at 6 
months 
 The throughput of patients from the Nurse Consultant caseload 
 The practicalities of time taken to recruit and collect data for 20 patients/ 
month 
 Death rate of 25% over two months (Bridel, Banks and Milton, 1996) 
 
Originally statistical guidance (Altman, 1991) p 349 was sought which 
suggested that ‘there is no rule.. but a guideline might be to look at no more 
than n/10 variables where n is the sample size’. This should allow the study of 
up to 20 variables or risk factors. Subsequent discussion with supervisors 
identified an error in the above text which would lead to an over estimate in the 
number of variables which may be considered. It is now recommended that at 
least 10 patients with the event of interest (ulcer healing) are required for each 
factor in the model (Harrell et al., 1985). 
 
As there was uncertainty over the number of ulcers that would reach the 
primary endpoint, the exact number of variables considered in the model was 
not pre-specified but were reconsidered at the analysis stage. With a 50% 
healing rate and 25% death rate between 75 and 100 patients might heal, 
allowing between 7 and 10 variables to be studied. 
 
4.12 Data Analysis 
Data were entered into an Excel spreadsheet and then subsets of data were 
copied into statistical data analysis package, Stata version 11.1 (2009). This 
was used for all data analysis. 
 
4.12.1 Analysis population 
The analysis population for the primary analysis was all heel ulcers identified at 
the start of the study with at least baseline data recorded. Where patients had 
more than one ulcer the healing of each heel ulcer was considered as a 
separate event. The analysis population included all heel ulcers on patients 
who: healed, died, had their limb amputated, or withdrew and hence were lost 
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to follow-up having completed at least one follow-up data collection. Any heel 
ulcers on patients that had not healed after 18 months or at the end of the 
study were censored at that point. Any patients who were lost to follow up with 
only baseline data collected were excluded. 
 
4.12.2 Endpoints (time to event) 
The primary endpoint was time to complete healing of the ulcer from the point 
of recruitment to the study. This is defined as the number of days between the 
day of baseline data collection until complete re-epithelialisation of the skin at 
the ulcer site. This was visually assessed and photographed by the researcher.  
 
4.12.3 Censoring 
Data are described as censored when either the event does not occur during 
the study period or the time at which the event occurs is unknown. Data were 
censored in this study when the following occurred: 
Loss to follow-up 
Moving away from the area in which data collection was possible: some 
patients who had been resident in Leeds prior to their admission to hospital 
were discharged to areas outside Leeds e.g. moved to Nursing Homes nearer 
families. Patients were also lost to follow-up if they withdrew from the study for 
other reasons.  
Amputation 
Pressure ulcers of the heel are often found on patients with very poor arterial 
supply. Where ulcers are not healing or deteriorating then amputation may be 
an option.  
Death 
High death rates are noted in pressure ulcer populations; Thomas et al. (1996a) 
found a death rate of 59.5% a year after acquiring a pressure ulcer in hospital 
compared to 38.2% for those without a pressure ulcer. When death occurs (and 
if possible the cause of death) this was recorded. 
Withdrawal from study 
Patients may withdraw themselves from the study for other reasons. 
Data collection suspended 
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Data were collected for each patient for a maximum of 18 months. Data was 
still being collected for some patients at the end of the study. This was also 
recorded. 
 
4.12.4 Baseline patient and ulcer characteristics  
Patient characteristics at baseline(age, gender, ethnicity, clinical speciality, co-
morbidities, smoking history, Braden score, medication, haemoglobin level) and 
ulcer characteristics (duration, duration prior to recruitment, ulcer area, severity, 
tissue type, surrounding skin, pain, neuropathic and arterial status and 
dressings) were described, including frequencies, percentages, means 
(standard deviations), medians (and ranges) were calculated. 
 
4.12.5 Primary analysis 
This was performed using Cox proportional hazards (PH) model (Cox, 1972) 
with robust standard errors (SE) to allow for clustering, to identify possible 
prognostic factors for healing.  
 
4.12.5.1 Choice of model 
The Cox PH model was chosen as there was a lot of censored data, and 
survival times were available. If a logistic model had been chosen for the 
primary analysis then much of this data would be un-usable. The Cox PH model 
has several benefits, including: 
 Performing as a semi-parametric model but also giving similar results to a 
parametric model e.g. Weibull, especially as the distribution (of the 
healing times?) was unknown with this data.  
 It is possible to calculate the hazards ratio (HR) without knowing the 
baseline hazards function.  
 Although the Cox model likelihood function only considers probabilities for 
those ulcers that heal, survival information from ulcers which are 
censored is used.  
 It is easier to use and makes fewer assumptions than other models 
Adapted from Kleinbaum (1996) 
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4.12.5.2 Analysing clustered (correlated) data 
If a patient has heel pressure ulcers on both legs then these cannot be seen as 
independent as certain variables e.g. diabetes will affect both ulcers and the 
effect size is likely to be magnified. SE estimates are usually based on the 
assumption of independence and would not be reliable. In this study the ulcers 
are clustered at the patient level; there are lots of clusters, each with a small 
number of variables. The intraclass correlation describes the relationship of the 
observations within a cluster.  
 
There were several possible alternatives for dealing with the intraclass 
correlations including multilevel modelling, robust SE (also know as Huber 
White or sandwich SE) or a frailty model. All these methods use the principle of 
an additional unmeasured/randomly distributed covariate, which will elevate the 
SE. Robust SE method was chosen because it did not require a model (was a 
straightforward implementation) and was available in standard statistical 
software packages 
 
4.12.5.3 Sensitivity analysis without clustering? 
A sensitivity analysis utilising the population of patients rather than ulcers was 
considered given the routine use of this approach. The issue of regression SE 
in clustered samples is discussed by Rogers (1993) and Williams (2000); they 
confirm that the use of robust SE is appropriate by supporting the view that if 
the largest cluster is 5% or less of the sample the bias should be negligible. 
Dupont (2009) p. 472 also comments that with large sample sizes the robust 
SE estimates converge to the true estimate. He does however note that the 
estimates may not apply if there are many missing values, particularly if these 
are not randomly distributed. 
 
In order to assess the reliability of the findings of this study it is important that 
the analysis methods used are comparable with other studies in the same field. 
A review of the analysis methods in published studies of prognostic factors for 
wound healing (or risk factors for non-healing) found a study that used robust 
SE (Winkley et al., 2007), and also two studies which analysed both the 
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clustered and un-clustered data, and found that both gave similar results 
(Margolis, Berlin and Strom, 1999) and (Bergstrom et al., 2005). 
 
Given the above information, small cluster size and the small number of 
missing values and the expectation that a sensitivity analysis would lead to 
similar results with and without clustering a decision was made not to include 
this analysis. 
 
4.12.5.4 Modelling process 
The Cox regression analysis was first performed with each variable separately; 
this gave a HR, a confidence interval (CI) and the statistical significance (p 
value). Each variable was then entered into a model and rerun with the addition 
of one other variable at a time. The model was then subject to an automated 
selection procedure (backwards stepwise selection) to fit each significant 
variable into the model. The accepted level of significance was p≤ 0.2 for entry 
in to the stepwise model and p≤0.1 for the final model. 
 
Automated model selection is a process whereby the computer program will 
allow the multiple testing of a number of variables by either entering each 
variable into the model (forwards) or withdrawing (backwards) them, one at a 
time and testing for significance at the specified level. If this is done in a 
stepwise fashion it allows for variables, which were originally discarded as non 
significant, to be re-entered into the model and potentially become significant 
given the presence of other variables. While this is a convenient process, 
caution is required as there is a risk of finding variables with false significance 
due to multiple testing. Backwards stepwise selection was chosen as this is 
less likely to miss a significant variable and it provides a fuller model that 
predicts better than other selection processes. 
 
The Cox regression analysis is based on the assumption that the hazards are 
proportional. In order to test the proportional hazards assumption i.e. that the 
ratio of the hazard rate to the baseline hazard is constant, survival curves were 
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plotted for each variable in the model. The hazards were proportional for all 
parallel straight lines on the plots.  
 
4.12.5.5 Data reduction and recoding 
The original Excel spreadsheet contains all the information collected 
unprocessed. Different analysis requires different numbers and format of 
variables, appropriate coding collapse was not clear before the start of the 
study. Where possible full information was used rather than reduced by 
recoding to prevent loss of information. 
 
For the Cox proportional hazards model, all variables were entered into the 
univariate analysis with their original coding. Data reduction was performed for 
two of the variables that reached significance at the specified level for the 
purposes of the multi-variate analysis. The intention was to reduce the number 
of variables which were entered into the final model and increased the number 
of observations in each category. This results in more chance of finding a 
significant estimate with smaller confidence intervals:  
 Severity. This was recorded in the CRF under 7 different categories (see 
box 4.4); these were reduced to two categories of superficial and severe. 
‘Superficial’ included dry scab, blisters with clear fluid or blood, and full 
thickness skin loss. ‘Severe’ included cavities, cavities with underlying 
structures and necrosis. The rationale for this split was clinically 
meaningful and has been used in other studies (Bergstrom et al., 2005). 
 ABPI. This was recorded as actual readings in the CRF and was included 
in the univariate analysis as a continuous variable. Following review of 
the high numbers of missing observations it was realised that several 
ABPI readings had not been taken due to inappropriateness (see section 
4.10.1). The re-categorised readings were entered into the univariate 
model, but the proportion of missing observations remained greater than 
a third, so ABPI was excluded from the multi-variate model. 
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4.12.5.6 Collinearity 
Collinearity occurs when two variables are highly correlated. If two variables are 
used in models which are strongly collinear then there is a chance that the 
output will suggest that neither is associated with outcome, when the one or 
both actually have a strong association (Kirkwood and Sterne, 2003).   
 
The variables that were significant at the p ≤ 0.2 following the univariate 
analysis, were examined for correlation. Where collinearity existed, the 
variables were examined for statistical and clinical quality e.g. absence of 
missing data, numbers of categories within variable, numbers of observations, 
clinical relevance of the variable and the most appropriate variable used in the 
multi-variate model. 
 
4.12.6 Descriptive analysis 
Ulcer characteristics were described during follow-up including: 
 ulcer tissue type 
 size and severity of the ulcers 
 surrounding skin descriptions 
 dressings used 
 debridement 
 bandages used  
 pain profiles 
 
Characteristics of current practice during follow-up were described including: 
 support surfaces used 
 specialist involvement 
 significant events 
 
Details of the patient’s journey were described including: 
 length of stay 
 change of accommodation 
 readmission rates and ward moves 
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4.13 Photographs 
Photographs of the ulcers were visually assessed for each patient and used to 
verify details of tissue type and ulcer classification.  
 
4.14 Study Approval  
The study protocol was completed March 2006. This was submitted to Leeds 
West Research Ethics Committee and received a favourable opinion in June 
2006. It was also submitted for research governance approval from the R&D 
department of Leeds Teaching Hospitals Trust, which was received in April 
2006 and Bradford South and West Primary Care Trust (PCT) Research & 
Development Unit (for approval of patient follow-up in Leeds PCT), which was 
received in June 2006. An application for an honorary contract with Leeds PCT 
was approved in August 2007. 
 
A substantial amendment request was made in December 2007 for changes to 
the frequency of collection of the Braden Score and ulcer photographs and 
patient withdrawal options (request to continue collecting data from patient 
records should the patient wish to withdraw from the study). The committee did 
not approve the patient withdrawal options. The Ethics committee also 
requested an application for Section 30 approval under the Mental Capacity Act 
for the inclusion of patients who do not have the capacity to consent for 
themselves. 
 
Subsequently two substantial amendments were approved in September 2008 
which included the approval under Section 30 and 34 of the Mental Capacity 
Act and an amendment to the pain assessment scale. The pain assessment 
scale was changed from a single question asking for the severity of current pain 
in a ‘likert’ type scale to include three further questions asking about pain 
triggers, pain relievers and a description of the pain. 
 
4.15 Detail of variables 
The derivation of the variables, the rationale for their collection and which 
analysis they were used for presented in table 4.1 
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Variable Derivation 
Age Age on admission to the study was taken from the date of 
birth in the medical records 
Gender This was taken from the medical records 
Ethnicity This was taken from the medical records 
Speciality This was recorded at each visit. It is the speciality of the 
patient’s current medical consultant practice 
Co-morbidities These were taken as described in the admission clerking in 
the medical records. They include: diabetes if known; 
neurological deficit to include CVA whether new or old, MS, 
etc; heart disease to include ischaemia and failure; 
respiratory disease to include COAD, bronchitis, 
emphysema; malignancy- progressive disease especially 
cachexia but not if resolved e.g. previous breast lump; 
fracture – related to this episode of care of below waist or 
spine; surgery > 2 hours this episode of care 
Smoking Smoking history was recorded. If the patient had been 
smoking up to the point of current admission (may not 
actually have smoked since admission) or within last 3 
weeks, this was recorded as current. Previously smoked 
was recorded if the patient stopped more than 3 weeks ago. 
Medication Details of the name of any prescribed medication were 
taken from the patients drug chart. These were then coded 
according to the body group they affected according to BNF 
(Martin, 2007) classifications 
Pain Patients were asked to rate the pain in each affected heel 
ulcer as none, mild, moderate or severe. 
Patients were asked to verbally describe their pain: whether 
it was present at time of assessment, what triggers the pain, 
what relieved it and how it felt at its worst. This information 
was recorded as free text at each visit and subsequently 
coded 
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Nutrition Measurement of blood haemoglobin levels were taken as a 
proxy measure for nutrition (Harris et al., 2007). The 
haemoglobin level was taken from the medical records, the 
most recent recorded level on admission to the study during 
the patient’s current episode of care 
Braden scores The Braden ((Bergstrom et al., 1987) scale is a risk 
assessment instrument for pressure ulcers. It has been 
proven to have a high reliability and validity. It constitutes six 
elements which are individually assessed then combined to 
give a score. It was used in this study for its individual 
elements. Each is considered to be a risk factor for the 
development of a pressure ulcer and may therefore be a 
prognostic factor for healing. Information for each factor was 
derived from patient assessment and details from the 
nursing records 
Neuropathy Neuropathic assessment was carried out in accordance with 
Leeds Community Podiatry service Protocol
 
(see Box 3) 
Arterial disease Assessment of arterial disease was carried out using a 
Doppler ultrasound to measure brachial and foot (dorsalis 
paedis and posterior tibial) systolic blood pressures and 
calculating the ratio (Ankle Brachial Pressure Index). The 
procedure was performed in accordance with published 
guidance (Vowden, Goulding and Vowden, 1996) This was 
then coded as Arterial disease absent if ABPI is ≥ 0.8; some 
arterial disease if ABPI was ≥0.6 and <0.8 or severe arterial 
disease if ABPI was <0.6 or if the ABPI had been 
inappropriate due to the obvious arterial disease (the 
procedure would be too painful) 
Support surface These were recorded at each visit. The classification used is 
found in the NICE guidelines (RCN, 2005), reproduced in 
Box 2.  If specific heel pressure relieving devices were used 
these were also recorded 
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Severity of ulcer This was recorded at each data collection. The cohort study 
commenced prior to the new EPUAP/ NPUAP (2009) 
classification. The researcher chose to use the previous 
EPUAP (1998) definitions which are defined in table 2.1. 
However these were felt to be inadequate for the type of 
damage seen on the heel in the researchers’ clinical 
practice. They were therefore adapted and the 
classifications used in the study are given in Box 4.4. 
Size of ulcer Wounds were mapped at each visit using a standard grid 
and a fine tip permanent marker pen, where possible with 
the foot at a 90° angle to the leg. Maps are marked with 
patient registration number, date, left or right heel, and 
arrow indicating direction of leg. The maps were used to 
calculate the ulcer area using ‘Mouseyes’ software program 
Duration of ulcer 
prior to 
recruitment 
If the ulcer was present prior to admission then an estimate 
of date of onset was established based on patients report 
and any record of ulcer on previous admission. 
Duration of ulcer during the study was also recorded 
Tissue type The tissue type was visually assessed and coded according 
to the stage in the wound healing process (adapted from 
(Black et al., 2010)). It was described as follows: 
Blister – either fluid or blood filled or drained 
Necrotic – desiccated eschar, non-viable tissue, black/ 
brown in colour 
Slough – non-viable tissue and bacteria, grey/ yellow/ white 
in colour 
Granulation – new capillary beds and intracellular matrix, 
red in colour 
Epithelialisation – new epithelial growth, pink/ white in colour 
Other – this is predominately dry scab, thought to be excess 
epithelialisation 
If more than one tissue type was present, the predominant 
type was recorded 
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Surrounding skin The condition of the skin around the pressure ulcer was 
visually assessed and described as follows: 
Callous – excessive thickening of the epidermis on the heel 
around the ulcer 
Fissure- a crack in the epidermis on the heel, which may or 
may not penetrate dermis 
Oedema – light finger pressure applied anywhere on the 
foot (below malleoli) which leaves an indentation when 
removed 
Erythema – the area of skin around ulcer is either bright red, 
dark red or darker than normal skin tone 
Macerated – saturation of epidermis with fluid, appears 
white and soggy 
Other – may include epidermal separation subsequent to 
blister formation 
Dressings A record was made of the actual dressings in situ on the 
ulcer at each visit. A judgement was made as to whether the 
intention was to keep the ulcer dry or moist: dry wound 
healing would include no dressing at all, gauze (including 
Release, Melolin type pads) with paper type adhesive e.g. 
Hypafix, Micropore, may include dressings such as Kaltostat 
or Inadine on a dry wound; moist wound healing would 
include any dressing with occlusive backing such as Allevyn, 
Tielle, films, may or may not have additional creams to 
assist hydration such as Aquaform gel. N.B. Foams such as 
Allevyn may be used for protection on dry eschar where 
debridement is not being attempted; these are classed as 
dry wound healing Where antiseptics were used as a 
dressing, these were also recorded. 
Debridement A record was made if active debridement had taken place 
since the previous visit. Sharp debridement is nursing, 
medical or podiatry staff either using a blade or scissors on 
the ward or surgically in an operating theatre. Other 
debridement includes larvae therapy, enzymatic (Varidase) 
or chemical (Eusol) 
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Bandages A record was made if bandages were in place at each visit: 
retention bandages would be crepe, K-band or K-lite or 
equivalent, stockinette (does not include tubigrip); 
compression bandages includes K-plus, Setopress, 
Tensopress, 4 layer bandages, short stretch bandages, 
Tubigrip, compression hosiery and anti-embolytic stockings 
Specialist 
involvement 
If the ulcer management of the pressure ulcer had been 
specifically prescribed by a specialist e.g. Tissue Viability, 
Podiatry, Vascular or Plastic surgeon, this was recorded at 
each visit 
Significant events A field diary was kept of any significant events including 
incidents of infection (both infection in the pressure ulcer 
site and unrelated infections), physical and psychological 
events which appeared to have an impact on the patients 
wellbeing. 
Occurrence of infection of the pressure ulcer 
Wounds may exhibit acute or chronic infections or a patient 
may become systemically unwell due to the bacteria in the 
ulcer. Definitions of infection are difficult to find. Table 4.3 
has been compiled from a review of the literature and is 
based on expert opinion 
Photographs Photographs were taken at each visit with a digital camera. 
This was set on ‘close up’ setting, positioned approx 40-50 
cm away from ulcer, all dressings removed and the ulcer 
cleaned if necessary. All photographs are stored on a 
memory card then transferred to main computer (see 
section 4.8 for changes following piloting) 
Change of 
accommodation 
Details of accommodation prior to admission, any transfers 
to other wards within the hospital, accommodation on 
discharge and any subsequent changes in accommodation 
are taken from the patient, nursing staff or medical notes 
Length of stay The date of admission and the date of discharge are taken 
from the medical records and the duration calculated in 
days 
Table 4.2 Variables collected, their derivation and application 
153 
 
 
Box 4.2 Classification of support surfaces 
The management of pressure ulcers in primary and secondary care (June 
2005) Royal College of Nursing and National Institute for Health and Clinical 
Excellence p80 of 245 
‘Pressure-relieving surfaces can be divided into two main categories: 
continuous low pressure (CLP) and alternating pressure (AP). 
Continuous low pressure surfaces aim to mould around the shape of the 
individual to redistribute pressure over a greater surface area. Alternating 
pressure surfaces mechanically vary the pressure beneath the individual, so 
reducing the duration of the applied pressure. 
CLP support surfaces can be grouped according to their construction: 
• Standard foam 
The conformability and resilience of foam products may vary considerably 
between manufacturers. Foam may be shaped, convoluted (“egg crate foam”), of 
various densities or of a combination of densities. 
• Visco-elastic foam 
This is specialised foam, available in varying densities, that moulds to body 
shape in response to body temperature. 
• Air flotation 
This is an inflated mattress replacement/overlay that manually or 
automatically adjusts airflow allowing immersion and redistribution of pressure. It 
is adjustable to individual reposition to maintain immersion and redistribution of 
pressures. 
• Air fluidised 
A constant flow of air is passed into a deep tank containing minute silicone 
beads retained by a permeable membrane. The agitated beads take on the 
properties of a fluid. Lying on the surface allows significant immersion and 
therefore redistribution of pressure. 
• Low air loss 
A constant flow of air inflates a row of permeable fabric cells. Manual or 
automatic adjustment of airflow allows significant immersion and therefore 
redistribution of pressure. 
• Gel/fluid 
Fluid surfaces – e.g. water-filled mattresses – which allow significant 
immersion and therefore redistribution of pressure. The density/viscosity of the 
gel/fluid will govern the degree of immersion and how stable the support surface 
is in terms of posture. 
• Combination products 
Many CLP surfaces, particularly cushions, use a variety of materials to 
provide optimum pressure relief and postural stability. 
N.B. The type and construction of cover material may have a significant 
impact on the conformability of the surface’. 
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Box 4.3 Leeds Community Podiatry Service Neuropathy testing Protocol 
 
Acute/local infection Chronic infection/critical 
colonisation 
Acute systemic 
infection 
 Abscess/pus 
 Cellulitis/ 
excessive 
inflammation 
 erythema 
 oedema 
 heat 
 pain 
 Unexpected pain 
/tenderness 
 Abnormal smell 
 Dehiscence 
 Delayed Healing   
 Discoloration of ulcer 
bed or reformation of 
sloughy/necrotic 
tissue 
 Friable bleeding of 
granulation tissue  
 Pocketing/bridging at 
the base of the    
ulcer   
 Increased exudate   
 Wound breakdown 
 Raised CRP 
 Raised white cell 
count 
 Pyrexia/fever 
 Flu like symptoms 
e.g. aching/ 
malaise 
Adapted from (Cutting et al., 2005; Wysocki, 2002) 
Table 4.3 Signs and symptoms associated with different types  
of infection 
 
 
 
1. Use 10 gram monofilament 
2. Sites to be tested are 1
st
, 3
rd
 5
th
 toe, plantar surface at base of each of previous 
toes and middle of heel pad. Mark with a tick if present and cross if absent 
3. Demonstrate monofilament test on patient’s hand (ask patient to close eyes) 
4. The approach, skin contact and departure of the filament should be 
approximately 1.5 seconds duration 
5. Apply sufficient force to cause the filament to bend 
6. Do not allow the filament to slide across the skin or make repetitive contact at 
the test site 
7. Randomize the selection of test sites and time between successive tests to 
reduce the potential for patient guessing 
8. Ask the patient to respond ‘yes’ whenever the filament is felt and record 
response  
9. Apply the filament along the perimeter of and not on ulcer site, callus, scar or 
necrotic tissue 
10. Monofilaments should not be used to test more than 10 patients in one session 
and should be left for 24 hours to recover. 
Neuropathy was considered present if there was a negative response in 2 or more test 
sites.  
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Box 4.4 Grades of severity of pressure ulcers used in cohort study 
 
4.16 Summary 
In order to meet the aim and objectives of this project a prospective cohort 
study design was used. The method was designed to minimise bias, particularly 
loss to follow-up and recruitment of the representative population. The study 
recruited patients from specialities known to have greater numbers of heel 
pressure ulcers. Data were collected from medical and nursing records, patient 
observations and interviews.  The sample size estimates were based on limited 
data and a pragmatic approach to time constraints. The primary data analysis 
utilised a Cox proportional hazards regression model based on time to event 
with robust standard errors to allow for clustering. Descriptive analysis of ulcer 
characteristics, current practice and the patients’ journey over the course of the 
study achieved the secondary objectives of the study. 
0 = No ulcer 
1 = Non-blanching erythema (discolouration, warmth, 
oedema, induration) 
2a = Blister with/without clear fluid 
2b = Blister with blood 
2c = Abrasion/friction damage (epidermis only) 
2d = Full thickness skin loss, no cavity 
3   = Full thickness skin loss with subcutaneous tissue 
involvement (cavity) 
4   = Extensive destruction including damage to muscle,   
bone or underlying structures 
5   = Tissue necrosis of undetermined depth 
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Chapter 5 Primary analysis 
 
5.1 Introduction 
This chapter follows the first section of the analysis plan described in Chapter 
four, meeting the primary aim of this study. It gives the patient recruitment rates 
and the baseline characteristics of the patients and ulcers. It then reports the 
results of the prognostic factor analysis using the Cox proportional hazard 
model with robust standard errors. The descriptive analysis of the findings of 
the secondary study objectives are described in chapter six. 
 
5.2 Patient recruitment 
The study took place during 33 months between Aug 2007 and April 2010. 
Patients were actively recruited during a 2 year period (24.8.07 - 6.8.09) and 
followed up for a period of 18 months or until their ulcer healed, the patient died 
or left the study for other reasons or the study ended. 
 
During the study 336 patients were screened for inclusion of which 148 were 
recruited. Figure 5.2 includes the reasons for non-recruitment. Figure 5.1 show 
the cumulative frequency of patients recruited. The troughs were mainly 
associated with the researcher’s holidays. The target was 20 per month. 
 
 
Figure 5.1 Cumulative total of patients recruited during study  
Figure 5.1 includes all 148 patients who consented. Following consent, eight 
patients were withdrawn and no follow-up data were collected. These patients 
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were excluded from the analysis population and any data which had been 
collected was discarded: 
  One was withdrawn by her son 
  Two were withdrawn at the patient’s request 
  One patient was reported to have a Grade 2 pressure ulcer but this was 
revealed to be a Grade 1 ulcer which did not deteriorate 
  One was found to have a wound that was not a pressure ulcer 
  One discharged himself with no known address 
  One patient was found to live outside the Leeds area 
  One patient was too ill for full data collection and subsequently died 
Figure 5.2 shows the flow of patients through the study.  
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Figure 5.2 Recruitment and outcomes for all heel pressure ulcers 
 
The reasons included in the ‘other’ section of ‘reasons for non-recruitment’ 
were due to the patient or their relative having major concerns over the 
development of the pressure ulcer and were in the process of considering legal 
action against a care organisation. It was felt that the research study may 
aggravate circumstances and the researcher was advised not to approach 
these patients or their families. 
Number of 
patients screened 
n= 336
Number of 
patients recruited 
n= 148 Number of patients not recruited n= 186
Reasons for non- recruitment:
Patient does not wish to take part in study = 16
Relative does not wish patient to take part = 12
Patient does not have capacity to consent (no 
relatives) = 10
Patient does not have capacity to consent 
(unable to contact relatives) = 56
Patient too ill (e.g. LCP) = 72
Patient lives out of Leeds = 16 
Other (e.g. family unhappy with care/ that 
patient has PU) = 4
Number of healed 
ulcers n = 77
Number of ulcers 
on patients who 
died prior to 
healing n = 88
Number of ulcers 
on a limb that was 
amputated prior to 
healing n = 5
Number of ulcer 
that did not heal 
after 18 months or 
end of study
n = 11
Number of 
patients with 2 
heel PUs n= 43
Number of heel 
PUs n= 183
Number of 
patients withdrawn  
n= 8
Number of ulcers 
lost to follow-up 
n = 2
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The two ulcers on patients who were subsequently lost to follow-up were 
included in the analysis: one discharged himself from hospital with no home 
address, the other left hospital to a location outside the Leeds area. 
 
5.3 Data analysis 
5.3.1 Baseline characteristics 
Table 5.1 gives details of the patient characteristics; table 5.2 gives details of 
the ulcer characteristics at baseline. The percentages given in the total column 
are based on the categories within the variable; the percentages given in the 
outcome groups are based on the outcomes within the category e.g. within the 
variable gender of the 66 males: 26% had one ulcer that healed, 41% had one 
ulcer which did not heal, 7.5% had two ulcers that both healed, 18% had two 
ulcers of which one healed and 7.5% had two ulcers of which neither healed. 
For gender variable 47% of the patients were male and 53% were female.  
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  Value / frequency (% for each variable, unless otherwise stated) 
Variable/ 
attribute 
 Patients with 1 ulcer Patients with 2 ulcers Total 
number of 
patients 
 
N = 140 
Ulcer 
healed 
N = 43 
Ulcer not 
healed 
N = 53 
Both ulcers 
healed 
N = 12 
Both 
ulcers not 
healed 
N = 22 
One not 
healed 
N = 10 
Age 
 
Mean (SD) 
Median (range) 
Missing 
77(13.5) 
81 (32-102) 
0 
80 (14.5) 
85 (27-95) 
 
0 
78 (14.9) 
81 (39-94) 
 
0 
88 (7.0) 
89 (72-99) 
 
0 
76 (20.0) 
81 (20-89) 
 
0 
80 (14.1) 
84 (20-102) 
0 
Gender 
 
Male 
Female 
Missing 
17 (26%) 
26 (35%) 
0 
27 (41%) 
26 (35%) 
0 
5 (7.5%) 
7 (10%) 
0 
12 (18%) 
10 (13%) 
0 
5 (7.5%) 
5 (7%) 
0 
66 (47%) 
74 (53%) 
0 
Ethnicity 
 
White British 
Asian 
Afro-Caribbean 
Eastern 
European 
Missing 
39 (29%) 
1 (50%) 
2 (100%) 
 
1 (100%) 
0 
52 (39%) 
1(50%) 
0 
 
0 
0 
12 (9%) 
0 
0 
 
0 
0 
22 (16%) 
0 
0 
 
0 
0 
10 (7%) 
0 
0 
 
0 
0 
135 (96%) 
2 (1.5%) 
2 (1.5%) 
 
1 (1%) 
0 
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Speciality 
 
Care of the 
Elderly 
Vascular 
Orthopaedics 
Neurosciences 
General surgery 
Diabetology 
Missing 
 
26 (28%) 
1 (6%) 
5 (46%) 
5 (62.5%) 
4 (45%) 
2 (50%) 
0 
 
34 (37%) 
10 (59%) 
3 (27%) 
2 (25%) 
2 (22%) 
2 (50%) 
0 
 
8 (9%) 
2 (12%) 
0 
0 
2 (22%) 
0 
0 
 
17 (19%) 
3 (17%) 
2 (18%) 
0 
0 
0 
0 
 
6 (7%) 
1 (6%) 
1 (9%) 
1 (12.5%) 
1 (11%) 
0 
0 
 
91 (65%) 
17 (12%) 
11 (8%) 
8 (6%) 
9 (6%) 
4 (3%) 
0 
Haemoglobin 
 
Mean (SD) 
Median (range) 
 
Missing 
10.8 (1.5) 
11(7.6-
14.5) 
1 
10.7 (1.9) 
10.9 (6.7-
15.9) 
0 
10.8 (2.0) 
10.3 (8.2-
15.4) 
0 
10.7 (1.2) 
11.1 (7.8-
12.4) 
0 
11.8 (1.8) 
11.8 (8.8-
15.6) 
0 
10.9 (1.7) 
11(6.7-15.9) 
 
1 
Smoking 
 
Current 
Previous  
Never 
Missing 
3 (22%) 
22 (33%) 
18 (31%) 
0 
8 (57%) 
22 (33%) 
23 (39%) 
0 
1 (7%) 
5 (7%) 
6 (10%) 
0 
2 (14%) 
13 (20%) 
7 (12%) 
0 
0 
5 (7%) 
5 (8%) 
0 
14 (10%) 
67 (48%) 
59 (42%) 
0 
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Medication* 
 
Anticoagulants 
Cardiovascular 
Endocrine 
Nutrition 
Steroids 
Analgesics 
Antibiotics 
Gastrointestinal 
Central nervous 
system 
Respiratory 
Obstetrics, 
gynaecology 
and  urinary 
tract 
Other  
Missing 
35 (31%) 
29(31%) 
15(28%) 
20(26%) 
6(50%) 
31(30%) 
12(37%) 
33(34%) 
 
25(33%) 
8(35%) 
 
4(40%) 
 
 
5(42%) 
0 
45(40%) 
39(42%) 
25(47%) 
32(42%) 
3(25%) 
37(37%) 
12(37%) 
36(37%) 
 
28(37%) 
7(31%) 
 
3(30%) 
 
 
5(42%) 
0 
7(6%) 
4(4%) 
2(4%) 
5(6%) 
1(8.3%) 
11(11%) 
2(6%) 
7(7%) 
 
5(7%) 
1(4%) 
 
1(10%) 
 
 
1(8%) 
0 
17(16%) 
14(15%) 
6(12%) 
17(22%) 
1(8.3%) 
14(14%) 
6(20%) 
15(15%) 
 
11(15%) 
6(26%) 
 
2(20%) 
 
 
1(8%) 
0 
8(7%) 
7(8%) 
5(9%) 
3(4%) 
1(8.3%) 
8(8%) 
0 
7(7%) 
 
6(8%) 
1(4%) 
 
0 
 
 
0 
0 
112 (80%) 
93 (66%) 
53 (38%) 
77 (55%) 
12 (9%) 
101 (72%) 
32 (23%) 
98 (70%) 
 
75 (54%) 
23 (16%) 
 
10 (7%) 
 
 
12 (9%) 
0 
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Braden score 
factor 
Sensory 
 
 
 
 
 
 
Completely 
limited 
Very limited 
Slightly limited 
No impairment 
 
 
0 
 
2(11%) 
25(34%) 
16(35%) 
 
 
1(100%) 
 
9(47%) 
31(42%) 
12(26%) 
 
 
0 
 
5 (26%) 
4(5%) 
3(7%) 
 
 
0 
 
2(11%) 
7(9.5%) 
13(28%) 
 
 
0 
 
1(5%) 
7(9.5%) 
2(4%) 
 
 
1(1%) 
 
19(13%) 
74(53%) 
46(33%) 
Moisture 
 
 
 
 
Completely moist 
Very moist 
Occasionally 
moist 
Rarely moist 
0 
5(29%) 
 
16(38%) 
22(28%) 
2(100%) 
11(65%) 
 
18(43%) 
22(28%) 
0 
0 
 
2(5%) 
10(13%) 
0 
1(6%) 
 
1(2%) 
20(25%) 
0 
0 
 
5(12%) 
5(6%) 
2(2%) 
17(12%) 
 
42(30%) 
79(56%) 
Activity 
 
 
 
 
Bedfast 
Chairfast 
Walks 
occasionally 
Walks frequently 
5(21%) 
17(26%) 
13(34%) 
 
8(58%) 
13(54%) 
23(36%) 
13(34%) 
 
4(28%) 
2(8%) 
7(11%) 
2(5%) 
 
1(7%) 
3(13%) 
12(19%) 
7(19%) 
 
0 
1(4%) 
5(8%) 
3(8%) 
 
1(7%) 
24(17%) 
64(46%) 
38(27%) 
 
14(10%) 
164 
 
Mobility 
 
 
 
 
Completely 
immobile 
Very limited 
Slightly limited 
No limitation 
3(18%) 
 
15(23%) 
13(36%) 
12(57%) 
10(59%) 
 
21(32%) 
15(42%) 
7(33%) 
1(6%) 
 
7(10%) 
3(8%) 
1(5%) 
2(11%) 
 
17(26%) 
3(8%) 
0 
1(6%) 
 
6(9%) 
2(6%) 
1(5%) 
17(12%) 
 
66(47%) 
36(26%) 
21(15%) 
Nutrition 
 
 
 
 
Very poor 
Probably 
inadequate 
Adequate 
Excellent 
4(20%) 
 
8(19%) 
11(37%) 
20(42%) 
9(45%) 
 
20(48%) 
11(37%) 
13(27%) 
0 
 
3(7%) 
4(13%) 
5(10%) 
6(30%) 
 
8(19%) 
4(13%) 
4(8%) 
1(5%) 
 
3(7%) 
0 
6(13%) 
20(14%) 
 
42(30%) 
30(21%) 
48(34%) 
 
Friction and 
shear 
 
 
Problem 
Potential 
problems 
No apparent 
problems 
Missing 
 
11(30%) 
 
19(25%) 
 
13(45%) 
0 
 
16(43%) 
 
25(33%) 
 
12(43%) 
0 
 
1(3%) 
 
10(13%) 
 
1(4%) 
0 
 
7(19%) 
 
14(19%) 
 
1(4%) 
0 
 
2(5%) 
 
7(10%) 
 
1(4%) 
0 
 
37(26%) 
 
75(54%) 
 
28(20%) 
0 
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Co-
morbidity* 
 
Diabetes 
Neurological 
deficit 
Heart disease 
Respiratory 
disease 
Malignancy 
PVD 
Fracture 
Surgery > 2 hours 
Missing 
15(31%) 
 
24(35%) 
14(27%) 
 
7(28%) 
9(47%) 
3(10%) 
8(36.5%) 
 
2(18%) 
0 
24(50%) 
 
25(36%) 
22(43%) 
 
10(40%) 
7(37%) 
16(55%) 
8(36.5%) 
 
3(27.5%) 
0 
2(4%) 
 
6(9%) 
3(6%) 
 
0 
2(11%) 
1(4%) 
2(9%) 
 
2(18%) 
0 
2(4%) 
 
11(16%) 
9(18%) 
 
7(28%) 
1(5%) 
5(17%) 
2(9%) 
 
3(27.5%) 
0 
5(11%) 
 
3(4%) 
3(6%) 
 
1(4%) 
0 
4(14%) 
2(9%) 
 
1(9%) 
0 
48 (34%) 
 
69 (49%) 
51(36%) 
 
25 (18%) 
19 (14%) 
29 (20%) 
22 (16%) 
 
11 (8%) 
0 
SD=Standard Deviation  
*Patients may have more than one co-morbidity or group of medication 
 
Table   5.1 Patient level information 
- 166 - 
It can be seen from table 5.1 that more patients had one ulcer than two; there 
was approximately equal numbers of male and female patients; most patients 
were recruited from Care of the Elderly speciality; approximately half the 
patients had previously been smokers; the most frequently prescribed 
medications included anticoagulants, cardiovascular medication, analgesics 
and gastrointestinal medication; most patients had reduced mobility and 
activity; diabetes and neurological deficit were the most common co-
morbidities.  
 
Variable Healed  
n = 77 
Did not heal  
n = 106 
Total  
n = 183 
Duration prior to 
recruitment 
(days) 
 
Mean (SD) 
Median (range) 
Missing 
105.39 
(223.18) 
21 (0-1475) 
3 
61.49 
(136.83) 
24 (0-1091) 
17 
80.93(181.48) 
23 (0-1475) 
20 
Neuropathy    Present 
 Absent 
 Missing 
23 (30%) 
31(40%) 
23(30%) 
24(23%) 
25(23%) 
57(54%) 
47(26%) 
56(30%) 
80(44%) 
ABPI     ABPI≥0.8       
 ABPI,0.8 but ≥0.6 
ABPI,0.6 or 
inappropriate 
Missing 
40(52%) 
4(5%) 
12(16%) 
 
21(27%) 
30(28%) 
7(6%) 
26(25%) 
 
43(41%) 
70(38%) 
11(6%) 
38(21%) 
 
64(35%) 
Severity 
 
Superficial 
Severe   
 Missing 
45(58%) 
32(42%) 
0 
38(36%) 
65(61%) 
3(3%) 
83(45%) 
97(53%) 
3(2%) 
Area 
 
Mean (SD) 
Median   (range) 
Missing 
7.9 (7.61) 
5.33 (0 .34 - 
43.14) 
2 
10.11(8.08) 
7.9 (0.24-
35.99) 
13 
9.09 (7.9) 
6.48 (0.24-
43.14) 
15 
Tissue type 
 
Blister 
Granulating 
Sloughy 
Necrotic 
Other  (dry scab) 
Missing 
19(25%) 
12(16%) 
15(19%) 
26(34%) 
4(5%) 
1(1%) 
21(20%) 
14(13%) 
17(16%) 
50(47%) 
1(1%) 
3(3%) 
40(22%) 
26(14%) 
32(18%) 
76(42%) 
5(3%) 
4(1%) 
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Surrounding 
skin 
 
Healthy 
Erythema 
Macerated 
Dry/ flaky 
Oedema 
Other 
Missing 
23(30%) 
3(4%) 
5(6%) 
12(16%) 
26(34%) 
5(6%) 
3(4%) 
28(26%) 
7(7%) 
7(7%) 
18(17%) 
30(28%) 
9(8%) 
7(7%) 
51(28%) 
10(5%) 
12(7%) 
30(16%) 
56(31%) 
14(8%) 
10(5%) 
Pain 
 
None 
Mild 
Moderate 
Severe 
Missing 
34(44%) 
8(11%) 
5(6%) 
5(6%) 
25(33%) 
32(30%) 
7(7%) 
16(15%) 
10(9%) 
41(39%) 
66(36%) 
15(8%) 
21(11%) 
15(8%) 
66(36%) 
 SD = Standard Deviation 
ABPI = Ankle Brachial Pressure Index 
 
Table 5.2 Ulcer level information 
 
There was a wide range in the number of the days prior to recruitment; the 
median number of days is slightly shorter for those which healed. There was a 
larger proportion of ulcers without neuropathy, a good arterial supply (ABPI), 
less severe ulcers, less sloughy and necrotic tissue that healed. Although the 
mean and median ulcer areas were smaller for those ulcers that healed, the 
range was very similar for both healed and unhealed. There is very little 
difference in the baseline tissue type or surrounding skin for those ulcers which 
did or did not heal, however there appears to be less in the ulcers that 
progressed to healing. 
 
5.3.2 Cox proportional hazard regression analysis 
Results are available for 183 heel pressure ulcers; 77 of these ulcers healed.  
 
5.3.2.1 Univariate analysis 
Table 5.3 shows the results of the univariate analysis for each variable 
considered a potential prognostic factor for healing. 
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 Variable Hazard 
ratio 
95% 
confidence 
interval 
Significance (p 
value) 
Age  1.002 0.983 - 1.021 0.812  
Gender Male (cf female) 1.340 0.841 - 2.133 0.2189  
Speciality 
 
Care of the Elderly 
Vascular 
Orthopaedic 
Neurosciences 
Surgery 
Diabetology 
1.509 
0.468 
0.594 
1.771 
1.051 
0.658 
0.930 - 2.446 
0.231 - 0.951 
0.251 - 1.405 
0.629 - 4.990 
0.595 - 1.856 
0.184 - 2.354 
0.095* 
0.036* 
0.235 
0.279 
0.864 
0.520 
 
Smoking 
 
Non-smoker 
Previous 
Current 
Referenc
e 
0.777 
1.130 
 
0.479 - 1.258 
0.363 - 3.510 
 
0.305 
0.832 
0.526 
(trend)** 
Haemoglobin 1.004 0.872 - 1.157 0.953  
Co-
morbidites 
Diabetes 
Neurological deficit 
Heart disease  
Respiratory 
disease 
Malignancy 
PVD 
Fracture 
Surgery > 2 hours 
0.818 
0.912 
0.772 
0.700 
1.351 
0.417 
1.049 
1.071 
0.505 - 1.324 
0.582 - 1.427 
0.489 - 1.282 
0.342 - 1.434 
0.810 - 2.256 
0.210 - 0 .825 
0.531 - 2.074 
0.408 - 2.810 
0.415 
0.687 
0.343 
0.330 
0.249 
0.012* 
0.890 
0.889 
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Medication 
 
Anticoagulants 
Cardiovascular 
Endocrine 
Nutrition 
Steroids 
Analgesics 
Antibiotics 
Gastrointestinal 
Central nervous 
system 
Respiratory 
Obstetrics, 
gynaecology and  
urinary tract 
Other 
0.943 
0.862 
1.013 
0.524 
1.570 
1.477 
0.887 
0.869 
1.105 
0.549 
0.907 
 
0.794 
0.535 - 1.661 
0.545 - 1.365 
0.632 - 1.628 
0.323 - 0.847 
0.680 - 3.628 
0.820 - 2.663 
0.479 - 1.643 
0.510 - 1.481 
0.697 - 1.754 
0.314 - 1.959 
0.456 - 1.800 
 
0.346 - 1.819 
0.838 
0.527 
0.954 
0.008* 
0.291 
0.194* 
0.703 
0.606 
0.670 
0.035* 
0.780 
 
0.585 
 
Braden 
 
Sensory 
Moisture 
Activity 
Mobility 
Nutrition 
Friction & sheer 
1.121 
0.976 
0.968 
1.119 
1.104 
1.041 
0.743 - 1.694 
0.672 - 1.417 
0.726 - 1.290 
0.876 - 1.430 
0.877 - 1.389 
0.754 - 1.438 
0.585 
0.897 
0.823 
0.367 
0.400 
0.804 
 
Duration prior to recruitment 0.999 0.999 - 1.000 0.357  
Neuropathy (present cf. absent) 0.738 0.432 - 1.260 0.265  
ABPI 
 
No arterial disease 
(ABPI≥0.8)     
Some arterial 
disease (ABPI,0.8 
but ≥0.6) 
Severe arterial 
disease (ABPI,0.6 
or inappropriate) 
reference 
 
0.478 
 
0.611 
 
 
0.181 - 1.262 
 
0.326 - 1.146 
 
 
0.136 
 
0.125 
 
0.149* 
(trend)** 
Ulcer severity (servere cf. 
superficial) 
0.498 0.319 – 0.777 0.002*  
Area 0.967 0.929 - 1.005 0.090*  
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Tissue type 
 
Dry scab 
Blister 
Granulating 
Sloughy 
Necrotic 
reference 
0.207 
0.163 
0.149 
0.153 
 
0.049 - 0.886 
0.040 - 0.663 
0.036 - 0.608 
0.038 - 0.612 
 
0.034 
0.011 
0.008 
0.008 
0.088* 
(trend)** 
Surrounding 
skin 
 
Healthy 
Erythema 
Macerated 
Dry/ flaky 
Other 
Oedema 
1.26 
0.510 
0.560 
0.839 
1.228 
1.124 
0.789 - 2.016 
0.204 - 1.277 
0.280 - 1.118 
0.436 - 1.614 
0.588 - 2.566 
0.713 - 1.771 
0.333 
0.151* 
0.100* 
0.599 
0.585 
0.614 
 
Pain 
 
None 
Mild 
Moderate 
Severe 
reference 
0.856 
0.837 
0.530 
 
0.463 - 1.580 
0.415 - 1.686 
0.184 - 1.528 
 
0.619 
0.618 
0.241 
0.700 
(trend) 
 * Indicates p≤0.2 
** Where the variable is an ordered categorical the 
significance of each category relative to the reference 
category (first/smallest) is given but also the level joint 
significance or trend for the whole parameter 
 
Table 5.3 Univariate analysis of potential prognostic factors  
 
From table 5.3, the following variables reached significance at the p≤0.2 level: 
 Speciality of Care of the Elderly 
 Speciality of Vascular 
 PVD as a co-morbidity 
 Prescribed nutritional medication 
 Prescribed analgesics 
 Prescribed respiratory medication 
 Presence of PVD (ABPI) 
 Severity 
 Area 
 Tissue type 
 Presence of erythema on surrounding skin 
 Presence of maceration of surrounding skin 
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The hazard ratios for Care of the Elderly speciality and prescribed analgesics 
were both greater than one, suggesting that the probability of healing was 
greater in the presence of these two variables. The hazard ratio for ulcer area 
was almost one, suggesting that this had very little effect on healing. All other 
variables suggested the probability of non-healing was greater in the presence 
of the variable (for the categorical variables) – or the value increased (for the 
continuous variables).  
 
It is also noted from table 5.3 that steroid medication and neurosciences 
speciality also have hazards ratios greater than 1.5, suggesting that the 
probability of healing was greater in the presence of these two variables, but 
these did not reach significance at the p≤0.2 level. 
 
The ABPI variable had 64 (35%) of the observations missing, so a decision was 
made not to include this in the multi-variate model. The number of observations 
for the presence of erythema and maceration of the surrounding skin was also 
very small. These were therefore also excluded from the multi-variate model.  
 
5.3.2.2 Test of collinearity 
All the variables in table 5.3 were examined for collinearity. A cut off point for 
the correlation coefficient was taken as ± 0.5. This identified several clinically 
meaningful correlations e.g. diabetes (an endocrine disease) and endocrine 
medication, Braden factors for activity and mobility, pain and neuropathy, 
vascular speciality and PVD, severity of the ulcer and tissue type.  
 
From the variables that reached significance at the p≤0.2 level, two correlations 
were considered further:  
 Vascular speciality and having PVD. The clinical setting is likely be related 
to the patient’s co-morbidity e.g. vascular speciality, having PVD and a 
low ABPI. 
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 PVD ABPI Vascular 
PVD 1.0   
ABPI 0.46 1.0  
Vascular 0.62 0.30 1.0 
 
Table 5.4 Correlation coefficients for arterial disease related variables 
 
PVD and Vascular speciality had a correlation of 0.6, so a decision was made 
not to include both in the multi-variate model. As there was a stronger 
correlation between ABPI and PVD than Vascular speciality and ABPI then it 
was decided to use the PVD variable in the final model. Vascular speciality was 
the least preferred variable as this would include all patients who were on the 
vascular ward, who may not have PVD and also patients with PVD who were 
admitted for other conditions. 
 Severity of the ulcer and the tissue type in the ulcer bed.  Both these 
variables included some of the same clinical descriptions. 
 
 Tissue type Severity 
Tissue type 1.0  
Severity 0.61 1.0 
 
Table 5.5 Correlation coefficients for ulcer categories 
 
Severity and tissue type had a correlation of 0.6, so a decision was made not to 
include both in the multi-variate model.  As severity had only 2 categories 
(therefore had greater numbers for each category) this was used in the multi-
variate model.  
 
5.3.2.3 Multi-variate model 
The following variables were entered in the multi-variate model: 
 Speciality of Care of the Elderly 
 PVD as a co-morbidity 
 Prescribed nutritional medication 
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 Prescribed analgesics 
 Prescribed respiratory medication 
 Severity 
 Area 
 Gender 
 
Gender was included in the model as this is a known factor that influences 
wound healing (see section 2.7.1) even though the level of significance in the 
univariate analysis was outside the cut off point of ≤0.2. 
 
In the final model two variables emerged that reached significance at the p≤0.1 
level. Details are given in table 5.6. 
 
Variable  Hazards 
ratio 
95% confidence 
interval 
Significance (p 
value) 
Severity 0.476 0.303 - 0.748 0.001 
PVD 0.404 0.202 - 0.808 0.010 
 
Table 5.6 Results of multi-variate modelling using a stepwise  
automated process 
 
This suggests that with this heel ulcer population:  
 the estimated effect of ulcer severity at baseline (having a severe rather 
than a superficial ulcer), after controlling for the confounding effects of 
the presence of all other variables in the model, will give approximately 
half the chance of healing (95%CI 0.3-0.8). 
 the estimated effect of the presence of Peripheral Vascular disease at 
baseline, after controlling for the confounding effects of the presence of 
all other variables in the model, will give approximately a 0.4 times the 
chance (i.e. 60% less chance) of healing (95%CI 0.2-0.8). 
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5.3.2.4 Sensitivity analysis 
In order to ascertain whether the choice of variable (where collinearity existed) 
to be included in the multi-variate model had affected the findings. The 
modelling was repeated with each of the excluded variables in turn. 
 
Variable  Hazards 
ratio 
95% confidence 
interval 
Significance (p 
value) 
Severity 0.481 0.303 - 0.761 0.002 
 
Table 5.7 Results of multi-variate modelling substituting vascular 
speciality for PVD 
 
Variable  Hazards 
ratio 
95% confidence 
interval 
Significance (p 
value) 
PVD 0.413 0.206 - 0.830 0.013 
 
Table 5.8 Results of multi-variate modelling substituting tissue type  
for severity 
 
While the same variables reached significance, this did not occur in the same 
model. This suggests that the choice of variable (where collinearity existed) was 
appropriate. 
 
5.3.2.5 Testing the proportional hazards assumption 
To check whether the hazards were proportional, charts were plotted of the log 
of the cumulative hazard function in the groups with and without each variable 
entered into the multi-variate model. They show that the proportional hazards 
assumption is correct as the lines were almost parallel for all variables. The 
charts for the two variables which were found to be significant at the p≤0.1 are 
shown in figures 5.3 and 5.4. 
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Figure 5.3 Cumulative hazard (log scale) against analysis time  
(log scale) for PVD variable 
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Figure 5.4 Cumulative hazard (log scale) against analysis time  
(log scale) for severity variable 
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5.4 Summary 
This prospective cohort study of 140 patients with 183 heel pressure ulcers 
recruited participants from the specialities of Care of the Elderly, Vascular, 
Diabetology, Orthopaedics and Surgery.  
 
Seventy seven of the 183 ulcers healed, 87 did not heal because the patient 
died, 5 were on limbs which were amputated, 11 had not healed after 18 
months or by the end of the study and 2 ulcers were on patients lost to follow-
up. 
 
From the data collected on baseline variables thought to be prognostic factors 
for healing, 12 factors were found to be significantly associated with healing at 
the p≤0.2 level in a univariate Cox regression model. Five variables were 
excluded from the multivariate model: two of these factors due to collinearity 
and three due to the very small number of observations. Eight factors (including 
gender) were included in the final model. Severity of the ulcer and the presence 
of PVD were found to be significant prognostic factors for healing at the p≤0.1 
level. 
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Chapter 6 Secondary descriptive results 
 
6.1 Introduction 
The previous chapter presented the results of the analysis of the prognostic 
factors  which met the primary aim of the study. The secondary objectives were 
to: 
1 describe the characteristics of patients who have heel pressure ulcers  
2 describe the characteristics of current practice i.e. the dressings and topical 
treatments including debridement, support surfaces used, specialist advice 
3 describe the progress of heel pressure ulcers through the stages of wound 
healing 
4 determine the adverse sequelae of this patient population e.g. death, 
septicaemia, amputation, infection, length of stay and destination post 
discharge 
 
This chapter describes the findings of these secondary objectives. A full and 
detailed discussion of these findings is presented in chapter seven.  
 
Some of the data used in this chapter was captured at baseline, however, most 
of the data were captured at the follow-up visits, some of the characteristics are 
described based on the actual number of times the observation was recorded, 
some are then described in terms of an episode e.g. an ‘episode’ of erythema 
was deemed to have occurred when it was recorded on one or more sequential 
occasions.  There were potentially 929 observations; where observations are 
quantified missing numbers are given in each section. 
 
6.2 Characteristics of patients  
Patient characteristics have already been described in section 5.3.1. 
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6.3 Characteristics of current practice  
6.3.1 Dressings 
The dressings in situ on the ulcer at the time of assessment were recorded at 
baseline and at each subsequent visit. Details are given in Table 6.1. The 
dressing at baseline is given in the top row. There were 928 dressing 
observations in total (one missing), the second row of the table gives details of 
the total number of dressing observations See Table 4.2 for details of how 
these were captured and coded. 
Dressings 
 Moist 
wound 
healing 
Dry wound 
healing 
Moist 
wound 
healing + 
antiseptic 
Dry wound 
healing + 
antiseptic 
No 
dressing 
Baseline 55 (30%) 72 (39%) 27 (15%) 19 (10%) 10 (6%) 
Total 
observations 
297 (32%) 234 (25%) 213 (23%) 51 (6%) 133 (14%) 
Table 6.1 Frequency of dressing type 
 
The most frequently occurring dressing type was moist wound healing. Only 20 
ulcers had one dressing type throughout their full episode of care. For nine of 
the ulcers this was moist wound healing.  If no dressings were in place this was 
seen on ulcers which were either dry black eschar (n=15) or dry scabbed 
(n=30) or blister (n=16). No ‘open’ or exudating ulcers were found without a 
dressing. 
 
6.3.2 Bandages 
There were 927 observations of ‘bandage’ variable (2 missing): 253 (27%) 
recorded no bandages, 648 (70%) recorded retention bandages and there were 
26 (3%) records of compression bandage on 11 ulcers. More than half the 
ulcers had both retention bandages and no bandages at different times during 
the study. No one ulcer had compression for the whole data collection period.  
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6.3.3 Debridement 
The process of passive (autolytic) debridement has been described in section 
2.3.2 and the reputed need for active debridement discussed in section 2.6.3. 
There were 929 observations for the ‘debridement’ variable of which 860 
(92.5%) recorded none/passive debridement, 66 (7%) occasions of sharp 
debridement on 45 ulcers and 3 (0.5%) episodes of larvae therapy on 3 
different ulcers were recorded. 
 
6.3.4 Support surfaces 
Table 6.2 shows the type of support surface in use at baseline. For details of 
the classifications see Box 4.2 in section 4.15. 
Pressure relieving support 
surface 
No of patients 
Standard foam 18 (13%) 
Visco-elastic foam 36 (26%) 
Low air loss 26 (18%) 
Alternating pressure 45 (32%) 
Air flotation 3 (2%) 
Heel specific support 1 (1%) 
Standard foam + heel specific 4 (3%) 
Visco-elastic foam + heel 
specific 
6 (4%) 
Missing 1 (1%) 
 
Table 6.2 Support surfaces including specific heel devices in  
use at baseline 
 
The majority of patients had a low air loss or alternating pressure mattress on 
their bed at some point during the study.  Of the 18 patients who had ‘standard 
foam’ at baseline only 6 had a low air loss or alternating pressure mattress at 
the next visit. Seven patients had ‘standard foam’ throughout the study with a 
low air loss or alternating pressure support surface for a maximum of one week 
only. 
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Thirty patients who had a low air loss or alternating pressure mattress for most 
of the study period had at least one week with a standard foam mattress. 
Twenty four patients had a heel specific device such as a Repose
©
 heel trough 
at some time in addition to the mattress but only one patient had a specific heel 
device for the whole study period.  
 
6.3.5 Specialist involvement 
Details of how this was recorded were given in section 4.15 table 4.1.There 
were 749 observations pertaining to whether specialists were involved in the 
care of the heel ulcer, of these 215 (29%) noted that specialists were involved. 
Of the 77 ulcers that healed, 40 (52%) had been seen by a specialist at some 
point; of the ulcers that did not heal, 36 (34%) had been seen by a specialist. If 
the specialists were Tissue Viability, their involvement was intermittent. Some 
patients with diabetes were regularly seen by the diabetic podiatry team. Some 
patients were in hospital because of their heel ulcer and were seen by the 
vascular surgeons or diabetologists, these would be recorded as having 
specialist involvement.  
 
6.4 Progress of heel ulcers 
6.4.1 Duration and outcome 
Patients recruited to the study were followed up for a maximum duration of 18 
months. For patients still in the study at this point, data collection was censored 
and the outcome classified as non-healed. Data were also censored for 
patients who were lost to follow-up, died, had their limb amputated or end of 
study. 
 
 Healed Non-healed 
(censored) 
Total 
Mean number of days(SD) 135 (102) 102 (130) 116 (120) 
Median number of 
days(range) 
121 (8-
440) 
43 (4-614) 63 (4-
614*) 
*Two patients had a final data collection at 20 rather than 18 months. 
Table 6.3 Summary of time to healing or censoring 
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A total of 140 patients with 183 ulcers were included in the analysis. Sixty 
patients died with 88 heel pressure ulcers. Details of the outcome for all ulcers 
are given in table 6.4.  
 
Endpoint Censored Total 
Healed 
n = 77(42%) 
Ulcer on 
patient who 
died 
n = 88 (48%) 
Ulcer on a 
leg which 
was 
amputated 
n = 5 (3%) 
Non-
healed* 
n = 11(6%) 
Lost to 
follow-up 
n = 2 (1%) 
Total number 
of ulcers 
n=183 
* Non healing was defined as ‘at end of study’ or ‘at end of 18 months’ 
Table 6.4 Details of ulcer outcome 
 
6.4.2 Tissue type    
Tissue type was recorded as one of five categories at each visit. Photographic 
examples are given for each category in figures 6.1 – 6.5. 
 
The tissue type at baseline is described in table 5.2. This stated that 42% of the 
ulcers presented as necrotic tissue, 22% were blisters, 18% were sloughy, 14% 
were granulation tissue, 3% were a dry scab and one observation was missing. 
It was related to stage of the pressure ulcer when the patient was recruited. If 
the ulcer was a new event then it would most likely be a blister. However, if the 
ulcer had been present for some time then the ulcer may be in the inflammatory 
or proliferative phase (or the transition between the two) seen as necrotic/ 
sloughy tissue moving to granulation. Details of tissue type collected at each 
time point illustrated progression of the ulcer through wound healing or not.  
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Figure 6.1 Blister Figure 6.2 Granulating 
  
Figure 6.3 Sloughy Figure 6.4 Necrotic 
 
 
Figure 6.5 Other – dry scab 
 
 
Of the 77 pressure ulcers that healed, 75% were seen to have progressed 
through the phases of wound healing to a ‘dry scab’ then intact skin, except 19 
(25%) ulcers. Table 6.5 gives a breakdown of the tissue type prior to healing. 
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Dry scab Granulation Necrosis Blister Total healed 
ulcers 
58 (75%) 12 (16%) 5 (6%) 2 (3%) 77 (100%) 
Table 6.5 Tissue type prior to healing 
 
6.4.3 Ulcer size 
Ulcer size is recorded as surface area (calculated from the tracing of the 
perimeter of the ulcer, see table 4.2) at baseline in given in table 5.2. This gives 
the mean area as 9.09 (S.D. 7.9) cm
2
. Data for changes in ulcer area were 
visually examined. The following trends were noticed in many of the ulcers: 
 Area can increase before it decreases 
 The rate of area reduction is greater during the early stages of wound 
healing 
 Final ulcer closure can be prolonged 
 
Ulcers which did not heal also showed similar trends. Some examples of wound 
healing trends in indicative ulcers are given in figures 6.6 – 6.9. Data were 
collected initially at weekly intervals but then monthly following discharge from 
hospital (hence the time points are not evenly distributed). 
 
Figure 6.6 Wound healing trend, Patient 1 
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Figure 6.7 Wound healing trend, Patient 2 
 
 
 
 
 
Figure 6.8 Wound healing trend, Patient 3 
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Figure 6.9 Wound healing trends, Patient 4: both ulcers unhealed 
 
6.4.4 Ulcer severity 
The original coding recorded for ulcer severity is described in table 6.6. The 
classification used in the prognostic factor analysis is shown in brackets: 
superficial and severe, following recoding as described in section 4.12.5.5. 
Details of the ulcer severity at baseline are described in table 5.2, this showed 
that 45% of ulcers were superficial 53% were severe and 2% of data was 
missing. 
Code Description (recoded) 
3 Blister/ clear fluid (superficial) 
4 Blister with blood (superficial) 
6 Full thickness skin loss (superficial) 
7 Cavity (severe) 
8 Cavity with underlying structures 
(severe) 
9 Necrosis (severe) 
10 Dry scab (superficial) 
 
Table 6.6 Descriptions of original coding for ulcer severity 
 
The relationship between severity and tissue type from the literature has been 
discussed in section 2.6. 
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Twenty four ulcers were identified as clear fluid filled blisters at baseline. Six 
(25%) of the blisters dried out with the epidermis still intact, this eventually ‘fell 
off’ to reveal intact skin. Other blisters became more severe wounds with 7 
(29%) progressing to necrotic ulcers.  
 
Thirty four ulcers were identified as blood filled blisters at baseline. Nineteen 
(56%) of the blood blisters progressed to become necrotic ulcers and 8 (23%) 
developed into open wounds; either full skin loss or a cavity. 
 
Twenty five ulcers were full thickness skin loss at baseline. Seven (28%) 
became necrotic, six (24%) were dry scabs at next visit, seven (28%) were 
unchanged when the patient died and five (20%) were healed  
 
Twenty nine ulcers were cavities at baseline. Fifteen (51%) progressed towards 
healing and granulated up to skin level, 8 (28%) remained unchanged, four 
(14%) became necrotic and two (7%) deteriorated to expose bone. Of these 
two, one had been debrided by the surgeons in the operating theatre and one 
had been debrided with larval therapy 
 
Seventy six ulcers were necrotic at baseline; however 87 ulcers became 
necrotic at some point. Nearly half of these ulcers did not progress i.e. either 
the patient died, the limb was amputated with the necrosis or the necrotic ulcer 
was still present after 18 months or the end of the study. Eleven of the ulcers 
which were necrotic, this tissue subsequently ‘dropped off’ to reveal intact skin.  
 
One ulcer was a cavity with exposed bone at baseline, this subsequently 
became necrotic.  
 
No time frames have been given for the above descriptions as there was so 
much variation for ulcers within each category. 
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Figure 6.10 illustrates some of the tissue types which were found in one ulcer. 
This was a clear fluid filled blister at baseline, One week later; the blister has 
‘de-roofed’ revealing:  
1. Edges of the old epidermis crusted with dried serous fluid  
2. Raw dermis (full epidermal loss) 
3. Full thickness skin loss (full dermal and epidermal loss) 
4. Ischaemic tissue which is mostly covered by a  
5. Layer of slough (dead tissue) 
 
 
 
 
 
 
 
 
 
Figure 6.10   Blister which has ‘de-roofed’  
 
The two blisters in figure 6.11 occurred on the same patient (left and right heel), 
figure 6.11a developed full thickness skin loss, figure 6.11b ‘fell off’ to reveal 
intact skin. 
   2 
   1 
3 
   4 
    5 
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Figure 6.11a Blister to full 
thickness skin loss        
Figure 6.11b Blister to intact 
skin 
 
6.4.5 Surrounding skin 
The condition of the surrounding skin at baseline is given in table 5.2, this 
showed 31% had oedema, 28% was healthy, 16% were dry/flaky, 7% were 
macerated, 5% had erythema 8% other and 5% missing. From the follow-up 
data, the most commonly occurring skin condition (mode) was ‘normal or 
healthy’. This was recorded on 329 (36%) out of 921 occasions. The next most 
frequently recorded surrounding skin condition was ‘dry and/or flaky’; this was 
recorded on 157 (17%) occasions.  
 
6.4.5.1 Erythema 
The presence of erythema (redness) was observed on 34 occasions (including 
14 episodes where erythema was recorded on two or more consecutive 
occasions). Erythema is considered to be associated with local inflammation, 
infection or pressure. As most of the ulcers were being assessed after the initial 
injury and had pressure relief it was felt that the erythema was more likely to be 
due to inflammation/ infection rather than pressure. 
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6.4.5.2 Oedema 
The presence of oedema in the surrounding skin was observed on 263 
occasions, either on its own or in association with maceration and/or erythema. 
Oedema in the foot and lower limb can be associated with co-morbidities such 
vascular disease, albumin deficiencies and gravitational effects e.g. after sitting 
for long periods. 
 
6.4.6 Pain 
Not all patients were able to report pain in their ulcers at each visit (usually due 
to cognitive impairment); no pain data is available at all for ulcers on 18 
patients. Severity of pain at baseline for each ulcer is given in table 5.2. This 
showed that 36% of patients reported no pain, 27% reported some pain and 
data for 66 ulcers (36%) are missing. 
 
Patients reported current pain levels at each visit, from the potential 929 
observations 114 (12%) were missing, 548 (59%) has no pain, 62 (7%) had 
mild pain, 108 (12%) had moderate and 97 (10%) had severe pain.  Most of the 
patients who reported no pain in their ulcer at baseline did report pain at other 
times.  
 
In addition worst pain severity was recorded; 55 ulcers showed a trend that 
suggested pain was reducing with reducing severity of the ulcer. Pain levels in 
13 of the ulcers fluctuated in association with fluctuations in ulcer severity i.e. if 
the ulcer deteriorated, the pain got worse and then as it improved the pain 
reduced. When patients were asked if anything triggered the pain, it was 
reported for 89 of the ulcers that pressure or contact with a support surface 
triggered the pain e.g. if the patient was laid in bed, the pressure of the 
mattress was causing the pain or if they were able to walk, it was the contact 
with the floor. Some other pain triggers were having the dressing removed or 
changed.  
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6.5 Adverse sequelae  
Any events during the study period which were considered to potentially have 
an effect on the wound healing but not part of the data being collected were 
recorded in field notes. It is likely that other events occurred that the researcher 
was not aware of due to the intermittent data collection. These were then coded 
for data entry. Most patients did not experience any notable events, some 
patients experienced several e.g. recurrent infections. Most readmissions to 
hospital were not due to the heel pressure ulcer. Table 6.7 gives the results of 
this. 
Number of events (percentage of all events) 
Infection (or 
antibiotics 
given) for 
study ulcer 
Other 
infection (or 
antibiotics 
given) 
Change in social 
circumstances 
e.g. bereavement 
Rapid 
deterioration 
of patient 
Readmission 
to hospital 
18 (13%) 74 (53%) 2 (1.5%) 6 (4%) 27 (19%) 
 
Table 6.7 Frequency of adverse events per patient  
 
Details of infection (or courses of antibiotics) episodes are given in table 6.7. 
Most other infections were due to Clostridium difficile bowel infections, some 
others were chest or urinary tract. 
 
Episodes of 
other infection 
Wound infection episodes 
0 1 2 3 
0 76 (54%) 6 (4%) 0 0 
1 42 (30%) 7 (5%) 0 0 
2 4 (3%) 0 0 0 
≥3 3 (2%) 1 (1%) 0 1 (1%) 
 
Table 6.8 Details of infections per patient  
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More than half the patients were not known to have any infections during the 
study, however 11% were known to have experienced at least one wound 
infection and 42% were known to have experience at least one other infection. 
 
6.6 Length of stay 
The mean length of stay in hospital of each patient from the time of recruitment 
was 25.2 days (S.D. = 42.5), the minimum was 0 (patient discharged on the day 
of recruitment) and the maximum was 313 (one patient). The median was 23 
days (inter-quartile range 13-44). 
 
6.7 Change of accommodation 
The patients’ type of accommodation was recorded prior to admission and 
following discharge. The category other was the home of a patient’s relative. 
The findings are presented in table 6.9. 
 
Accommodation prior to 
admission 
Accommodation following 
discharge 
Number of patients 
(percentage) 
Home  
n=100 (71%) 
Home 
Residential home 
Intermediate care bed 
Nursing home 
Died 
Other 
Missing 
45 (45%) 
2 (2%) 
12 (12%) 
20 (20%) 
16 (16%) 
2 (2%) 
3 (3%) 
Nursing home   
n=14 (10%) 
Nursing home 
Died 
Missing 
12 (86%) 
1 (7%) 
1 (7%) 
Residential home 
n=15 (11%) 
Nursing home 
Residential home 
Intermediate care bed 
Died 
Missing 
4 (27%) 
5 (33%) 
1 (7%) 
2 (13%) 
3 (20%) 
Intermediate care bed  
n=4 (3%) 
Home 
Intermediate care bed 
Died 
Missing 
2 (50%) 
1 (25%) 
1 (25%) 
0 
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Other 
n=5 (4%) 
Home 
Other 
Missing 
1 (20%) 
3 (60%) 
1 (20%) 
Missing  
n=2 (1%) 
Missing 
 
2(100%) 
Table 6.9 Type of accommodation for each patient prior to  
admission and following discharge 
 
Nearly half of the patients admitted from their own home returned there, some 
who went to an intermediate care bed would have gone home later after the 
follow-up period was completed. Of the patients who died, these were from all 
types of accommodation although a smaller proportion died who were admitted 
from nursing homes than other accommodation: however this may have 
occurred by chance as the numbers in this group were very small.  
 
6.8 Readmission rates and ward moves 
Information was collected regarding how many times the patient moved wards 
and whether they were readmitted during the study. Table 6.10 summarises 
these. 
Frequency 0 1 2 3 4 5 
No. of ward moves/ 
person 
113 
(81%) 
16 
(11%) 
6 
(4%) 
3 
(2%) 
1 
(1%) 
1(1%
) 
No. of readmission 106 
(76%) 
23 
(16%) 
9 
(6%) 
1 
(1%) 
1 
(1%) 
0 
Table 6.10 Number of ward moves and readmissions 
The information on ward moves was taken from the point of recruitment. Many 
of the elderly patients who were admitted via A&E would have been on the 
medical admissions unit prior to speciality where they were recruited from. 
Some patients may have been on several wards prior to recruitment. Although 
over 80% of patients never moved wards, a number of patients did move 
several times, many of these were transfers to and from the infectious diseases 
ward when they had a bowel infection, some were moves within the speciality to 
accommodate operational requirements of the wards, a few were between 
specialities when patients required different interventions.  
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Three quarters of the patients were not readmitted during the study, the reason 
for readmission for most patients who were readmitted one or two times was 
not related to the heel pressure ulcer. The patient who was readmitted three 
times was a lady with uncontrolled epilepsy who fell several times requiring 
hospital admission. The patient who was readmitted four times had diabetes 
and other co-morbidities; three readmissions were due to his heel pressure 
ulcer and one was due to a urinary tract infection. 
 
6.9 Additional analysis 
6.9.1 Changes over time 
The study spanned a period of more than five years including preparation, data 
collection and analysis Changes in patients, the researcher, the organisation or 
political and economic issues may have been influential. Changes in the 
researcher are discussed in chapter 7. In chapter 4 there was a concern that 
practice may change over time with regard to the management of heel pressure 
ulcers, for example different dressings or support surfaces may have improved 
healing rates. Figure 6.12 shows the length of time patients were in the study 
for each consecutively recruited patient. No trend is noticed. 
Figure 6.12 Relationship between duration in study and time of 
recruitment 
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No new national guidelines were published during the study. Local guidelines 
were updated and staff training on pressure ulcer prevention and management 
continued throughout the study. Figure 6.13 shows the type of dressings used 
at baseline for each patient, this suggests that fewer antiseptic dressings were 
used later in the study, less ulcers had no dressings but there is no noticeable 
difference between the number of ulcers with ‘moist’ as opposed to ‘dry’ wound 
healing. Coding for the dressings is given in table 6.11, details of how these 
were collected and coded is given in table 4.2. Similar coding was used in the 
Bergstrom et al.(2005) study. 
 
 
Figure 6.13 Relationship between dressing type and patients 
consecutively recruited 
 
Code Dressing 
1 Moist wound healing 
2 Dry wound healing 
3 No dressing 
4 Antiseptics 
5 Moist wound healing with antiseptics 
6 Dry wound healing with antiseptics 
Table 6.11 Coding for dressings 
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Figure 6.14 shows the type of support surface used at baseline for each 
patient, although no trend is noticed, there does appear to be less code 1 
(standard foam mattress with no pressure relief used later in the study) 
 
Figure 6.14 Relationship between support surface and patients 
consecutively recruited 
 
The coding for figures 6.14 is given in table 6.12, this has been adapted from 
the RCN guidelines (RCN, 2005) and details are given in Box 4.2. 
 
Code Support surface 
1 Standard foam 
2 Visco- elastic foam 
3 Low air loss 
4 Alternating pressure 
5 Air flotation 
6 Heel specific support 
7 Other 
8 Standard foam + heel specific 
9 Visco- elastic + heel specific 
 
Table 6.12 Coding for support surfaces 
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The patients were all cared for by particular specialities, the researcher is not 
aware of any changes in admission criteria for these specialities such as 
changes from inpatient to day case surgery. It is possible that the dependency 
of the population may have changed. A review of the annual pressure ulcer 
prevalence for the Trust for the last 5 years showed very little change in the 
proportion of patients at risk high of pressure ulcers although the overall 
proportion of patients at risk has apparently decreased. See table 6.13 for 
details. 
 
Year % of patients at 
risk 
% of patients at high 
risk 
2010 49 18 
2009 49 18 
2007 71 19 
2006 75 17 
2005 75 21 
 
Table 6.13 Proportion of inpatients at risk of pressure ulceration  
during annual prevalence audits 
 
This is the collective data for the whole organisation and not specifically the 
specialities from which the patients were recruited. It is suggested that this is 
representative, however no work has been identified which confirm this. 
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6.10 Summary of findings for the secondary objectives 
This study identified on 140 patients who were included in the study with 183 
heel pressure ulcers. Fewer than half the ulcers healed, Eighty eight of the 
ulcers were on 60 patients who died during the study. Most of the ulcers that 
healed had a ‘dry scab’ prior to full re-epithelialisation. Ulcer area did not 
change in a uniform manner, some ulcers got bigger before they got smaller. 
Treatments such as support surfaces and dressing were notably inconsistent 
over the period of the study. Details were given of the patients’ journey, most 
patients were admitted from their own homes but fewer than 50% returned 
home following discharge. Approximately a third of patients experienced a 
significant event during the study; these were mostly non-pressure ulcer related 
infections. Further discussion of these issues can be found in chapter 8. 
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Chapter 7 Being a practitioner researcher 
 
7.1 Introduction 
Throughout this report I have acknowledged that I am also a clinical 
practitioner. The reflections and potential implications of this have been 
considered worthy of a separate chapter of this thesis. The aim of this chapter 
is to fully inform the reader of my clinical and research background; what 
demands, constraints and opportunities were available to me and the likely 
effects of these on the research project.  
 
7.2 Context 
Over recent years there has been an increased awareness of the benefits of 
clinical research in healthcare in the UK. The Department of Health has 
produced several reports which will enable the recommendations set out in the 
‘Research for Patient Benefit Working Party’ report (Research for Patient 
Benefit Working Party, 2004) to be implemented. In 2005 a report was 
produced in response to concerns about ‘the perilous state of academic 
medicine and dentistry in the UK’ (UKCRC, 2005). This highlighted the lack of 
career structure, lack of flexibility and balance between clinical and academic 
training and the shortage of posts following completion of training for doctors 
and dentists. The report made recommendations about training for all staff from 
undergraduates to Specialists to Consultants and the further development of 
clinical academic careers.  A similar report was produced for nursing (UKCRC, 
2007). This set out the principles for improving the clinical academic workforce 
in nursing; however the contribution to this report from senior NHS staff as 
stakeholders was small. This is reflected in the report as its perspective 
appears to be that of the academic institutions and there is no 
acknowledgement of the barriers within the nursing management structure that 
the researcher has experienced. Without clear incentives for the NHS, this 
report is unlikely to have much impact. 
 
A review of the available literature on clinical practitioners who are researchers 
provided some additional comment. Some documented discourse on the lack of 
medical practitioners who pursue a research career alongside their clinical 
practice has been identified. A survey (Pfeiffer, Burd and Wright, 1992) carried 
out in a mental health care setting in the USA asked psychiatrists, 
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psychologists and social workers for their views on scientist-researchers. Most 
respondents in this study reportedly approved of the scientist-researcher model 
however they did not participate in research due to time, lack of funding and 
thought not to be part of their job.  
 
The notion of the researcher, who is also a clinical practitioner, has been 
presented and debated in detail by Reed and Proctor(1995). While their work 
primarily considers qualitative research by non-medical practitioners, their 
comments can be considered and evaluated for all research studies and 
healthcare professions.  
 
A publication by Miller et al. (1998) on professional integrity in clinical research 
was produced in response to allegations of ethical abuse in clinical research 
which had been reported in the media. This paper focused on physicians 
conducting drug trials, particularly in cancer and schizophrenia. They describe 
two models: one of the physician investigator as a clinician, the other the 
investigator as a scientist. The risks presented include; the financial incentives 
to recruit, the misconception existing in the patients, and to a certain extent the 
clinicians, that the research is therapeutic and not exclusively ‘for the sake of 
science and the benefit of future patients and present researchers’. They do 
however conclude that the solution is not to remove the clinical role from the 
investigators, but cultivate a concept of ‘moral identity’ of the physician 
investigator with equal elements of the scientist and clinician.  
 
7.3 Background of the researcher, a personal perspective 
My career has been mainly in clinical nursing practice within the NHS except for 
two years in management. The last 20 years has been in the field of Tissue 
Viability, a specialist area focusing on the prevention and management of 
wounds. I have always had an interest in the evidence base supporting practice 
and frequently experienced frustration with the fundamental lack of good quality 
research into the development of the treatments used and the lack of analytical 
and reflective skills of nurses. In this speciality, some practitioners have a 
strong partnership with treatment manufacturers. It is sometimes difficult to 
separate the benefits of a contribution to development, research, provision and 
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use of products and a marketing strategy. I have been particularly conscious of 
this and have always strived to maintain an objective approach to dealing with 
commercial representatives. I have always had a desire to understand any 
research data presented as evidence; to interpret the relevance and value of 
any investigation in this field and its applicability to practice and ultimately to 
investigate and therefore contribute to the evidence particularly in areas where 
controversy exists or patient outcomes are significantly affected.  
 
An influential text in my early career (Walsh and Ford, 1989) proposed that 
nursing needed to change from its ritualistic practices which were continued 
even in the light of research evidence e.g. evidence for improved healing rates 
with a moist wound healing environment was known yet porous dressings which 
promoted a dry wound environment were used. It suggested that nursing could 
not call itself a profession, until this change happened, it could only be 
considered a caring craft. I think it is likely that a review of practice would raise 
similar concerns today. 
 
Jarvis (2000) suggests that the theory practice/gap, which still existed 11 years 
ago in nursing, is being addressed to some degree by practitioner-researchers, 
although they are experiencing feelings of inadequacy in their research findings 
as these have been produced only from their own work environment. He states 
that nurse consultants are probably in a better position than others who work 
within tight organisational constraints, to reduce the theory practice gap by 
making pragmatic changes in practice. I support this view and feel I am in a 
privileged position as a nurse consultant to bring about change. 
 
My future career plans are to stay in clinical practice, while developing my 
research skills. I value highly the role of the practitioner researcher and feels 
this role makes an important contribution to both research and clinical practice. 
I am concerned that researchers who do not engage with clinical staff and 
patients are at risk of investigating irrelevant topics, and clinicians who do not 
engage with researchers are at risk of carrying out ritualistic rather than patient 
focused care. The potential for bias, if I felt dependent on a positive outcome of 
the research study to support my career has been considered, but is thought 
not to be present.  
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I am a Nurse Consultant in Tissue Viability (NCTV) at the study site. I had been 
in this role for 14 years, of which the last seven have been at the study site. 
Plans to conduct the study were discussed prior to my appointment to the 
current post. The NCTV role consisted of approximately 50% clinical 
consultation for the prevention and management of wounds including pressure 
ulcers.  Other elements of the role included teaching, research and strategic 
development. Since as I had instigated the new service within the organisation I 
had worked hard to establish relationships with clinical staff, primarily nurses, 
but also medical staff and allied health professionals. Referrals for clinical 
consultation arose predominantly from the specialities included in this research 
study. 
 
I was responsible for setting standards of care for patients with and at risk of 
developing pressure ulcers, through written guidelines, education, clinical 
education and as a role model in delivering care to patients. 
 
I had some experience of clinical research having undertaken a small study to 
inform my MSc dissertation while with a previous employer. Although this 
previous organisation had been very supportive of the research, there were 
very few nurses undertaking research. Fortunately a nursing research 
development unit had recently been established and I was attached to this unit. 
When I was appointed to my current role, no other nurse researchers were 
identified within the organisation and managerial support and understanding 
was limited. Although research is a core element of the Nurse Consultant role, 
the performance measures of the post did not include research and there was 
an expectation that I would deliver a new clinical service and improve 
organisational performance on key indicators such as pressure ulcer incidence 
and prevalence. 
 
A limited research training had been undertaken as part of my MSc 
programme. Certain courses were available through the University during the 
preparation of this thesis; however competing demands for time were frequently 
an obstacle to accessing this support. Research ethics and governance 
approval process can be a challenge for seasoned academic researchers, to 
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proceed with these as a novice clinical researcher was challenging. Although 
support networks existed in the University, to access these meant time out of 
either research or clinical time and travelling to the different venue. 
 
I had acted as local Principal Investigator on a Health Technologies 
Assessment research study (Iglesias et al., 2004) that had given me valuable 
experience of research project management, designing, implementing and 
evaluation data collection tools and working with a research nurse.  
 
Access to library and Information Technology facilities was a mix of both 
University and NHS Trust. Overall this worked well to allow me to work 
remotely.  
 
7.4 Implication for the study 
7.4.1 Constructing the research question and the design of the study  
 In my role as NCTV, during clinical consultations there is a need to advise on 
the management of pressure ulcers. While international guidelines existed 
(EPUAP, 1998), these were explicit about the uncertainty of relevance to heel 
pressure ulcers, in particular, the role of debridement. My preference would 
have been to have undertaken an intervention study of debridement, however 
full cognisance was taken of the lack of information on healing times, death 
rates, types of interventions currently used, such that sample size and power 
calculations would be difficult if not impossible. The current study was primarily 
exploratory with the aim of informing a potential future intervention study. The 
variables collected in this study were numerous. I was advised against ‘data 
greed’ and consequently some were removed. The choice of variables was 
mostly based on my clinical experience given the lack of available valid 
evidence. Particular examples include:  
 I felt that some patients, who were on Inotropic drugs to improve cardiac 
function in critical care, were experiencing poor blood supply to their feet 
which would affect wound healing. 
 I felt that some patients, who were on anti-coagulant therapy, were being 
over medicated and the excessive bleeding may affect wound healing 
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This resulted in details of all medication being collected. In hindsight most of 
these were actually proxy measures for a disease or co-morbidity. The 
presence of the actual disease was also a variable collected. It was probably 
un-necessary to collect both sets of variables. With regard to the two specific 
examples, only 2 patients had received Inotropes (numbers too small to be 
significant) and the data collected on the use of anti-coagulants did not include 
information on whether this was being over prescribed.  
 
I was aware of variability of treatments e.g. dressings and pressure relieving 
aids, both between patients and within individual patients over time. In order to 
identify any potential effects of treatments it was considered important to 
capture these changes over time. The primary analysis was undertaken with 
baseline data, excluding those factors which varied over time. While data is 
available on the time dependent variables, it was beyond the scope of this 
study to include a time dependent analysis. However my intention is to analyse 
and publish at a future date. 
 
My knowledge of the research population was influential. It was known that they 
would be aged and thus challenge the researcher in regard to their cognitive 
abilities and in particular their understanding and resultant capacity to consent. 
This perspective therefore resulted in modification and adaptation to the 
research design, with particular regards to the process of relative assent and 
latterly consultee agreements (in response to changes in the research guidance 
around capacity and consent contained in the Mental Capacity Act (2005)). It 
aimed to minimise the burden of data collection from the patients and gave an 
option for ‘opt out’ for the ABPI diagnostic assessment as this could potentially 
cause discomfort or inconvenience. This was particularly helpful when relatives 
were consulted on the decision to participate, but did result in a large amount 
missing data for this variable. 
 
7.4.2 Conducting the research  
I was aware of the potential conflict of interest of my clinical role during data 
collection, this included identification of patients, recruitment, objectivity of data 
collection and ethical dilemmas over nursing practice.  
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An essay written by a group of complementary therapists discusses some of 
the problems of being practitioner researchers (Lewith et al., 2009). This paper 
included a series of vignettes in which practical examples of practitioner 
research are given. One example presents the individual’s concerns over giving 
a ‘sham’ (placebo) treatment and feeling nervous about being ‘found out’. Some 
of the problems of randomised trials such as recruitment and administering the 
control arm as a practitioner did not occur in the current study as it was 
observational. A practitioner researcher will be well aware of the differences in 
patients included in a study and those not recruited. In Lewith et al. (2009) a 
herbalists describes his concerns that the patients in the trial did not have all 
the co-morbidities of his usual patient group and felt uncomfortable over how 
useful the findings would be. I felt that the patients included in my study were 
representative of the population based on both the screening data and intuitive 
knowledge and therefore the potential for selection bias was low. 
 
Patients were identified by visiting wards and asking staff whether they had 
anyone who met the inclusion criteria. This could potentially have been an 
emotive question as it required nurses to admit to the NCTV to having patients 
with pressure ulcers which could have been perceived as a measure of their 
standards of care. I tried to ensure a non-judgemental attitude when recruiting.  
 
Occasionally I would carry out the dressing change on the ulcer in order to 
collect the data; this would assist the nursing staff by relieving them of the task 
that day. It is likely that this action could be seen to encourage reciprocation by 
staff identifying other patients for the study. The number of occasions when this 
occurred was small, I carried out the dressing change according to the plan of 
care; it is unlikely that my participation would influence the outcomes. 
 
Some of the patients who were recruited had already been referred to me for 
clinical advice. I was very careful to provide impartial advice about the study in 
order to ensure there was no coercion to take part. Reassurance was given 
such that the patients would continue to receive the same level of care from me 
and other staff, even if they chose not to take part.  
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The possibility of selective recruitment was considered. I was aware of the 
probability of patients dying in this population; it would have been tempting to 
selectively recruit patients who were considered more likely to survive. As 
mortality rates were higher than other similar studies (42% in the current study 
compared with 26% in the Berlowitz (1997) study), this suggests that no 
selective recruitment occurred. 
 
All data collected were in accordance with a predetermined protocol. Most of 
the data collected were objective information from nursing and medical records. 
Subjective assessments were made of the ulcer severity, tissue type and 
condition of the surrounding skin with the assistance of agreed tools to aid 
decision making. It is difficult to provide full assurance of the reliability of these 
assessments; however data for a wound selected at random was compared 
with the photographic evidence at a later date when the researcher was less 
likely to be influenced by the presence of the patient or a desire for the wound 
to be improving. During the later part of the study a research nurse assisted 
with data collection. This nurse was trained by the researcher in assessment. 
No formal inter-rater reliability tests were undertaken although the research 
nurse was supervised and again data were checked against the photographic 
evidence. It may have been helpful to test out the inter-rater reliability of the 
assessments by requesting another wound care expert to examine some of the 
data alongside the photographic evidence, especially as severity of the ulcer 
was found to be a prognostic factor. 
 
It was possible that I may have encountered some ethical dilemmas while 
observing clinical practice during data collection. Consideration would have to 
be given with regard to how and what was acceptable and unacceptable 
practice. Every attempt was made to keep the two roles separate, if clinical 
consultation was requested during data collection the staff were asked to make 
a formal referral to the TV service. Occasionally I came across a safety issue 
such as an electrical mattress which was alarming and not functioning properly. 
In these cases I did intervene to rectify the problem. Where clinical consultation 
regarding dressings or pressure relieving devices was not sought I relied on my 
knowledge of the scarcity of evidence of effectiveness of any of these 
interventions to restrain myself from intervening in practice.  If I was particularly 
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concerned when a ulcer was deteriorating I would suggest a clinical 
consultation request would be appropriate. I was aware of a few occasions, 
where medical staff assumed, that because they had seen the NCTV with a 
particular patient, that clinical consultation was being provided. These 
assumptions were corrected where possible, however the full extent of this 
problem may not have been known.  
 
Changes in me did occur. As thesis preparation is an ongoing process, I 
became more knowledgeable in the subject matter, developed and refined my 
critical appraisal skills and continually challenged my beliefs about clinical 
practice. My clinical role continued alongside the research and practice 
development took place based on increasing knowledge, reflective practice and 
networking with other experts.  
 
7.4.3 Data analysis 
It is important that my values were known and the study design was such to 
reduce their influence. I had insight into my desire to improve outcomes for 
patients and to be able to give good evidence based advice on the 
management of heel pressure ulcers. This was considered in the analysis and 
caution was taken with interpretation. 
 
The analysis plan was predetermined. When potential risk factors were 
identified through the univariate model, careful consideration was given to the 
clinical significance and relationship with other variables prior to entry into the 
multivariate model.  While potential prognostic factors were identified, this was 
a small exploratory study and the evidence was suggestive of association not 
conclusive of causation. Generated theories can be tested in larger studies.  
 
7.4.4 Dissemination of findings 
The findings of any study of pressure ulcers have the potential to be 
contentious as the association between pressure ulceration and practice falling 
below an agreed standard can be strong. This particular study included: 
 Patients who developed pressure ulcers while in the care of my employers  
 Identified variability in nursing practice (e.g. dressings, support surfaces) 
including practice outside Trust guidelines 
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  Is explicit about the number of patients who died with a pressure ulcer.  
 
It is important that this information is firstly communicated appropriately within 
the organisation; particularly to staff that were caring for these patients.  
 
Findings will be presented both internally and externally to the academic, 
professional and public within the context of reasonableness and sufficiency of 
clinical practice. I must ensure that I do not compromise my future role as a 
clinician and a researcher within the organisation. 
 
7.5 Review of potential bias and validity due to the researcher 
practitioner 
The above sections have considered many aspects of being a researcher 
practitioner and they have been structured following the format introduced in 
Reed and Proctor (1995). Detection bias may have been present if patients with 
heel pressure ulcers were not identified e.g. if particular ward staff were 
reluctant to disclose patients to the researcher, or if I was more aware of 
patients particularly with severe pressure ulcers because of my clinical 
specialist role; every effort was made to overcome this.  
 
Recruitment bias may have been present if there had been difference in those 
who were recruited and those who declined participation. Although reliable 
records of patients with heel pressure ulcers do not exist, I was particularly 
careful not to coerce patients who were already know to me, or avoid recruiting 
those who were near death; screening and recruitment rates were similar.   
 
Internal validity of the study was felt to be enhanced due to my knowledge of 
the patients (co-morbidities, duration of healing, potential changes of location to 
ensure minimum loss to follow-up), study site (patients were representative) 
and variables (could be fully defined and precisely measured and available for 
most patients). 
 
When the characteristics of the patients recruited were examined, external 
validity was not thought to be compromised by me being in the post of a NCTV 
in study organisation. 
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7.6 Summary 
I have been explicit and transparent throughout this report in describing my dual 
role as clinician and researcher. I have been cognisant of potential biases due 
to competing loyalties. Hopefully the study has benefited from my detailed 
knowledge of clinical patient pathways to elicit useful research information 
which may have been overlooked by a non-clinical researcher. Sufficient detail 
has been given such that the research could be repeated by a non-clinician and 
the same results obtained.  
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Chapter 8 Discussion 
 
8.1 Introduction 
This chapter starts with a summary of the strengths and weaknesses of the 
study. It then provides a critical appraisal of the study methods and results; it 
follows the order of the Methods, Primary then Descriptive analysis chapters. 
includes comparisons with other relevant studies, setting the results in the 
context of the body of knowledge, including other studies about prognostic 
factors for wound healing. The key findings and new knowledge are highlighted 
and implications for clinical practice are considered. The systematic review 
chapter included a critical appraisal of its own study methods, its findings are 
noted in section 8.7. Potential areas for future research are suggested in the 
following chapter.   
 
8.2 Summary of strengths and weaknesses 
This is the first study to identify prognostic factors for healing of heel pressure 
ulcers. Three studies have looked at prognostic factors for healing pressure 
ulcers not confined to the heel; two of these have used retrospective data from 
case note reviews (Berlowitz et al., 1997; Bergstrom et al., 2005) and one 
performed a secondary analysis of prospective cohort study data (van Rijswijk 
and Polansky, 1994). The prospective cohort methodology in this study has 
ensured minimal missing data and only two patients were lost to follow-up. The 
study inclusion criteria were very broad and very few patients were screened 
and then not recruited; this ensured that the study population was 
representative of the heel pressure ulcer population. The use of relative assent 
and latterly the use of personal or nominated consultees ensured that those 
patients who lacked capacity to consent were represented in the study.  
 
The study used the endpoint of complete healing, this was achieved with a long 
duration of follow-up (18 months) and the ability to continue data collection in 
the community when patients were discharged from hospital. Most other studies 
choose an outcome of healed or not healed by a given time which means that 
time to complete healing in unknown for a number of patients (van Rijswijk and 
Polansky, 1994; Berlowitz et al., 1997; Bergstrom et al., 2005; Takahashi et al., 
2009). Although the majority of pressure ulcers not confined to the heel will heal 
within six months very little is known about those that continue beyond this 
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point. This study has provided valuable information about ulcers that take a 
long time to heal. This will assist healthcare professionals (and enable them to 
inform patients) to have realistic expectations about difficult to heal wounds. It 
will help inform resource needs and enable patients and their carers to make 
choices about treatments which will affect their quality of life. It will also help 
inform future research studies, in particular trial planning. 
 
This study thus identified new information regarding the prolonged final stage of 
ulcer healing and the presence of scab formation during this time. However, the 
relevance of this information has yet to be established. 
 
This study identified two prognostic factors that were independently associated 
with healing; the severity of the pressure ulcer (as determined by ulcer Grade) 
and the presence of peripheral vascular disease. The severity of the ulcer has 
also been identified in a study of pressure ulcers on residents in a long term 
care institution (Berlowitz et al., 1997) and has good clinical validity. The 
presence of PVD has been identified in two prospective cohort studies of 
patients with diabetic foot ulcers (Winkley et al., 2007; Nather et al., 2008) 
which also has good clinical validity. 
 
Although the study population was chosen from specialities which were 
considered to have a higher proportion of heel pressure ulcers and the setting 
was a large tertiary hospital with Nurse Consultant level of Tissue Viability 
expertise, these factors were thought to have minimal influence on the 
outcomes. The sample represents normal patients with heel pressure ulcers, 
seen in practice with a range of ulcer durations. The findings are therefore likely 
to be generalisable to most acute care institutions in the UK. 
 
More than half of the heel pressure ulcers did not heal, but most of these were 
on patients who died. The Cox proportional hazard model was chosen to 
enable maximum use of the data available; nevertheless, the lack of data would 
still have had some influence of the power of the variables to be prognostic. 
When patients had ulcers on both heels, data was collected for both ulcers and 
robust standard errors were used in the analysis to overcome the effects of 
clustering (Williams, 2000).  
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Patients were recruited who already had pressure ulcers. While an estimation 
of the start date of the ulcer was made; no information was collected for 
variables which may have affected the healing prior to recruitment. Although 
time to healing was calculated, this was only from the time of recruitment. An 
inception cohort would have been preferable, but this would have required 
additional resources.  
 
Data were missing for important variables such as neuropathy, ABPI and pain. 
The reasons for this were discussed and the main reason was cognitive 
impairment. Some of the data therefore were missing at random and so with 
more information, imputation methods could have been used, which would 
have improved the generalisability of the findings.  
 
The reliability of some variables e.g. wound area measurements, co-morbidity, 
has been questioned. These have been considered and the variance is thought 
to be random and therefore will have limited influence on the findings. There 
was however a concern over how the smoking variable was defined and coded 
as this was expected to be prognostic; this should be reconsidered for future 
studies. The data on co-morbidity may have been insufficient to be prognostic, 
a better measure of severity and impact of a disease needs to be considered 
for future studies.  
 
The time intervals for follow-up data collection when patients were discharged 
were longer, this was based on the assumption that there would be less change 
in variables e.g. less rapid wound healing, changes in dressings, tissue types. 
Changes in treatments and tissue types had more variability than expected, 
what happened in between data collections was unknown, however this did not 
affect the key findings (prognostic factors) of the study.  
 
Two factors which may have been prognostic (based on evidence from other 
studies) were not collected: the presence of multiple wounds and mental state. 
In hindsight these should have been included.  
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This study has followed the reporting recommendations suggested in the 
Strengthening the Reporting of Observational Studies in Epidemiology 
(STROBE) (Vandenbroucke et al., 2007) statement. This has assisted in 
promoting the quality of the study and its report.  
 
8.3 Research design 
8.3.1 Choice of method 
A prospective cohort study was chosen as this was considered to be the 
preferred method for an observational study to identify prognostic factors 
(Altman, 1991). It can identify exposures or characteristics of interest which are 
thought to influence outcome. It was acknowledged that potential difficulties 
may occur if the outcome of interest was rare or the time to event was long. 
This would result in the need to recruit a high number of patients and become 
costly in terms of follow-up time. It has already been acknowledged in section 
4.3.1 that data from a record review would risk large amounts of missing data 
and retrospective data collection is at risk of many biases. This study proved to 
have a long time to event (median time to healing was 121 (range 8-440) days) 
given the available time for data collection; however the lack of missing data 
confirms that this was the most appropriate method. 
 
8.3.2 Sample size 
The sample size calculation for the current study took into account healing and 
death rates from other studies (see section 4.11). The target recruitment rate 
was 20 patients per month; unfortunately the actual rate of 6 per month was 
lower than expected. This was mainly due to the time needed to screen and 
recruit patients. If further studies were being considered recruitment rates could 
be improved with more researcher time. The sample size calculation was based 
upon a patient level analysis i.e. 1 ulcer per patient, this was expected to give 
75-100 events (of ulcers healed). This would allow for between 7 and 10 
variables in the model based on the assumption that 10 events per variable are 
needed for the analysis (Harrell et al., 1985). During the development of the 
statistical analysis plan, other papers were identified that analysed data at the 
ulcer level. Further discussions with the statistician confirmed that this would 
have the benefit of being able to use all the data when a patient had 2 heel 
ulcers. The impact of this was a higher number of events which allowed more 
variables to be considered in the model. The implications of including 2 ulcers 
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per patient are considered in section 4.12.5.2. By limiting the number of 
variables considered and in particular excluding those with small numbers of 
events gives more confidence in the findings (narrower confidence intervals). 
 
8.3.3 Overcoming bias 
8.3.3.1 Loss to follow-up 
While only two ulcers (on two patients) were lost to follow-up during the study 
there were more ulcers (106 of 183 ulcers) which were censored than healed 
e.g. due to the death of the patient. Although there were no systematic reasons 
for censoring that the researcher was aware of and no patients were known to 
have died due to their heel ulcer, the effects of the variables can only be 
included up to the point of censoring. This had a major impact on the amount of 
data included for analysis. When compared to other studies, the proportion of 
patients who were lost to follow-up (e.g. 21% were lost to follow-up during the 6 
months follow-up period in the study by Berlowitz et al. (1997)) was much less, 
although the proportion who died was more (25.7%). This is probably due to the 
study methodology and the population. Berlowitz et al (1997) studied patients in 
a long term care facility and did not follow-up patients who were discharged; 
their method was a retrospective cohort study, data were obtained from an 
administrative database. The overall impact of the high number of patients who 
did not reach the endpoint of healed was to limit the number of variables which 
could be considered in the final analysis. 
 
8.3.3.2 Selection of participants 
Although the study site was chosen for convenience, not only was it the place 
of work for the researcher, it was also a large city centre teaching hospital 
providing both local and tertiary services. Whilst it is possible that patients who 
were admitted for tertiary care due to their complex needs, may not be 
representative of the heel pressure ulcer population, the majority of these 
patients were excluded as they did not live in the city (could not be followed up) 
and most patients were recruited from Care of the Elderly, which is a non 
tertiary service. This suggests that the findings are generalisable to non-tertiary 
care.  
 
The choice of clinical specialities that the patients were recruited from was 
intended to optimise potential recruitment in the time available. The specialities 
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were chosen as they had consistently high levels of heel pressure ulcer 
prevalence in the annual internal audits. By restricting the sample population in 
this way it may have affected the generalisability of the findings. For example, if 
patients had been recruited from other specialities e.g. respiratory or cardiac 
medicine, other prognostic factors may have been more prevalent, such as 
respiratory disease, which would have produced different results in the 
modelling. If other specialities had been included this would have increased the 
screening time and reduced recruitment rates.  
 
Patients were followed up after discharge from hospital, and approximately two 
thirds of the data of the patients’ episode collection time was following 
discharge, all but 13 of the ulcers that healed did so following discharge. Most 
patients were recruited from Care of the Elderly; this speciality provides a close 
affiliation with long term care such as Nursing Homes and Community nursing 
care for patients in their own homes. If future analysis of time dependent co-
variates was performed, where the data was collected could be important as 
this could be influenced by the care environment e.g. treatments could depend 
the local formulary of products available, skill mix of nursing staff, etc. 
 
During data collection a record was made when the patient was being seen by 
a specialist specifically for the management of the heel pressure ulcer. The 
specialist could have been the researcher herself as a Tissue Viability Nurse 
Consultant (TVNC), a Diabetologist, a diabetic Podiatrist or a Vascular surgeon. 
However no distinction was made between which one. In section 6.3.4 the 
involvement of the specialist is discussed and it is noted that 52% of the 
patients who healed were seen by a specialist. However 34% of the patients 
who did not heal were also seen by a specialist. It is likely that patients referred 
to a specialist will differ systematically from those who are not e.g. they are 
likely to have worse ulcers but as no data is available for this it is difficult to 
comment further on any association between specialist involvement and 
healing. 
 
It could be suggested that an organisation supported by a TVNC should have 
an above average standard of care for pressure ulcers with the result of better 
outcomes for these patients, but no literature has been found to support this. A 
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survey carried out by the Patients Association (The Patients Association, 2010) 
compared acute Trust activity levels (based on finished consultant episode bed 
days) against the number of TVNs in post. While the researcher’s Trust is not 
quoted in this table (Patients Association (2010) Figure 1.1) it has one of the 
highest activity levels compared to all the Trusts and a lower than average 
Whole Time Equivalent (WTE) Tissue Viability Nurses. There are fewer Tissue 
Viability resources available compared to other Trusts. It unlikely that one 
person could have an extraneous impact and therefore limit the generalisability 
of the findings. 
 
The issue created by having a researcher who is also a clinical practitioner was 
considered worthy of further detailed discussion as presented in Chapter 7. 
 
8.3.3.3 Changes over time 
Changes in patients, the researcher or the organisation over time are 
considered in section 6.9.1. Slight changes such as progressively less 
antiseptic dressings and less wounds without dressings and less ‘standard 
foam’ mattresses, have been demonstrated but these were unlikely to influence 
findings. 
 
8.3.4 Recruitment 
It has been discussed in section 4.3.3 that an inception cohort study of new 
incident pressure ulcers would have been a preferred method as the duration of 
the ulcer prior to recruitment is thought to be unreliable and the factors 
influencing healing prior to recruitment are unknown. However, this would have 
markedly reduced the number of patients recruited. This is a shortcoming of the 
study and were it to be repeated with an inception cohort design then more 
recruiting centres would be needed. However a lot more resources would be 
required. 
 
The inclusion and exclusion criteria were comparable with other studies. From 
the screening data and the researcher’s experience it would seem that most 
patients with heel ulcers were considered for the study and nearly half (72 out 
of 186) of those not included were near death, see figure 5.2.  
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When a ward was visited, screening data were captured to enable comparisons 
of the recruited and non-recruited populations. Recruitment rates were lower 
than expected; this was attributed to the time taken for data collection. It is 
likely that there were patients with heel pressure ulcers who were not screened 
or recruited, as there were sometimes periods of several weeks in between 
visits to a particular ward. This may have led to the possibility of selection bias. 
However the range of age, gender, co-morbidities, ulcer duration and severity, 
etc suggest that any that were missed were likely to be at random (no 
systematic differences) and therefore reduce the potential for selection bias. 
 
8.3.5 Consent process 
Patient recruitment commenced before the introduction of the Mental Capacity 
Act (DoH, 2008). A protocol amendment (September 2008) led to the 
researcher being able to be clearer with relatives with regard to their role as 
personal consultee for the patient as well as utilising healthcare professionals 
as nominated consultees (see section 4.6).  With this amendment, the rate of 
non-recruitment due to patients lacking capacity, reduced for those who did not 
have a relative. A nominated consultee (in all cases the medical consultant) 
was used for three patients. The overall recruitment rate was not noticeably 
affected.  
 
Mason et al. (2006) describe the consent process utilised in a large randomised 
control trial of pressure relieving mattresses. Their process included relative 
assent but found that 45% of relatives approached refused to provide assent 
for their incapacitated relative compared to 17.7% of patients with capacity that 
were approached. As their study pre-dates the MCA, there was no facility to 
approach a professional legal representative of the patients who lacked 
capacity.  A large proportion (93%) did not have a relative; the authors felt that 
proxy consent did not really help with recruitment.   
 
There is very little written about the effects of the MCA on recruitment to 
research studies. Most of the literature relates to the concern for the 
inappropriate recruitment to intervention studies. However a comment in the 
British Medical Journal does suggest that the MCA is supportive of those who 
wish to study people with diminished capacity (Ludman, 2008). A paper by 
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Warner et al.(2008) based on their RCT of a dementia treatment discusses the 
issue of assessing capacity to consent. They used the Mini Mental State 
Examination (MMSE), which is a measure of cognitive function as a criterion for 
capacity, but found it not to be a reliable proxy measure (as an independent 
predictor of capacity in a regression analysis). The patients’ capacity was 
assessed by the researcher, but there were no details of the training or 
experience of assessing capacity. They did clearly present some of the 
arguments for demonstrating capacity in terms of the patient’s ability to 
understand and retain information, whilst balancing their ability to choose and 
be able to communicate that choice. They acknowledge that patients may have 
lucid intervals and capacity can vary depending on the complexity of the issue. 
In the current study whenever a patient’s capacity was of concern, the 
researcher endeavoured to establish capacity with respect to study participation 
only and was mindful of the ability to retain information and changes in lucidity: 
capacity and consent were re-established or confirmed at each visit. 
 
8.4 Data collection 
8.4.1 Variables collected 
The variables collected were derived from the potential prognostic factors for 
healing presented in chapter 2, including demographic details and attributes 
that would inform the secondary objectives. Some factors are worthy of further 
discussion in terms of their reliability, validity and the precision with which they 
can be measured: 
Speciality 
Speciality was taken from the patient’s current medical consultants practice 
(rather than the ward as patients could be ‘outliers’ from their consultant’s 
regular ward). While this was not a physiological attribute of the patient it was 
included as it informed the baseline characteristics. It was used in the 
regression analysis, partly as a marker for the dominant disease processes but 
also as a proxy measure of the care environment. It is possible that ward 
organisation, nursing, medical and allied health professionals’ skills and 
knowledge have influenced the healing outcomes. It is difficult to study all these 
variables as predictors of patient outcomes. Some studies have attempted to 
look at length of stay based on nursing hours, skill mix and expertise. These are 
reviewed in the background to one study (Tschannen and Kalisch, 2009) which 
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then investigates the same issues. This finds that nurse ‘hours per patient day’ 
reduced length of stay, but level of ‘nursing expertise’ (level of understanding 
and grasp of the clinical situation) increased length of stay, and skill mix had no 
impact. The authors acknowledge that there are many other factors which 
influence length of stay and theirs was a small study with length of stay being 
as little as one day, so differences would be difficult to detect. A comprehensive 
study of the effects of nurse staffing levels on patient outcomes was carried out 
by Aitkin et al. (2002). They found that in surgical patients, for each additional 
patient per nurse there was an associated 7% increase in likelihood of the 
patient dying within 30 days of admission and a 7% increase in the likelihood of 
failure-to-rescue. 
Co-morbidities 
Co-morbidities were extracted from the medical records. This information has 
several limitations: it was only as accurate as the recorded history taking of the 
medical staff, no checking of this information took place; no measure of the 
severity of the disease was recorded; several co-morbidities were grouped 
together based on body systems e.g. patients who had Multiple Sclerosis were 
grouped together with those who had a CVA, while both have experienced 
damage to the nervous system, the type and extent of damage could be very 
different as could the possible effect on wound healing. 
Smoking 
Smoking history was established through asking the patient.  This was recoded 
into very broad categories: previous smoker could be anything from a life long 
smoker stopping 40 cigarettes a day three weeks previously to 10 cigarettes a 
day from someone who only smoked for a couple of years as a teenager. This 
has two potential shortcomings:  
 Patient self report could be unreliable; the patients may not wish to 
disclose their ‘bad habits’. A letter by (Hajek and Snuggs, 2011) 
questions the validity of the self report of smoking in the 2001-2008 
National Health and Nutrition Survey. The authors’ (Yeager and 
Krosnick, 2011) response critiques the studies that challenge the 
assumption that self report is valid and reaffirms the assumption. The 
debate seems to be whether participants are aware of their blood being 
tested for cotinine (a marker for cigarette consumption). There appears 
to still be uncertainty over the reliability of self report. Although the 
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studies quoted are all based on maternity populations (Ford et al., 1997; 
Parna et al., 2005) rather than the predominantly elderly population of 
this current study, the drivers to mislead may differ across populations.  
 The category of previous smoker is very wide (nearly 50% of patients). It 
may have been more appropriate to record this variable differently e.g. 
as number of ‘pack years smoked’. A ‘pack year’ is 20 cigarettes 
smoked/day for one year (Prignot, 1987). While there is little work 
published on the affects of smoking on the healing of chronic wounds 
such as PUs, some studies have looked at surgical wounds and dental 
wound healing. Dental wound healing is not considered here as the 
direct effect of smoking on the mouth is know to be a confounder. 
Sorensen et al.(2002) looked at wound healing complications in breast 
cancer surgery and found that both light and heavy smoking to be 
significantly and independently associated with post operative wound 
infection (Odds ratio 2.05 (CI 1.07-8.16) and 3.46 (CI 1.52-7.85) 
respectively). An earlier study of wound healing complications following 
surgical repair of calcaneous fractures (Folk, Starr and Early, 1999) 
based on retrospective data also identified current smoking as a risk 
factor but also a history of smoking more than 10 pack years was 
significant risk factor for complications such as dehiscence or infection.   
Medications 
Details of medications were taken from the patients drug chart. This was 
recorded for two reasons: both as a marker for a disease process or for the 
direct effects of the medication on the PU healing. The potential limitation was 
the grouping of the coding of the medications. These were coded according to 
the British National Formulary (Martin, 2007) based on body system on which 
they act e.g. insulin (for diabetes) and thyroxine (for thyroid disease) were both 
coded as endocrine treatments. Each group of drugs was used as a variable in 
the univariate analysis. If endocrine treatments had emerged as significant it 
would have been difficult to comment on the association. However the three 
which emerged as significant were nutrition, analgesics and respiratory, all of 
which are reasonably homogenous groups. It may have been more appropriate 
to record the actual drug and use this in the analysis rather than the generic 
category.  
Braden scores 
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The data for the Braden score was taken mainly from the nursing records 
(unless this was clearly out of date, in which case the patient was reassessed). 
Studies of sensitivity and specificity or validity and reliability of the Braden scale 
found the summary score as a predictor of risk (Pancorbo-Hidalgo et al., 2006). 
The Braden scale was utilised in the current study for its individual components. 
Kottner et al. (2009) studied the inter-rater reliability of its constituent items and 
found the reliability of ‘moisture’, ‘sensory perception’ and ‘nutrition’ were low. It 
is perhaps therefore, not surprising that these items did not emerge as 
significant in the univariate analysis. The researcher had recently become 
aware of some lack of reliability (both in her practice and that of the ward 
nursing staff) between the Braden sensory perception score and the 
neuropathic status of the foot. When data from both these characteristics were 
tested for collinearity (see section 5.3.2.2) there was no association between 
these factors. This could be due to the lack of awareness of neuropathy when 
assessing using the Braden score or inaccurate reporting of sensation 
(particularly with patients with poor cognition) for the neuropathy test.  
Sensory Neuropathy 
Many patients (44%) did not have their neuropathic status established with the 
monofilament. The test was not performed on some patients either because it 
was inappropriate at the time of data collection (the patient was about to go for 
an investigation or was waiting to have a meal), or they did not appear to 
understand the test and how to respond appropriately when asked whether they 
could feel the monofilament. The impact of missing data is discussed in section 
7.3.2. 
Arterial status 
Similarly, many patients (35%) did not have their arterial status established by 
measuring their ankle brachial pressure index (ABPI). This was either not done 
due to the inappropriate time of data collection as above or the patient had not 
consented to the test or the limb was considered too ischaemic or the 
procedure was too painful to obtain a reading.  The impact of missing data is 
mentioned in section 5.3.2.3 and discussed further below in section 8.4.2. 
Support surfaces 
The data with respect to the support surface was based on equipment seen 
under or with the patients. No record was made when a mattress was not 
working properly or the proportion of time the patient spent in bed with the 
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pressure relief. When patients were sat out of bed they mostly had their feet on 
the floor, although occasionally a foot stool was used. No record of pressure 
relief for the heel was made for patients if and when they walked. Although 
most heel specific devices were Repose
©
 heel troughs, these are not suitable to 
wear when walking. Occasionally a PRAFO
©
 boot was used which could also 
provide pressure relief when walking, although the details of this was not 
recorded. The unknown efficacy of support surfaces has already been 
discussed in the systematic review in chapter 3. 
Size of the ulcer and photographs 
Area was measured using a clear acetate mapping grid to trace the perimeter 
of the wound. Difficulties with mapping and photographing ulcers have already 
been discussed in section 4.8. Much has been written about the reliability and 
validity of various techniques to measure wound size (Gethin and Cowman, 
2006; Shaw et al., 2007; Bowling et al., 2009; Mayrovitz and Soontupe, 2009). 
These studies generally compare different wound techniques and overall the 
findings suggest that with larger wounds acetate tracings are reasonably 
reliable. However the study by Shaw et al (2007) looked at diabetic foot ulcers 
and found the measurements were less accurate than digital photography 
image processing or the additional use of a formula to calculate the area of an 
eclipse. Although a variety of wounds were studied, only one study has been 
identified which considers the problems of measuring wounds over a curved 
surface (Liu et al., 2006). They acknowledge a number of devices already exist 
e.g. stereophotogrammetry and laser scanners, but these are complex and 
expensive. They propose a combination of laser scanners and photographs, 
while their study reports that lasers are becoming cheaper, this method would 
have been beyond the scope of this project. The main outcome in this study 
was time to complete healing; data for ulcer area was used in the descriptive 
analysis and not subject to any statistical testing. Changes in ulcer area may be 
clinically important in terms of type of dressing used, associated levels of 
exudate and feedback on ulcer progress to the patients.  
Wound treatments 
Treatments such as dressings, debridement or bandages were recorded at 
each visit; the inconsistencies of treatments have already been identified in 
chapter 6. It is likely that further inconsistency occurred in between visits 
especially when patients were out of hospital and data collection was at 
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monthly intervals. No formal record was made of treatments between visits 
although the researcher was aware from talking to patients and informal 
reviews of the nursing notes that variation did occur. From the data collected it 
was not clear whether changes in treatments were in response to a change in 
the condition of the wound or for some other reason. 
 
8.4.2 Missing data 
Data was missing at baseline for the following variables used in the prognostic 
factor analysis: one entry for haemoglobin, 20 observations for duration prior to 
recruitment, 80 (44%) observations for neuropathy, 64 (35%) observations for 
ABPI, three observations for severity, 15 observations for area, 4 observations 
for tissue type, 10 observations for surrounding skin and 66 (36%) observations 
for pain. The haemoglobin observation was missing as this test had never been 
performed on this patient; the duration prior to recruitment was due to lack of 
the patients’ ability to recall this information and insufficient detail in the records 
to provide a reliable estimate. It is uncertain why the other data were missing. A 
more timely data checking system may have prevented this.  
 
If these patients had been omitted totally from the analysis it would have 
reduced the power of the analysis, variances would be over estimated, 
confidence intervals would be too wide and it would have resulted in an un-
representative subset of patients (Burton and Altman, 2004).  
 
The missing variables of neuropathy and pain were mainly due to the patient’s 
lack of cognitive ability to respond to the questions. It is possible that this may 
reduce the generalisability of the findings to populations with cognitive 
impairment. Data were collected for the variable of ‘sensory perception’ on the 
Braden scale which should include patients with sensory neuropathy. However 
no correlation between these two variables was seen. The reliability and validity 
of each measure may be worthy of further investigation, particularly in 
populations with cognitive impairment. In terms of healing there was more of 
missing neuropathy data (71%) in the ulcers that did not heal compared to 
those that did.  
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Reasons for missing ABPI data has been discussed previously. Data not 
collected due to ischaemia had PVD; vascular speciality, PVD and ABPI were 
correlated (see section 5.3.2.2) so PVD was used in the final model. A 
sensitivity analysis using vascular speciality resulted in the same variable 
emerging as significant which gave some level of assurance of the findings; 
however the lack of reliability of these measures is acknowledged. Some 
patients did not have ABPI performed due to pain; given that a high amount of 
data were also missing for pain it possible that this may have affected the 
generalisability of the findings to the population of patients with painful heel 
pressure ulcers. There were more ulcers (67%) with missing ABPI data that did 
not heal compared to those that did. 
 
Reasons for missing pain data were mainly due to the patient’s inability to 
report this due to cognitive impairment.  There were also more ulcers (62%) 
without baseline pain data in the non-healing group than in the healed group. 
 
There are several methods for dealing with missing data including substituting 
values from surrogate variables, with median values calculated from the non-
missing data or with multiple imputation methods(Burton and Altman, 2004). 
For imputation methods to produce unbiased hazard ratios, a multiple 
imputation method is preferred providing less than 50% of cases have missing 
data and the data is missing at random (Marshall et al., 2010). Data can be 
‘missing completely at random’ (the missingness is an entirely random process 
that doesn’t depend on anything), ‘missing at random’ (the missingness 
depends on some measurable variable, this could be cognitive function in this 
study) or ‘missing not at random’ (where there is a systematic reason which has 
the potential for bias). As suggested above, some of the data are ‘missing at 
random’ so it would be possible to impute, however the percentage missing 
was so small this was not considered to be necessary. This study has followed 
the guidelines suggested by Burton & Altman (2004) (table 2) for reporting 
prognostic studies with missing data. The overall amount of missing data was 
low (7.6%), no imputation methods were used and full explanations are given of 
how these variables were dealt with and known reasons for missing data are 
discussed. This has reduced the potential for bias and allows the reader to 
make informed judgements about impact of the missing data. 
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8.5 Primary analysis 
8.5.1 Baseline characteristics 
The baseline characteristics have been split into patient and ulcer level. 
Demographic characteristics were compared to the two similar studies that 
have looked at predictors of pressure ulcer healing in long term care 
residents(Berlowitz et al., 1997; Bergstrom et al., 2005). The average age of 
this study population was greater (above 80 years in the current study 
compared to around 75 in the 2 cited studies); the ratio of males to females was 
47:73 in the current study, 36: 64 in the Bergstrom et al. study and 96:4 in the 
Berlowitz et al. study (this was carried out in a facility for military service 
veterans); ethnicity was not reported in the other studies; mental status in terms 
of dementia and depression were reported in the Bergstrom et al. study in 72% 
of the population; terminal illness (6.6%), incontinence (81%), immobility (90%) 
and confined to bed (15%) were reported at baseline in the Berlowitz et al. 
study. In the current study skin moisture was 14%, immobility was 12% and 
confined to bed was 17%. This shows that the current study had a slightly older 
population who had low levels of incontinence, were generally less active but 
more mobile. This is in keeping with the fact that the current study recruited 
from acute care setting rather than long term care facility. 
 
8.5.2 Prognostic factors  
The 12 candidate variables identified (see table 5.3) as significant at the p≤0.2 
level and the final model are consistent with the findings in other studies (see 
tables 2.3 – 2.5) and reflect the aetiological factors that are commonly 
described as associated with pressure ulcer healing. Care of the Elderly and 
prescribed analgesics were positively associated with healing. It is possible that 
being an elderly person (as most of the population were) cared for in this 
speciality would provide care that was more sensitive to the patients overall 
needs. As such more health deficits would be identified and addressed, giving 
better patient outcomes. However it may be that being in another speciality that 
the other co-morbidities e.g. having PVD or a hip fracture, were more important 
than being elderly. Further work would be needed to explore this. Being 
‘prescribed analgesics’ can be considered either a marker for pain (which may 
not be related to the heel pressure ulcer) or for having an opportunity for pain to 
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be controlled. No data were collected to inform this; therefore no assumptions 
can be made. 
 
The hazard ratio for ulcer area suggested this variable had very little effect on 
healing. This is consistent with the van Rijswijk and Polansky (1994) study.  A 
particular feature of pressure ulcers is that superficial ulcers (such as blisters) 
can be larger in area than severe ulcers. A large blister is more likely to heal 
than a small necrotic wound due to the processes involved (see section 2.6.1). 
When Bergstrom et al (2005) separated out Grade 2 ulcers (which may have 
included blisters) from Grade 3 and 4 ulcers and analysed them separately, 
they found that ulcer area was independently associated with healing. The 
study of diabetic neuropathic foot ulcers by Margolis et al.(2000) did find area 
an independent predictor of healing, although not enough detail was provided 
to know whether blisters were included in this study. It would appear that 
pressure ulcer size is not necessarily related to severity.  
 
8.5.3 Significant independent variables 
Two variables were found to be independently associated with heel pressure 
ulcer healing. 
Severity/Grade 
The impact of ulcer severity on prognosis for healing has some consistency 
with the other literature in pressure ulcer and foot ulcer healing. Severity of the 
pressure ulcer as a prognostic factor for healing has clinical validity. There are 
more processes involved in healing a severe rather than a superficial ulcer. 
There are a few studies that include severity as a variable. It was found to be 
an independent predictor by Berlowitz et al. (1997). Bergstrom et al (2005) 
analysed superficial and severe ulcers separately and van Rijswijk and 
Polansky (1994) only included severe pressure ulcers so severity could not be 
included as a variable. In the study by Margolis et al.(2000) of diabetic 
neuropathic foot ulcers severity was an independent risk factor and in Winkley 
et al. (2007) increased severity was a predictor for amputation. 
Peripheral vascular disease 
This variable is also consistent with the other literature in foot ulcer healing 
literature. It also has clinical validity. Perfusion to the foot is reduced as this 
disease compromises the patency of the blood vessels. The supply of oxygen 
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and nutrients to the ulcer will therefore be compromised and delay healing. 
PVD is a crude measure of perfusion. This factor was not reported in all the 
studies of pressure ulcers, as most studies do not list the candidate factors it is 
impossible to know whether it was not considered or did not emerge as 
significant. It is only likely to be considered as a candidate factor for peripheral 
pressure ulcer rather than pressure ulcers of the trunk (sacrum, buttocks, hips, 
etc) and no studies of healing of these wounds have been identified.  This 
appears to be the first study to identify this prognostic factor. It was found not to 
be an independent predictor in the Takahashi et al. (2009) study which included 
all chronic wounds including pressure ulcers (52.4%), venous leg ulcers (5.8%), 
ischaemic ulcers (28%) neuropathic ulcers (3.3%) and mixed ulcers (10.4%). 
However, PVD was an independent predictor in the diabetic foot ulcer study by 
Nather et al. (2008). Unfortunately the authors did not define how they 
measured PVD. 
 
8.5.4 Non-significant variables  
The following variables were expected to be prognostic given the review of the 
evidence and previous studies.  
Nutrition 
It has already been suggested in section 2.7.1 that some of the reason why 
nutrition does not show as a prognostic factor is due to how it is measured. The 
current study captured nutrition as part of the Braden score, haemoglobin as a 
proxy measure and nutrition associated medication (included prescribed 
supplements and vitamins). Only the nutritional medication (as a prognostic 
factor for delayed healing) emerged from the univariate analysis as reaching 
the appropriate significance level. It may be that nutritional support was a 
marker for poor nutrition. A review (not reported to be systematic) by Thomas 
(2001) considered the evidence for nutrition in the treatment of pressure ulcers 
and concluded that the impact of nutrition on healing remains uncertain. This is 
probably due to lack of studies of reasonable size and heterogeneity of 
populations, interventions or measures used.  
Co-morbidities 
It was surprising that particular co-morbidities such as diabetes and 
cardiovascular disease did not emerge as significant factors as they may have 
a particular impact on perfusion and wound healing. In other studies they were 
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associated with poor healing but not independent of other variables (Berlowitz 
et al., 1997; Bergstrom et al., 2008; Takahashi et al., 2009). They may have 
been well controlled in this patient population and were therefore less important 
than other variables such as PVD. Further research is required that considers 
the severity and impact of a disease process.  
Wound duration 
This is known to be a predictor of long healing in other wound healing studies 
(see section 2.7.2) such as leg ulcers (Margolis, Berlin and Strom, 1999). It was 
noted in section 2.7.2 that duration prior to recruitment was not considered in 
other studies even though van Rijswijk and Polansky (1994) recorded that 14% 
of the pressure ulcers had been present for > 9 months. While prolonged 
duration of the wound is well known in leg ulcer research, it is possible that 
researchers have overlooked that it is also an issue in pressure ulcer healing.  
Although duration prior to recruitment was included as a variable it did not 
appear to have any influence on outcome. This may have been due to the 
inaccuracy of this information.  
 
8.5.5 Other factors not considered as candidate variables in the 
cohort study 
Multiple wounds 
The presence of multiple chronic wounds has been identified in the univariate 
analysis in one study (van Rijswijk and Polansky, 1994) and in the multi-variate 
analysis in another study (Takahashi et al., 2009). It had been intended to 
include this variable in the current study but during piloting it was found difficult 
to elicit this information accurately from either the patients or their records so it 
was excluded. In hindsight more effort could have been made e.g. full skin 
assessments, to enable inclusion. This may have affected the ability to recruit 
patients. 
Mental condition 
There is some evidence that mental state (confusion cognitive ability) is a 
predictor of non-healing, as described in section 2.7.1. In the Bergstrom et al. 
(2005) study dementia, agitation, and depression were defined from the 
‘Comprehensive Severity index’, ‘International Classification of Disease’ and 
‘Minimum Data Set’. The researcher was uncertain whether these 
classifications would be as explicit in medical records in the UK. Mental 
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condition (both cognitive state and mood) is a relatively unexplored area in 
wound healing research, there is some face validity in the association between 
both of these and movement (confusion and agitation or lack of motivation to 
move respectively) but the physiological pathways e.g. the effects of serotonin, 
etc on healing have not been considered. Some exploratory work with medical 
records would be worthy if mental condition was considered for a future study. 
 
8.6 Descriptive analysis 
In this section the data used to inform the characteristics of current practice and 
the progress of the heel ulcers included information from follow-up visits. No 
statistical analysis was performed on these data.  
 
8.6.1 Characteristics of patients  
8.6.1.1 Mortality rates 
The mortality rate of patients in this study was higher than expected; this may 
have been due to the longer follow-up time, compared to other studies. 
Pressure ulcers are known to be associated with increased mortality rates 
(Berlowitz and Wilking, 1990; Thomas et al., 1996b; Brown, 2003; Takahashi et 
al., 2008) in hospital, community and long term care settings. Most authors 
acknowledge that pressure ulcers are not the cause of death; when mortality 
rates are adjusted for age, co-morbidity, etc then pressure ulcers are no longer 
a predictor of death(Berlowitz and Wilking, 1990; Thomas et al., 1996b). The 
proportion of patients who died was 42.8% in the current study with 18 month 
follow-up. Twenty six percent of patients died in the Berlowitz et al. (1997) study 
and 27% in a previous study by Takahashi et al. (2008) of patients with 
pressure ulcers in long term care institutions both with a 6 month follow-up.  
 
Donini et al. (2005) in their retrospective review of long term care patients found 
the mortality of patients whose pressure ulcers were healing was significantly 
lower (10.3 vs. 61.1%) than the remaining sample. Berlowitz and Wilking (1990) 
calculated the relative risk (RR) for mortality of patients admitted with pressure 
ulcers compared to those admitted without pressure ulcers. This was 1.9, those 
who developed pressure ulcers after admission (RR= 3.1), those whose 
pressure ulcers failed to improve (RR= 3.3) in long term care hospital for six 
week follow-up.  
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Brown (2003) examined the relationship between healing and mortality in a 
cohort of 74 inpatients at a Veterans Affairs Medical Centre with a median age 
of 75 years. He found a 180 day mortality rate of 68.9% with an average of 47 
days from ulcer onset to death. Patients with spinal cord injury and foot lesions 
were excluded from this cohort.  
 
Langemo and Brown (2006) reviewed the evidence for ‘skin failure’ as a 
constituent of multi-organ failure. They differentiated between ‘acute skin 
failure’, which is an event associated with an acute illness or an extreme 
medical condition. ‘Chronic skin failure’ is described as being associated with a 
steady decline in chronic illness and occurs near the end of life and, as such, 
may be inevitable. The findings of their review do not provide much evidence to 
support this hypothesis although it has clinical validity. Insufficient detail was 
collected on severity and progress of co-morbidities to comment on whether the 
above proposition applied in the current study.  
 
8.6.2 Characteristics of current practice 
All the variables in this section were collected at baseline and follow-up. The 
baseline observations were not considered as potential prognostic, as they 
were known to vary during the data collection period, such that the baseline 
observation would not be representative of the whole episode. 
 
8.6.2.1 Dressings 
Type of dressings was presented in the follow-up data. The most frequently 
occurring dressing type was ‘moist wound healing’ on 32% of observations. The 
objectives of the study by Bergstrom et al. (2005) included identifying treatment 
characteristics associated with pressure ulcer healing. Their coding of 
dressings included moist, dry, none or multiple dressings and found that moist 
wound healing was a significant predictor of healing in both the Grade 2 and 
the Grade 3 and 4 pressure ulcers. This supports national and local guidance 
for moist wound healing for pressure ulcers. It needs to be acknowledged 
however that cohort studies cannot attribute cause and effect. Systematic 
reviews of randomised controlled trials of treatments would have the potential to 
demonstrate effectiveness; unfortunately a search of the Cochrane library 
(http://www.thecochranelibrary.com/view/0/index.html) revealed only a small 
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number of systematic reviews that have looked at specific types of treatments 
in pressure ulcers and have found very little evidence of effectiveness (Kranke 
et al., 2004; Baba-Akbari Sari et al., 2006; Jull, Rodgers and Walker, 2008; Aziz 
et al., 2010).  
 
Bergstrom et al. (2005) were surprised at the large variation of treatment 
practices. These changes in treatments did not appear to be consistent or 
related to the reassessment or changes in the condition of the ulcer. They 
expressed concern at the lack of adherence to treatment protocols and 
guidelines and suggest an impact on outcomes and costs. In the current study 
similar variations were noticed. Dressings at baseline were not included in the 
prognostic factor analysis as the subsequent inconsistencies would have made 
this unreliable. It is possible that a time dependent co-variate analysis could be 
undertaken at a future date see section 9.2. 
 
8.6.2.2 Bandages 
Bandage use was presented in the follow-up data. Retention bandages were in 
place at 70% of the observations. This is related to the use of non-adherent 
dressings (the bandage holds the dressing in place). It is uncertain whether the 
use of non-adherent dressings is an active decision based on the concern for 
the condition of the skin surrounding the ulcer being unable to tolerate 
adhesives or a decision based on the lack of availability of adhesive dressings 
in the organisation. Further work would be needed to explore this.  
 
Eleven ulcers had compression bandaging applied for some of the time. A 
search for evidence on the compatibility of compression bandaging for venous 
incompetence and the presence of heel pressure ulcers has found a lack of 
studies or guidelines. One study does report the risk of amputation subsequent 
to pressure damage in a cohort of patients with compression bandaging 
(Callam et al., 1987). An audit by Cock (2006) considers the safe and effective 
use of anti-embolism stockings and suggests that there is a strong link between 
development of pressure ulcers on the heels and stockings such that they 
should be contra-indicated. More research is needed in this area. 
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8.6.2.3 Debridement 
The majority of ulcers were not actively debrided (see table 4.1). However on 
7% of observations sharp debridement had been performed and 3 ulcers had 
larval therapy for debridement. It has been acknowledged in section 2.3.2 that 
the evidence base for active debridement is sparse. The active debridement 
was generally carried out by specialists. The researcher was particularly 
interested in whether heel pressure ulcers would heal quicker with active 
debridement. It was surprising that sharp debridement occurred on so few 
occasions; this may be due to concerns over the competency of nurses in 
carrying out sharp debridement procedures (O'Brien, 2003). Enzymatic 
debridement was not available on the formulary in the acute Trust so was 
unlikely to be used in the study. Larva therapy is expensive and requires skills 
in application so its use is predominantly in areas where staff are competent 
e.g. Diabetology so limited use is not surprising. 
 
8.6.2.4 Support surfaces 
The lack of good evidence (see chapter 3) to underpin guidelines on treatment 
of heel pressure ulcers (McGinnis & Stubbs 2011) is reflected in the variation of 
pressure relief found in the study. 
 
8.6.3 Progress of heel ulcers 
8.6.3.1 Duration and outcome 
The time taken for the ulcers to heal from the point of recruitment was variable. 
The median time to healing from recruitment was 121 days with a range of 8 to 
440 days. The original sample size calculation was based on a study by 
(Berlowitz et al., 1997) which gave a healing rate of 50% at 6 months. In this 
study patients were recruited from a long term care institution and the mean 
age was 70.4 years. No details were given of body site affected, 22% had 
Grade 4 ulcers. The follow up time was 6 months, during which time 25.7% of 
the patients died. The reasons for the differences in healing rates (current study 
42% healed after 18 month follow-up) could be that heel pressure ulcers take 
longer to heal than pressure ulcers on other body sites and are not 
representative of all pressure ulcers and superficial ulcers take less time to heal 
than severe. The latter reason was confirmed in the current study with the 
analysis of prognostic factors. 
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No other prospective cohort studies of pressure ulcer with an endpoint of 
healed ulcer have been identified. However van Rijswijk and Polansky (1994) 
carried out a secondary analysis of data (for Grade 3 and 4 pressure ulcers) 
collected prospectively with the original intention of comparing the 
characteristics of patients with partial thickness or full thickness pressure 
ulcers. They found a median time to healing of 69 days with 25% healing after 
50 days and 75% healing after 243 days with an overall 37.5% of patients 
whose ulcers healed. Time to healing (using Cox proportional hazard model) 
was used in the van Rijswijk and Polansky (1994) and the Bergstrom et 
al.(2005) study. However the duration of follow up was limited to 4 months 
(healing time given above is assumed to include duration prior to recruitment as 
times given exceed data collection time) and 12 weeks respectively. The 
proportion healed after 6 months in the Bergstrom et al. (2008) study was given 
as 45%. Details of these studies can be found in tables 2.3-2.5. Differences in 
the time to healing could be due to: 
  Case mix: although van Rijswijk and Polansky (1994) recruited in-patients 
in acute care they also recruited from extended care and rehabilitation 
facilities. The other two studies (Berlowitz et al., 1997; Bergstrom et al., 
2005) recruited from long term care facilities. Overall the patient 
population in the current study was more likely to be more ill. 
 The definition of time to healing: for the current study this was calculated 
from time of recruitment (although duration prior to recruitment was 
included as a variable this was not thought to be very precise). Van 
Rijswijk and Polansky (1994) is assumed to include duration prior to 
recruitment.  
 Types and severity of pressure ulcers: all of the studies included pressure 
ulcers on all body sites, no specific information has been found on 
healing times for heel pressure ulcers. Not all studies included Grade 4 
(Bergstrom et al., 2008) and Unstagable ulcers which were included in 
the current study. 
One of the explanations suggested by van Rijswijk and Polansky (1994) as to 
why prognostic factors for wound healing have not been clearly defined for 
patients with chronic wounds with long duration, (such as pressure ulcers) is 
because of the loss to follow-up for reasons unrelated to the study . Many 
studies report proportion of pressure ulcers healed by given points in time and 
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healing trajectories are calculated; these are unlikely to be reliable for ulcers 
that take longer than 6 months to heal as there are no pressure ulcer studies 
that follow patients beyond this time. The importance of ‘complete healing’ as 
an outcome measure is discussed by Bradley et al. (1999) in their systematic 
review. Changes in wound area and proportion of wounds healed are 
dependent on baseline comparability of wound size. They are also not 
meaningful to patients, who may still be experiencing a detrimental effect on 
their quality of life if their wounds are persisting. If complete healing is not 
established the additional costs to the healthcare provider are unknown. A 
major strength of this study was the 18 month follow-up to maximise the 
number of pressure ulcers that achieved complete healing. 
 
8.6.3.2 Trends in healing 
In section 6.4.3 trends were noted in healing trajectories for the heel pressure 
ulcers. The main findings of note were the trends in changes in area. While it is 
generally acknowledged that smaller ulcers heal quicker (O'Meara et al., 2000), 
no relation between healing and ulcer size was seen in this study. This is 
probably due to the severity of the ulcers e.g. large blisters usually healed 
quicker than small necrotic ulcers (this was observed in the current study). In 
the researchers’ clinical experience, ulcers which have non-viable tissue are 
likely to increase in size due to debridement prior to healing. This could explain 
some of the increase in sizes noted in this study. Some ulcers may have been 
subject to further pressure damage which resulted in increasing size. The initial 
rapid decrease in size followed by a slower rate (noted in some of the study 
wounds), has been observed by the researcher in many wounds. Van Rijswijk 
and Polansky (van Rijswijk and Polansky, 1994) noted that after two weeks, the 
percentage reduction in ulcer area was significantly different between those 
whose ulcers went on to heal and those whose did not.  
 
Wellenstein and Brem (2004), in their attempt to establish a functional model 
for pressure ulcer healing rates, observe the variability in changes in area 
including increases and decreases (plotted as a percentage of the observed to 
baseline area). They reviewed previous studies on wound healing rates and 
found that as far back as 1916 it was observed that cicatrization (the process of 
scar formation) was greater at the beginning than the end of repair. No trends 
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are specifically identified but Grade 4 ulcers and those smaller than 2 cm
2
 were 
excluded and patients were only followed up for 8 weeks, which makes 
comparison difficult with the current study.  
 
Bergstrom et al. (2005) noted that pressure ulcers do not heal in a linear 
fashion; that periods of decrease in ulcer area were interspersed with periods of 
worsening and again by improvement. No studies have been identified, which 
specifically look at healing rates. However many wound healing studies find that 
a proportion of patients do not reach full healing at given time point and 
duration of ulcer is often included as a predictor of non healing (Margolis, Berlin 
and Strom, 1999) 
 
The feature of a prolonged final stage of healing (see section 6.4.3) is an 
important finding from this study, which has not been identified in other studies 
of pressure ulcer healing. If this was subject to further analysis and found to be 
a common trend, this would raise concerns over studies which do not follow 
wounds to complete healing. These trends are worthy of further investigation. 
 
8.6.3.3 Tissue type and severity 
The need for differentiating between tissue type and severity has been 
discussed in section 2.6, although the tests of collinearity (section 5.3.2.2) 
confirm that that they are closely related.  
 
Table 6.5 described the final stages of healing. Most ulcers had a dry scab prior 
to re-epithelialisation. Where this was not recorded, it is possible that a dry 
scab did occur with some of the ulcers which had been granulating prior to re-
epithelialisation, especially when the data collection interval was a month.  
 
The ‘dry scab’ is not described in any of the classic models of wound healing. It 
appears to be a build up of epidermal tissue (see figure 6.5), but has not been 
classified as a healed wound in this study as there is uncertainty over whether 
intact dermis is present beneath. Although most of these wounds were almost 
healed and did not have dressings on, they were not the same as ‘dry scabs’ 
seen on exposed wounds on other areas of the body, where the scab appears 
to be made up of desiccated wound exudate.  Dry scabs were often present for 
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several weeks or months prior to healing. In the researcher’s clinical experience 
dry scabs are sometimes seen in healing leg ulcers, particularly sited in the 
malleolar region. It is possible that this is an anomaly of the skin structure on 
the lower limb. This is also a key finding from this study, which has not been 
identified in any other studies of pressure ulcer healing and is worthy of further 
investigation as it may inform the understanding of the prolonged final stage of 
healing. 
 
This study has raised many questions about the nature of pressure damage to 
the heel and progress of ulcer healing. Further work is needed to enable the 
extent of tissue damage to be quantified particularly when blisters (either clear 
fluid or blood filled) are identified to enable clinicians to have some informed 
expectations of healing times and instigate appropriate treatment.  
 
8.6.3.4 Surrounding skin 
In a third of the ‘surrounding skin’ observations the skin was found to be 
normal/ healthy (36%). In 17% of observations skin was dry and flaky. This may 
have been normal for this mainly elderly population. Section 6.5.5 describes the 
presentation of the surrounding skin. The condition of the surrounding skin was 
a candidate variable in the model developed by van Rijswijk and Polansky 
(1994), but was found not to be significant. No details are given of how this 
variable was defined. No other descriptions of dry flaky skin in relation to wound 
healing have been found. The presence of erythema is described as being 
associated with infection. Further analysis of associations of erythema and 
infection would be worth considering. Similarly the presence of oedema and 
associated immobility, may be worthy of further consideration particularly for the 
heel pressure ulcer population. 
 
8.6.3.5 Pain 
In a quality of life study, during interviews with 23 in-patients with pressure 
ulcers, pain was found to be present in (n=21) 91% of pressure ulcers 
(Spilsbury et al., 2007). For those patients able to report pain in the current 
study more than half reported it was present. Some trends were noticed with 
regard to reducing pain and healing, but no detailed analysis of these trends 
has been carried out. A systematic review of the literature on pressure ulcer 
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pain acknowledges that pressure ulcer pain is under-represented in the funded 
research (Pieper, Langemo and Cuddigan, 2009). However there is no mention 
of an association of pain levels and healing. This topic is worthy of further 
investigation. 
 
8.6.4 Adverse sequelae 
8.6.4.1 Infection  
Although more than half the patients did not experience any sort of infection, 
both wound infection and infections in other body systems occurred in 42% of 
patients. A review by Penhallow (2005) concluded that there is no consensus 
on the impact of bacterial colonisation on wound healing and the difficulties 
differentiating between colonisation, critical colonisation and infection in chronic 
wounds such as pressure ulcers mean that it is difficult to attribute association 
between infection and delayed wound healing.  It has face validity due to the 
increased metabolic demands of an infected wound. Bacteraemia from infected 
pressure ulcers is a rare but serious complication with a high risk of death (48% 
mortality in a small study of 21 patients with sepsis from pressure ulcers (Galpin 
et al., 1976)). Infection is thought not to have been included in the pressure 
ulcer prognostic factor studies (Berlowitz et al., 1997; Bergstrom et al., 2005; 
Takahashi et al., 2009). However it has been identified as an independent 
predictor of non-healing of diabetic foot ulcers (Nather et al., 2008). 
 
8.6.4.2 Length of stay, change of accommodation, readmission rates and 
ward moves 
Data were collected on all of the above and details are recorded in section 6.6 - 
6.8 and some particular observations were commented on. Unfortunately no 
comparative data were available at this time to suggest any associations with 
the heel pressure ulcers. One study has been identified which reports that 
orthopaedic patients who develop heel pressure ulcers have an increased 
length of stay of 3 days, although this was not statistically significant (Campbell, 
Woodbury and Houghton, 2010). 
 
8.7 Key findings and contributions to knowledge 
This study has made an important contribution to the knowledge of healing heel 
pressure ulcers. Very little was known about pressure ulcer healing and it has 
been demonstrated that heel ulcers are likely to be different in terms of healing. 
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Very few studies of prognostic factors for healing pressure ulcers on all body 
sites have been identified and no previous work has been carried out for 
specifically for heel ulcers. 
 
The literature review revealed many gaps in knowledge regarding pressure 
ulcer healing and heel pressure ulcers specifically. The systematic review 
revealed a lack of evidence for the effectiveness of support surfaces and 
pressure relieving devices for treating heel pressure ulcer.  
 
The study has been the first to identify the characteristics of the heel pressure 
ulcer population in acute care settings. It has quantified the event rate for heel 
pressure ulcer healing and outcomes other than healing such as death or 
amputation of the affected limb. The long follow-up time and the continued data 
collection following discharge from hospital, has enabled better estimates of 
healing rates and mortality rates for this population. 
 
The presence of tissue types such as blisters and blood blisters dry scab during 
the end stage of healing have not been described in other pressure ulcer sites 
on the body. The potential time to heal, probability of healing and other 
outcomes has been quantified. Prognostic factors have been explored and two 
have been identified that are independent predictors of heel pressure ulcer 
healing.  
 
Although guidelines exist for management of pressure ulcers, whether these 
are implemented in clinical practice has been uncertain. This study has found 
high amount of variability in treatments such as dressings, debridement and 
support surfaces. 
 
Healing trajectories for pressure ulcers have not previously been studied 
specifically; this study has contributed to this knowledge (in particular identifying 
a prolonged final stage of healing) and identified a need to investigate this 
further.  
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The study has identified factors such as pain associated with heel pressure 
ulcers. Details of the pain are also now known such as what triggers it and 
changes in pain levels that may be associated with the stage of healing.  
One of the reasons for carrying out this study was to provide data to inform the 
planning of a randomised controlled trial of treatment interventions for heel 
pressure ulcers e.g. for power calculations. The study has achieved this aim.  
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Chapter 9 Summary and Recommendations 
 
9.1 Summary 
Pressure ulcers occur due to localised injury to the skin and/or underlying tissue 
usually over a bony prominence, as a result of pressure, or pressure and shear. 
They are a major health problem estimated to cost £1.2 -2.1 billion annually 
(4% of total NHS expenditure) (Bennett, Dealey and Posnett, 2004) and have a 
serious impact on patients in terms of morbidity and their quality of life (Gorecki 
et al., 2009). The most common body sites for pressure ulcers to develop are 
the lower trunk and heels (Dealey, 1991a). The lower limb extremities (including 
the heels) are different from other body sites such as the sacrum, ischeal 
tuberosity and trochanter areas due to their anatomy (section 1.6.8) and 
susceptibility to certain diseases (section 1.7.5).  
 
Much of the pressure ulcer research has been in prevention. Many studies have 
been undertaken which look at factors associated with the development of 
pressure ulcers (Nixon et al., 2010) but few have been found which look at 
factors which affect healing. Logically in clinical practice the healthcare 
professionals primary aim should be prevention, however this is not always 
achievable. In the unfortunate event of a pressure ulcer occurring, it is 
important to know about the healing process and identify any factors which will 
affect healing in order to plan appropriate care. This will allow the clinicians to 
correct any factors they can to optimise healing.  
 
Existing guidelines for the treatment of pressure ulcers include 
recommendations for dressings and other treatments, support surfaces and 
supplementary interventions such as nutrition (EPUAP, 1998; RCN, 2005; 
NPUAP, 2009). Much of this guidance is based on expert opinion in the 
absence of good quality trials. There is no specific guidance for pressure ulcers 
on the heels, although some guidelines advise caution with necrotic pressure 
ulcers in the presence of peripheral arterial disease. There are two areas here 
where there are gaps in the evidence: there is a lack of evidence to inform the 
management of pressure ulcers in general and there is a lack of evidence 
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specifically for the management of heel ulcers which may well be different in 
terms of physiology and disease processes. 
 
Good quality epidemiological evidence is needed to inform the planning of 
intervention studies. This study recognises the differences in heel pressure 
ulcers and makes a contribution to the epidemiological evidence. Planning a 
heel pressure ulcer trial will require appropriate heel specific data.  
 
This study set out to initially summarise the evidence for healing of heel 
pressure ulcers. It was acknowledged that healing pressure ulcers should 
consider the local wound management, the management of internal risk factors 
and the relief of pressure. The review of the evidence for the relief of pressure 
was studied in a systematic process, looking for the effectiveness of support 
surfaces. Then it proceeded to identify prognostic factors for healing of heel 
pressure ulcers and describes some of the characteristics of the patients, their 
ulcers, the treatments and events which occurred while the ulcers were healing.  
 
The systematic review identified only one study for which data for healing heel 
pressure ulcers could be analysed separately. The number of patients lost to 
follow-up led to a high risk of attrition bias, other risks of bias were also noted. 
Although the analysis performed by the authors show statistically significant 
difference in healing between the two mattress systems studied, these results 
were viewed with extreme caution. Sensitivity analysis showed that the findings 
were dependent on what happened to the patients who were lost to follow-up. 
 
Two factors were identified that were independently prognostic for the healing 
of heel pressure ulcers in a multi-variate analysis. Superficial ulcers (blisters 
and full thickness skin loss) were likely to heal quicker than severe ulcers 
(cavities and necrotic ulcers) and ulcers were less likely to heal in patients who 
had peripheral vascular disease than those who did not. Other factors may be 
prognostic but were not found to be statistically significant in this small study. 
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Patients were recruited from specialties within an acute care hospital where the 
numbers of heel ulcers was known to be high. Most patients recruited were in 
Care of the Elderly wards, approximately equal numbers of men and women 
were affected and half had previously smoked. Most patients had several co-
morbidities and had reduced mobility and activity. 
 
One hundred and forty patients were recruited with 183 heel pressure ulcers. Of 
these 77ulcers healed, 88 ulcers were on the heels of 60 patients who died, 5 
were on limbs which were amputated, 11 remained unhealed at the end of the 
study period and 2 were lost to follow-up. For those ulcers that healed, the 
median time to healing from the point of recruitment was 121 (range 8-440) 
days. 
 
Information was obtained on the type of tissues that were present on the heel 
ulcers at different stages of healing; particular note was made of ‘dry scabs’ 
and the difference between clear fluid and blood filled blisters, which have not 
previously been described in any of the wound healing literature. Changes in 
wound area were recorded during follow-up visits, certain trends such as 
fluctuations in area and rates of change (initial rapid reduction and prolonged 
final stage reduction) were observed which have been suggested in other 
healing literature but not studied specifically to complete healing. The condition 
of the skin surrounding the ulcers was mostly observed to be normal or dry; 
however erythema and/ or oedema were noted on several occasions, which 
may have been associated with other pathological processes. Levels of pain 
(prevalence and severity) were observed, which were not noted in other 
studies, however the researcher was unable to assess pain according to the 
protocol for some patients with cognitive impairment. Trends in pain levels and 
triggers for pain were noticed (see section 6.4.6) which have not been reported 
elsewhere.  
 
Follow-up data were obtained on treatments such as dressings, bandages, 
debridement and support surfaces. A large variation in treatment practices was 
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witnessed in this study that was similar to a previous study (Bergstrom et al., 
2005), however this was the first study in the UK to report these finding. 
 
A record was made of any adverse events that affected the patients during the 
course of the study. The majority of patients had an infection at some point 
although these were mostly affecting organs or systems away from the heel 
ulcer e.g. respiratory or urinary tract. Details of patients’ pathways were 
recorded showing in which care environments patients are treated and how 
frequently they move between them, this information will be most helpful in 
planning an intervention study. 
 
Overall, this was felt to be a worthwhile study which produced a remarkable 
amount of new information that will be useful both clinically and to inform future 
research studies.  
 
9.2 Recommendations for research 
A lot of data were collected during the follow-up visits. This was used in this 
thesis to inform the descriptive analysis, however the data could be used in a 
further regression model with time-dependent covariates. This process utilises 
the fact that the variables may change over time and involves constructing a 
function of time in the model (Fisher and Lin, 1999). The effects of variables 
such as dressings, bandages, debridement, support surfaces, pain, tissue type, 
surrounding erythema and oedema and infection could then be considered. 
This work will require specialised techniques and the involvement of a 
statistician.  
 
Further similar cohort studies with more patients are required to confirm or 
strengthen or refute the prognostic factors for heel ulcers identified in this study. 
A high quality prognostic factor study of healing of all pressure ulcers with data 
analysed by body site would be valuable. This would enable researchers and 
clinical staff to understand what might be the similarities and differences in 
terms of healing according to body site. If these studies were to be carried out, 
improved definitions of variables are suggested e.g. co-morbidity could be 
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defined in terms of disease severity and impact e.g. using markers of diabetic 
control such as HbA1c (Krishnamurti and Steffes, 2001), smoking history 
should be worked out as ‘pack years smoked’, nutrition should be better 
defined in terms of adequacy of energy and protein intake and 
supplementation.  Future studies should preferable be inception cohorts or 
better attempts should be made to improve the accuracy of the estimated start 
dates of the ulcers and this time point should be used to estimate time to 
healing. The notion of ‘acute’ or ‘chronic’ skin failure has been suggested by 
Langemo and Brown (2006), this has good clinical validity. If pressure ulcers 
could be defined in terms of this variable then it may be prognostic for healing. 
Studies which look at associations with other organs and/or systems failure and 
pressure ulcer outcomes may inform this debate. 
 
The systematic review of support surfaces identified a lack of trials in this area. 
Intervention trials should be undertaken for support surfaces, topical treatments 
such as dressings and debridement particularly for heel pressure ulcers as 
there is very little guidance for all these aspects of pressure ulcer care. These 
could be interventions specific for heel pressure ulcers or treatments for all 
pressure ulcers with separate data for each pressure ulcer site. The data 
produced by this study would be useful in informing sample size calculations, 
recruitment rates, follow-up times, healing rates, dropout rates, types of 
interventions and potential prognostic factors to be considered in case mix 
adjustment in the analysis. 
 
The trends in ulcer healing trajectories are worthy of further exploration. The 
suggestion by van Rijswijk and Polansky (1994) that there may be a cut off time 
beyond which pressure ulcers are unlikely to heal, would be clinically useful. 
This would enable health care professionals and patients to plan realistic 
treatment goals i.e. if healing is unlikely then symptom management (pain, 
exudate) should be a priority. The actual time to healing and the likelihood of 
healing would be helpful to patients. 
 
- 244 - 
An investigation of the relationship between pain as a time-dependent covariate 
and ulcer healing has been suggested above. Associations between the level of 
pain and the stage of healing and the descriptors and trigger factors of pain are 
worthy of further analysis from the data available.  
 
Information on patient pathways was collected for this study; it may be possible 
to review case notes of case matched patients without pressure ulcers to 
identify any sequelae of having a pressure ulcer. Studies of this type have not 
been identified in the literature.  
 
9.2 Conclusion  
Two significant independent prognostic factors have been identified for healing 
of heel pressure ulcers: these are the severity of the ulcer and the presence of 
peripheral vascular disease. These have good face validity, the former also 
been found in other studies of pressure ulcer healing and the later in studies of 
diabetic foot ulcer healing. Further work is needed to confirm or refute these 
and indentify other prognostic factors. 
 
The median time to complete healing of heel pressure ulcers has been 
identified for this cohort of patients. Few studies have used the outcome of time 
to complete healing of the ulcer; proportion of ulcers healed at a given time is 
more commonly reported. When compared to other pressure ulcer healing 
studies, it is likely that similar healing times would be demonstrated with similar 
case mix and follow-up. This information will be useful in planning intervention 
studies.  
 
The effectiveness of appropriate pressure relieving aids for heel ulcers has yet 
to be established. Clinically a variety of devices are used with associated costs 
to the health service and possible discomfort and inconvenience to the patients 
with no assurance of their benefits. Intervention studies of pressure relieving 
devices are needed. 
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The healing trajectory for heel pressure ulcers has been found to vary with 
many ulcers having an initial rapid reduction in ulcer size, others having 
temporary increases in size, which may be associated with debridement and 
most importantly a prolonged final stage of healing. Other studies have 
suggested similar findings.  Further work needs to be done specifically looking 
at factors associated with the end stage of healing. 
 
Tissue types found in heel pressure ulcers are not well documented for ulcers 
in other sites e.g. clear fluid and blood filled blisters at the start of the ulcer and 
dry scabs at the end stage of healing. The relationship with severity (Grade) 
and tissue type and the significance of these has yet to be defined. 
 
The relationship with the condition of the surrounding skin and wound healing 
e.g. dry and flaky, erythema or oedema has not been explored. Whether these 
presentations are frequently occurring or significant has not been well 
documented.   
 
Pain has been found to be frequently reported in heel pressure ulcers, the 
impact of this on the patients’ quality of life is likely to be different to pain in 
other body sites as mobility will be affected. Any association of pain with wound 
healing has yet to be established.  
 
There will now be opportunity and motivation to publish not only the main 
findings of the prognostic factor analysis but also information which may help to 
stimulate and inform future research. Topics will include: 
 The findings of the prognostic factor analysis 
 The impact of the mental capacity act on recruitment of cognitively 
impaired patients  
 Illustrated process of wound healing: heel ulcers 
 Pathophysiology of heel pressure ulceration 
 The relationship between pain and wound healing 
 SR of support surface for treating heel ulcers 
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 Patient characteristics, pathways and treatments for healing of heel 
pressure ulcers 
 
9.3 Implications for practice 
As severe pressure ulcers are likely to take longer to heal than superficial 
ulcers, long term care plans should reflect their needs for ongoing ulcer 
management e.g. the provision of aids and adaptations, care setting suitable for 
long term health care.  
 
The need for the assessment of the severity/grade of the pressure ulcer to be 
accurate is essential. In the researchers clinical experience many general 
nurses do not reliably assess the Grade of the ulcer.  This study has identified 
the gaps in knowledge regarding the relative importance of the Grade of the 
ulcer (the anatomical structures affected), the tissue types such as slough and 
necrosis, the size (area) of the ulcer and other presenting features such as 
blisters and dry scabs. Until their role in wound healing is fully understood it is 
important for clinical staff to record these details. This will be used to develop 
empirical knowledge and contribute towards future research.  
 
The presence of PVD is also likely to delay healing; it is desirable that all heel 
pressure ulcer patients should have their peripheral arterial status established 
to inform ongoing ulcer management.  
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Appendices 
Appendix 1: Patient information sheet 
A Study of Wound Healing in Heel Pressure Ulcers 
 
Patient Information Sheet 
 
Please read this document carefully. 
I would like to invite you to take part in a research study. Before you decide whether to 
take part it is important for you to understand why the research is being done and what 
it will involve. Please take time to read the following information carefully. Feel free to 
discuss this with anyone else you wish to, for example, friend / nurse / doctor or 
relative. Ask me if there is anything that is not clear. I am happy to provide more 
information. Take as much time as you need to decide whether your relative would 
want to take part. 
Thank you for reading this. 
 
What is the purpose of this study? 
This is a study of the treatment of pressure ulcers (pressure sores) found on people’s 
heels. The study will not introduce any new treatments. It is an observation of the 
progress of the heel ulcers and the treatments used. 
Pressure ulcers can occur on different areas of the body, usually when someone is 
immobile for long periods of time and are caused by the pressure on the parts of the 
body which are supporting the person. Pressure ulcers usually start as a reddened 
area on the skin. They may develop into blisters or wounds; it is these ulcers which will 
be studied. Although in most cases where the immobility is anticipated measures are 
taken by nurses to prevent pressure ulcers occurring, these are not always successful 
or possible.  
 
Why have I been chosen? 
You have been identified as having a heel pressure ulcer. Within the hospitals in Leeds 
over the next 2 years, about 200 people with heel pressure ulcers will be asked to take 
part in this study. 
 
Do I have to take part? 
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Participation in this study is entirely voluntary. It is up to you to decide whether or not to 
take part. If you decide they will take part you will be given this information sheet to 
keep and asked to sign a consent form. If you do decide to take part you can still 
change your mind at any time. Their future care and treatment will not be influenced by 
your decision for them to take part or not. If you do agree to take part in this study and 
decide at a later time to withdraw then you are free to do so at any time without 
influencing your future care or treatment.  
 
What will happen to me if I agree to take part? 
If you agree to take part I will collect some information about you and the treatment of 
your heel ulcers at our first meeting. I will then visit you every week to collect more 
details about the progress of your heel ulcer until it heals. When you are discharged 
from hospital, if the ulcer is still present, I will visit you once a month.  
Most of the information I need I will be able to get from  medical and nursing records, 
for example, the reason for  admission, any other medical conditions such as diabetes 
and the dressings which are used. Sometimes I will carry out a change of dressing as 
part of your normal treatment to enable me to measure and photograph the wound. I 
will carry out two extra tests which the nurses may not routinely do, these are to 
assess your circulation and nerve sensation, these 2 tests will only be carried out every 
3 months. I will also take a photograph of the heel ulcer at the first meeting then again 
after every month. 
 
What will I have to do? 
You will continue to be treated for the heel pressure ulcer according to the normal 
practice of the staff that are caring for you. I will identify some additional information 
about your activity, mobility and any pain. The dressing change may take up to 5 
minutes longer if I am taking a photograph of the wound.  
 
Why do the study? 
Pressure ulcers usually take a long time to heal (often months) and are often cared for 
in different places by different people, for example in hospital and at home. Because of 
this, information about how they are treated and studies to identify what works best are 
not easily available. 
 
Are there any implications for me taking part? 
There will be no personal advantages to you taking part; I will only be observing the 
standard treatment you are receiving. However the information derived from the study 
will be used to inform future management of heel pressure ulcers. The information will 
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be shared locally, nationally and internationally so that it will benefit as many people as 
possible.  
Being involved in the study will not affect your care at all. At our first meeting I would 
like to carry out a couple of extra tests: a Doppler test to assess the circulation in your 
legs and a Monofilament test to assess sensation in your legs and feet. If your relative 
still has a heel ulcer after 3 months I will repeat these tests. These tests can 
sometimes cause slight discomfort. If you wish to take part in the study but don’t want 
to have these tests then this can be arranged.  
All subsequent visits may take slightly longer than usual while I complete the 
paperwork. 
 
Will my taking part in this study be kept confidential? 
All information that is collected about you during the course of the research will be kept 
strictly confidential. Any information about you that leaves the hospital/ your home will 
have your name and address removed so that you cannot be recognised from it. Your 
hospital Consultant and GP will be notified of your participation in the trial. 
 
What happens to the results of the study? 
The results of the study will be used as part of a PhD thesis. It is also planned to 
publish in medical and nursing journals. You will not be identified in any publication 
arising from this study. If you wish to receive a copy of the study report on completion, 
then please let me know.  
 
Who is organising and funding the research? 
The study is being funded by a Leeds Teaching Hospitals Trust Charitable Trustee 
Fellowship. The Fellowship has provided funds for my time to undertake the research 
and for the equipment I use e.g. the camera and the wound tracing maps. I am being 
supported with the study by the University of Leeds. 
 
Who has reviewed the study? 
The Leeds (West) Trust Research Ethics Committee and Leeds Teaching Hospitals 
and Leeds Primary Care Trust’s Research Governance Committees have reviewed the 
study. 
 
What do I do now? 
If you are interested in taking part let me know when I return and we can discuss this 
further. 
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Where can I get more information about the study? 
If you do not understand anything on this information sheet or would like further 
information please contact me on the telephone number below or ask the ward staff to 
contact me. 
 
Research Investigator: Elizabeth McGinnis, Nurse Consultant – Tissue Viability 
Leeds Teaching Hospitals Trust. c/o Nursing Directorate, Old Trust HQ, Leeds General 
Infirmary, Great George Street, Leeds LS1 3EX 
Telephone: 0113 3926238 or mobile 07717 573 956 
 
If you wish to discuss this with someone who is not involved in the study, you can 
contact:  Ms Alison Raycraft, Matron Specialist Acute Care for Older People 
Leeds Teaching Hospital Trust c/o Ground Floor, Old Trust Headquarters, Leeds 
General Infirmary, Great George Street, Leeds LS1 3EX  
Tel: 0113 3923641 or mobile 07786250841 
 
Thank you for taking the time to read this information sheet 
Version 1.1 15.5.06 
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Appendix 2: Honorary contract for Leeds Primary Care Trust 
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Appendix 3: Leeds West Research Ethics Committee Approval 
(June 2006) 
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Appendix 4: Leeds Teaching Hospitals NHS Trust R&D 
approval (April 2006) 
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Appendix 5: Leeds PCT (Bradford South & West) R&D approval 
(June 2006) 
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Appendix 6: Leeds West Research Ethics Ammendment 2 
approval (Sept 2008) 
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